LIBRA-linked wallets tied to Kelsier Ventures have fallen from nearly $300 million in tracked holdings in February 2025 to about $2 million, according to blockchain analytics firm Arkham.
Summary
Arkham says Kelsier-linked wallets now hold about $2 million, down from nearly $300 million today. Over 1,000 addresses were originally linked to Hayden Davis and Kelsier Ventures during February 2025. Most of the original wallet value came from LIBRA tokens and extracted USDC and SOL. A U.S. judge dismissed the LIBRA investor class action with prejudice on September 29, 2026. Separate criminal proceedings tied to LIBRA continue in Argentina despite the U.S. civil case dismissal. Arkham said on Oct. 5 that it had identified more than 1,000 addresses belonging to Kelsier Ventures and Hayden Davis when it first published the wallet cluster in February 2025.
At the time, the addresses held close to $300 million, with most of the value coming from LIBRA tokens. Arkham now puts the remaining value across the tracked cluster at approximately $2 million.
ARKHAM FOUND 1,000 KELSIER VENTURES ADDRESSES
In February 2025 we identified over 1,000 addresses belonging to Kelsier Ventures (Hayden Davis). We were the first to publish the full set.
Those addresses held almost $300M at the time, mostly LIBRA coin. They now hold only $2M. pic.twitter.com/dq3eRSeVs2
— Arkham (@arkham) October 5, 2026 The change in wallet value does not by itself show where the difference went. Token prices, transfers between addresses, sales, liquidity movements and changes in Arkham’s tracked holdings can all affect an entity balance. Arkham’s Oct. 5 post did not provide a transaction-by-transaction breakdown explaining the decline.
Kelsier’s LIBRA wallets once held nearly $300 million Arkham first reported the Kelsier wallet cluster on Feb. 19, 2025, five days after LIBRA launched.
Its original analysis divided the identified addresses between a LIBRA entity containing wallets tied to the token and a separate Kelsier Ventures entity for addresses not directly associated with the project.
Across both groups, Arkham valued the holdings at nearly $300 million. Most of the amount consisted of LIBRA, while approximately $100 million was held in USDC and SOL that Arkham said had been removed from LIBRA liquidity pools.
Arkham described itself at the time as the first blockchain analytics service to publish the full set of more than 1,000 linked addresses.
The company identified Davis as the person behind Kelsier Ventures. A recent U.S. federal court opinion describes Kelsier Labs LLC, doing business as Kelsier Ventures, as a family-run firm incorporated under Texas law in 2021, with Hayden Davis serving as chief executive.
LIBRA launched on Solana on Feb. 14, 2025. Argentine President Javier Milei posted the token contract and promoted the accompanying Viva La Libertad project shortly after launch, according to the subsequent federal court record.
Investor demand pushed the token sharply higher before its price collapsed within hours. Milei later removed his post and said he had not been aware of the project’s details.
As previously reported, LIBRA reached a multibillion-dollar valuation before collapsing shortly after Milei’s post. Davis later acknowledged that he controlled funds connected to the project while denying that LIBRA was intended as a scam.
U.S. LIBRA lawsuit was dismissed days before Arkham update Arkham’s latest wallet disclosure comes less than a week after a major U.S. civil case involving Kelsier Ventures ended.
U.S. District Judge Jennifer L. Rochon ruled on Sept. 29 that the amended investor complaint against Kelsier, Davis family members, former Meteora CEO Benjamin Chow and other defendants could not proceed.
The case, Hurlock v. Kelsier Ventures, had accused the defendants of fraud, conspiracy, violations of the Racketeer Influenced and Corrupt Organizations Act, New York consumer law violations and unjust enrichment.
For Kelsier and the Davis defendants, the judge dismissed the RICO counts for failure to state a claim. Other claims against them were dismissed because the court found it lacked personal jurisdiction.
Claims against Chow were dismissed for failure to state a claim, while Dynamic Labs secured dismissal of claims brought against Meteora.
Rochon denied the plaintiffs’ request to file a second amended complaint and dismissed the case with prejudice, directing the clerk to close it. LIBRA class action was dismissed after the court rejected the plaintiffs’ RICO and fraud theories.
The ruling did not amount to a judicial finding that every disputed event around LIBRA’s launch did or did not happen. The court decided whether the plaintiffs’ allegations met the legal and jurisdictional requirements needed for their claims to continue.
The original class action had been filed in New York state court in March 2025 before being removed to federal court in May.
Frozen LIBRA-linked funds became part of the legal fight Wallet tracing played a role in the LIBRA litigation long before Arkham published its latest $2 million figure.
In May 2025, Circle froze approximately $57 million in USDC held in addresses tied to the dispute after a U.S. court order.
Crypto.news previously covered the $57 million USDC freeze tied to the LIBRA case, which applied to two addresses while investors pursued claims against Kelsier and related defendants.
The New York federal court later lifted its asset restraints in 2025. The Sept. 29, 2026 dismissal subsequently closed the underlying U.S. class action.
The current $2 million Arkham figure should not be read as a direct comparison with only the assets once frozen by the court. Arkham’s entity cluster covers a much larger set of addresses identified as connected to Kelsier Ventures and LIBRA.
Its February 2025 estimate included LIBRA tokens, stablecoins, SOL and other assets spread across more than 1,000 addresses.
Arkham’s Oct. 5 post does not say that $298 million was transferred out of the wallets in cash terms, nor does it identify the balance change as realized profit, investor recovery or seized funds.
Argentina’s LIBRA investigation remains separate The end of the U.S. civil lawsuit has not closed the separate criminal investigation in Argentina.
Argentina’s federal prosecutor’s office said in March that federal prosecutor Eduardo Taiano remained in charge of the investigation and was continuing work on evidence connected to LIBRA.
Prosecutors have been examining the circumstances surrounding the token’s creation and launch, including possible fraud, influence trafficking, bribery and abuse of authority.
Digital assets have already been frozen as part of that inquiry. In August 2025, prosecutors announced that an Argentine federal judge ordered the freezing of 323,275 USDT held across two addresses identified during the investigation.
Prosecutors said those addresses had received funds from a multisignature wallet examined in the case. Investigators linked activity in that wallet to the period between December 2024 and February 2025.
A separate prosecution request had sought to freeze nearly 44.6 million USDC connected to the inquiry before the U.S. court froze related stablecoin addresses in May 2025.
The Argentine prosecutor’s office said its technical investigation included analysis of electronic devices seized during the case. A final forensic report was delivered to prosecutors in January 2026 and added to the judicial case-management system in February.
The Sept. 29 U.S. ruling does not resolve those Argentine proceedings.
Arkham continues tracking the remaining Kelsier wallets Arkham’s public entity page continues to group wallets it attributes to Kelsier Ventures, allowing changes in token holdings and transfers to be monitored on-chain.
The analytics company has not said in its latest update that the approximately $2 million still visible represents all assets controlled by Davis or Kelsier Ventures outside the addresses it has identified.
Its February 2025 research was similarly limited to wallets Arkham had attributed to the entity.
Earlier reporting around LIBRA showed why attribution can change as investigators connect additional addresses. Blockchain researchers including Arkham, Nansen and other analytics firms spent months tracing wallets tied to the launch, liquidity pools and subsequent token movements.
Nansen tracked large profits and losses among LIBRA traders after the token’s rapid collapse, while separate investigations focused on early wallets and liquidity providers.
Arkham’s latest update leaves the identified Kelsier cluster at roughly $2 million compared with nearly $300 million when the firm first disclosed the addresses in February 2025.
Gate Europe získala autorizaci podle MiCA před koncem přechodného období a prostřednictvím passportingu v rámci EHP rozšiřuje služby v Evropě. Mezi 16. červnem a 22. zářím přidala nejméně 68 spotových párů.
PANews reported on October 5, citing U.Today, that as the EU MiCA transition period ended on July 1, obtaining MiCA authorization has become an important foundation for crypto trading platforms to continue serving European users. Gate Europe obtained MiCA authorization before the end of the transition period and is expanding related services through the European Economic Area passporting mechanism. Gate data shows that between June 16 and September 22, the platform added at least 68 spot trading pairs, now covering approximately 190 assets and 382 trading pairs.
Citing CASP Tracker data, the article noted that as of September 28, 84 of the world's 100 largest crypto trading platforms still had not obtained MiCA authorization. Meanwhile, Gate Europe passed the PCI DSS v4.0.1 Level 1 compliance assessment on September 15, covering Gate Connect and Gate Card. Gate Europe CEO Dr. Giovanni Cunti said that security and compliance are key to building trusted payment services in Europe, and passing PCI DSS certification is an important step in strengthening payment infrastructure.
In terms of liquidity, Gate data shows that between September 14 and 27, the order book depth within 0.1% of the mid-price for BTC/USDC and ETH/USDC increased by approximately 14% and 12% respectively, reaching $1.32 million and $555,000. Meanwhile, DefiLlama MiCA exchange data shows that Gate Europe's spot market depth within 2% of the mid-price reached $15.9 million, higher than other platforms during the same period. Building on the compliance foundation established by its dual MiCA and Payment Institution (PI) licenses, Gate Europe will continue to improve asset coverage and liquidity building, providing European users with richer digital asset trading options and a better trading experience.
According to the official announcement, the on-chain burn of GateToken (GT) for Q3 2026 has been successfully completed. A total of 1,987,321.2431520 GT has been transferred to the burn address, with a total burn value exceeding $22.35 million.
On-chain transaction details can be viewed at: https://etherscan.io/tx/0x4d0e1a6c996f1e9720a1b87f9d12999eee65f0ee83c7f61456fc5992b03cb5e2
Key Details of This Burn:
Burned amount this round: 1,987,321.2431520 GT Burn value this round: over $22.35 million Total burned to date: 191,934,541 GT Total burned value: over $1.504 billion (calculated based on the quarterly average price) GT is the core platform token of Gate and the native asset of Gate Chain. As the utility token and gas fee token on Gate Chain, GT plays a fundamental role in powering the network’s core transfer infrastructure. Since the Gate Chain mainnet launch in 2019, GT has implemented a sustained deflationary mechanism. The total token supply has been significantly reduced from its initial 300 million, with an overall reduction of approximately 63.98%.
As Gate continues to expand its platform, its ecosystem is extending beyond digital asset trading into a broader range of Web3 applications. Gate now serves more than 61 million users globally and supports over 5,300 crypto assets alongside 12,800+ stocks and ETFs, while continuing to strengthen infrastructure such as Gate Chain and Gate Layer. Across on-chain trading, asset issuance, and application development, products including Gate Perp DEX, Gate Fun, and Gate Meme Go are being rolled out, while AI products such as Gate.AI and Gate for AI Agent are driving more intelligent applications into the Web3 ecosystem.
Amid this development, the fundamentals supporting GT are also continuing to strengthen. The growth of Gate’s user base, product ecosystem, and on-chain applications is creating broader real-world utility for GT, while the ongoing token burn mechanism further optimizes its supply structure. As a result, GT’s long-term development is becoming more closely linked to the overall growth of the Gate ecosystem and its deflationary process, with its underlying value support gradually extending beyond platform benefits to broader ecosystem development.
In terms of market performance, GT has maintained strong upward momentum recently. Data shows that GT has gained 32.49% over the past 30 days and 63.63% over the past 90 days, demonstrating robust market performance. As the ecosystem continues to expand and the burn mechanism continues to advance, GT’s market attention and foundation for long-term value have also been further strengthened.
Looking ahead, Gate will continue to advance innovation in Web3 infrastructure and ecosystem applications, expand the real-world utility of GT across on-chain trading, network interactions, and other use cases, and remain committed to implementing the GT burn mechanism to further optimize the token’s supply structure. By advancing ecosystem expansion and deflationary mechanisms in tandem, Gate will further strengthen the utility foundation of GT, provide users with richer ways to participate in Web3, and build stronger support for GT’s long-term development.
Read the Full Report here.
About GateGate, founded in 2013 by Dr. Han, is one of the world’s leading cryptocurrency and integrated financial services platforms. Serving over 61 million users globally, it supports trading across 5,300+ digital assets and 12,800+ stock assets, while providing access to a comprehensive range of TradFi assets, including metals, stocks, indices, forex, and commodities, delivering users a one-stop, multi-asset trading experience and blockchain-related services. As an industry benchmark, Gate was among the first platforms to implement 100% Proof of Reserves. Its ecosystem includes Gate Wallet, Gate Ventures, Gate for AI Agent, and a wide range of products and services.
For more information, please visit: Website | X | Telegram | LinkedIn | Instagram | YouTube
Disclaimer:This content does not constitute an offer, solicitation, or recommendation. You should always seek independent professional advice before making investment decisions. Note that Gate may restrict or prohibit certain services in specific jurisdictions. For more information, please read the User Agreement.
Disclaimer
BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
Měnový pár EUR/USD klesl na 1,1160, nejníže od května 2025, kvůli francouzskému fiskálnímu a politickému riziku. Klíčová hranice 1,1185 zatím nebyla potvrzeně proražena.
French Risk Has Brought the Euro to the Line; 1.1185 Decides Whether the Downtrend Accelerates What’s happening: EUR/USD fell to around 1.1160, its lowest since May 2025, before recovering to 1.12. French fiscal and political risk is the dominant Euro-specific pressure, while Spain’s snap election on November 29 has added a headline without comparable market stress. The pair pierced the 1.1185 Fibonacci projection but has not yet confirmed a break, even though Fed hike expectations have eased and French bond yields have stabilized somewhat.
Why it matters: Neither interest-rate differentials nor a generalized Eurozone panic explain the move; it is French-specific risk with broader Euro implications. A decisive loss of 1.1185 would strengthen the case that the decline from 1.2081 is developing into an impulsive medium-term downtrend, with the current leg from 1.1710 potentially entering its strongest phase. The next move around 1.1185 will determine whether the bearish trend is solidified and begins to accelerate.
EUR/USD has reached a point where today’s political headlines matter less for the size of the immediate move than for what could come next. The pair fell to around 1.1160, its lowest since May 2025, before recovering to 1.12. French fiscal and political risk remains the dominant Euro-specific pressure, while Spain’s snap election adds another headline without yet producing comparable market stress. France is identified as the main drag as EUR/USD hit a 17-month low, while Spanish equities largely shrugged off Prime Minister Pedro Sánchez’s call for a November 29 election.
The more important development is technical. EUR/USD has pierced 1.1185, the 100% projection of 1.1848 to 1.1323 from 1.1710, but has not yet confirmed a break. A decisive loss of that level would strengthen the case that the decline from 1.2081 is developing into an impulsive medium-term downtrend, with the current leg from 1.1710 potentially entering its strongest phase. In that sense, French political risk has brought the Euro to the line; the next move around 1.1185 will determine whether the broader bearish trend is solidified and begins to accelerate.
France Is the Core Risk, Spain Is Secondary Europe has two political stories today, but markets are not treating them equally.
France Fiscal Snapshot OAT-Bund spread: pushed above 100bp during September OAT-Bund spread: briefly above 150bp on Friday, before retreating France’s debt: around 119% of GDP France’s deficit: roughly 5.4%, which the government is trying to reduce through its 2027 budget In France, the repricing has been building for weeks. The OAT-Bund spread pushed above 100bp during September and surged to levels last seen during the Eurozone sovereign debt crisis period. The spread was briefly above 150bp on Friday, before retreating, as investors focused on France’s fiscal position and the difficulty of repairing it through a fragmented parliament ahead of the 2027 presidential election.
The fiscal backdrop explains why the political uncertainty carries market weight. Prime Minister Sébastien Lecornu’s government has proposed a combination of tax increases and spending restraint, but the legislation still faces a difficult parliamentary process.
The key point is that this is no longer simply a generic global bond-market selloff. France has developed its own risk premium. The widening relative to Germany—and the fact that French sovereign stress has at times exceeded Italy’s—shows investors differentiating between Eurozone credits rather than selling the bloc indiscriminately.
Spain is different.
Prime Minister Pedro Sánchez called an early election for November 29 after parliament rejected key housing measures, adding another layer of political uncertainty to Europe. But the market reaction has so far been restrained. Spanish equities remained positive on the day, while investors saw limited reason to worry about Spain’s finances given comparatively solid growth.
France vs Spain: How Markets Are Treating Each France Spain Political trigger Fragmented parliament and a difficult 2027 budget process Snap election on November 29 after parliament rejected key housing measures Fiscal backdrop Debt around 119% of GDP; deficit roughly 5.4% Limited reason to worry about finances given comparatively solid growth Market reaction OAT-Bund spread briefly above 150bp on Friday; CAC 40 underperforming Spanish equities positive on the day The distinction is simple:
France is being priced. Spain is being watched.
Bonds Stabilize, but Euro Keeps Falling That distinction also helps explain today’s cross-asset pattern.
French bonds opened under renewed pressure, but yields subsequently eased from their early levels and remained below last week’s peak. The OAT-Bund spread also pulled back from Friday’s extreme rather than extending immediately higher. That is important because today is not another acceleration of the bond shock.
Cross-Asset Moves EUR/USD: fresh 17-month low CAC 40: fell, underperforming the major European equity indices STOXX 600: advanced Spanish equities: gained DAX, FTSE and Ibex: firmer Instead, the incremental pressure is showing more clearly elsewhere. EUR/USD made a fresh 17-month low, while the CAC 40 underperformed the major European equity indices. Paris shares fell while the broader STOXX 600 advanced and Spanish equities gained.
The FX heat map adds another useful clue. The Euro is broadly weak against the Dollar, Sterling, Canadian Dollar and Australian Dollar, but there is no comparable cross-market surge into every traditional haven. That argues against treating today as a generalized systemic risk event.
French sovereign stress remains serious, but the immediate move looks more like a Euro-specific risk premium being expressed through the currency and French equities while the bond market pauses after last week’s repricing.
The Rate Story Alone Does Not Explain EUR/USD The usual interest-rate explanation is also incomplete.
Fed expectations have become less aggressive at the very front end after softer US labor data, with October hike probability sharply reduced. Normally, that should remove at least some Dollar support. Yet EUR/USD is still making new lows.
That suggests the Euro side of the equation matters increasingly. French fiscal uncertainty, fragmented sovereign pricing inside the monetary union, weak confidence around the durability of the regional recovery and elevated energy costs are creating a risk premium that ordinary rate-differential analysis does not fully capture.
This is particularly important because today’s Euro weakness is occurring even as French yields themselves stabilize somewhat. The market is no longer simply demanding a larger premium to hold OATs; the political and fiscal uncertainty is also being reflected in the currency.
That does not mean the bond problem has disappeared. It means today’s incremental repricing is being expressed more visibly elsewhere.
Why This Is Not Yet a Eurozone Panic There are several reasons not to overstate the move.
Four Reasons Not to Overstate It French yields are below last week’s extreme rather than accelerating through it. Spanish bonds and equities are not showing the same degree of stress. If France’s problems were rapidly becoming a broader Eurozone sovereign event, Spain and Italy would be expected to begin moving much more aggressively alongside it. Broader European equities are not collapsing. The CAC is the outlier, while DAX, FTSE and Ibex have been firmer. The currency heat map does not show the sort of uniform rush into defensive currencies associated with acute systemic stress. The right description is therefore French-specific risk with broader Euro implications, not contagion.
That distinction could change if the OAT-Bund spread drives decisively back through last week’s extremes while Bunds rally and peripheral spreads begin widening together. But that is not the configuration today.
French Bond Spread, Budget and Spain: What Could Change the Picture The first test remains the French bond spread. Another sustained move above the 140–150bp area, particularly if accompanied by renewed demand for Bunds and widening in Spain and Italy, would indicate that the stress is broadening rather than merely consolidating.
The second is the French budget process. Markets need evidence that the 2027 fiscal package can survive a fragmented parliament and produce a credible path toward stabilizing the debt burden. France’s proposed measures are substantial, but parliamentary amendments are expected and implementation remains central to the credibility question.
Spain’s November 29 election is a secondary political catalyst, but the more immediate question is whether Spanish assets continue to distinguish themselves from France.
For EUR/USD, however, the most important signal may arrive before any of those political events. It is already sitting on the level that can decide whether the existing decline becomes something materially larger.
EUR/USD Technical Outlook: 1.1185 Is the Decision Point EUR/USD is testing 1.1185, the 100% projection of the decline from 1.1848 to 1.1323, projected from 1.1710.
Today’s 1.1160 low pierced that level intraday, but EUR/USD recovered back above it. That makes the current setup a warning rather than a confirmed breakdown.
A decisive daily close below 1.1185 would materially change the technical picture. The decline from 1.2081 could then increasingly be interpreted as an impulsive sequence:
1.2081 to 1.1408, rebound to 1.1848, fall to 1.1323, rebound to 1.1710, followed by the current decline. That is, a 1-2-i-ii.
Under that count, the fall from 1.1710 would represent the potentially powerful wave iii of the developing bearish sequence.
Key EUR/USD Levels Level Significance 1.1710 A break above invalidates the impulsive count 1.1323 First critical resistance on any recovery; a sustained recovery above it would weaken the immediate impulsive count 1.1185 100% projection of 1.1848 to 1.1323 from 1.1710; the decision point 1.0904 Larger 61.8% retracement 1.0861 161.8% projection, the next major downside projection, close to the 61.8% retracement 1.0759 Next projection below the 1.0861–1.0904 zone The next major projection would be 1.0861, the 161.8% projection. That sits close to the larger 61.8% retracement around 1.0904, creating a significant downside target zone. Below there, the next projection lies around 1.0759.
The larger implication is more important still. A confirmed impulsive fall from 1.2081 would strengthen the case that EUR/USD has begun reversing the entire three-wave corrective rise from the 0.9534 low of 2022. That would represent a meaningful medium-term trend change rather than merely another pullback inside the previous recovery.
For now, however, that conclusion is premature. Daily RSI is already deeply oversold, and EUR/USD has recovered from below 1.1185 intraday. A daily close beneath the level is the first confirmation; a weekly close below 1.1185 would carry considerably more weight.
On any recovery, 1.1323 has become the first critical resistance. As long as that former support holds as resistance, downside risk remains dominant. A sustained recovery above 1.1323 would weaken the immediate impulsive count, while a break above 1.1710 would invalidate it.
French political risk has helped drive EUR/USD to this point. Whether 1.1185 now gives way will determine whether the Euro’s medium-term decline merely continues—or begins to accelerate.
Related Coverage Europe: Data and Sentiment Eurozone Sentix Slips as Expectations Fall, France Replaces Germany as the Main Concern: investor sentiment data pointing to the same geographic shift in worry that is driving the Euro-specific risk premium. Eurozone PMI Hits 41-Month High as Growth Broadens and Price Pressures Reheat: September growth at a 41-month high, but with stronger selling prices and backlogs that make the release notably more hawkish. Eurozone PPI Re-Accelerates as Energy Shock Spills Into Broader Producer Costs: August producer inflation re-accelerated, with stronger ex-energy prices suggesting pipeline pressure is broadening beyond energy. UK Composite PMI Falls to 52.0 as Growth Slows and Costs Rise: services still expanding but with slower new orders, falling employment and higher fuel and payroll costs. Gold, Yen and Asia-Pacific Gold: Fed Hike Delay Isn’t Relief, FOMC Minutes Put the Rate Plateau to the Test: the Gold angle on collapsed October hike odds, with Wednesday’s FOMC minutes testing the extended tightening path priced into 2027. Nikkei Eyes Record High, But Four Forces Stand Between USD/JPY and 164: why this equity breakout may not repeat the last run in USD/JPY, with 160 now inside a tougher resistance zone. BoJ Uchida: AI’s Demand Shock Has Arrived Before Its Productivity Payoff: the BoJ Deputy Governor on AI’s first macro impact arriving through demand, prices and easier financial conditions. Japan PMI Growth Slows, But Hiring and Price Pressures Stay Firm: a weaker services headline, but with faster hiring, rising backlogs and exceptionally strong selling-price inflation underneath. Australia PMI Services Falls to 51.9 as Growth Slows and Price Pressures Rise: softer activity and falling employment paired with faster input and output-price growth. FAQ Why is EUR/USD making new lows when Fed hike expectations have eased? Fed expectations have become less aggressive at the front end after softer US labor data, which should normally remove some Dollar support. Yet EUR/USD fell to around 1.1160, its lowest since May 2025. French fiscal uncertainty, fragmented sovereign pricing inside the monetary union, weak confidence in the regional recovery and elevated energy costs are creating a risk premium that rate-differential analysis does not fully capture, and that premium is now also being reflected in the currency.
Is France’s bond stress turning into a Eurozone panic? Not yet. French yields and the OAT-Bund spread have pulled back from last week’s extremes, Spanish bonds and equities are not showing the same stress, broader European equities are not collapsing and the currency heat map shows no uniform rush into defensive currencies. The better description is French-specific risk with broader Euro implications, not contagion. That could change if the OAT-Bund spread drives decisively back through last week’s extremes while Bunds rally and peripheral spreads begin widening together.
What would a break below 1.1185 mean for EUR/USD? 1.1185 is the 100% projection of 1.1848 to 1.1323 from 1.1710, and EUR/USD pierced it intraday without confirming a break. A decisive daily close below it would support reading the decline from 1.2081 as an impulsive sequence, with the fall from 1.1710 as a potentially powerful wave iii. The next projection is 1.0861, close to the 61.8% retracement around 1.0904, with 1.0759 below that. A weekly close below 1.1185 would carry considerably more weight, while a break above 1.1710 would invalidate the count.
Key Takeaways EUR/USD fell to around 1.1160, its lowest since May 2025, before recovering to 1.12, with French fiscal and political risk as the dominant Euro-specific pressure. France is being priced and Spain is being watched: the OAT-Bund spread was briefly above 150bp on Friday and French debt is around 119% of GDP, while Spain’s November 29 election drew a restrained market reaction. Today is not another acceleration of the bond shock: yields and the spread pulled back, and the pressure is showing more clearly in EUR/USD and the CAC 40. Rates do not explain the move: Fed expectations have become less aggressive, yet EUR/USD is still making new lows. This is French-specific risk with broader Euro implications, not contagion, though that could change if the spread breaks back through last week’s extremes while peripheral spreads widen with it. EUR/USD pierced 1.1185 but has not confirmed a break; a decisive daily close below would strengthen the impulsive count, and a weekly close below would carry considerably more weight. Below 1.1185 the next projection is 1.0861, near the 61.8% retracement around 1.0904, then 1.0759; 1.1323 is first resistance and a break above 1.1710 would invalidate the count. What to Watch Next For EUR/USD, the decision point is 1.1185: a daily close below is the first confirmation and a weekly close below would carry considerably more weight, while 1.1323 is the first resistance on any recovery. On the political side, watch whether the French bond spread makes another sustained move above the 140–150bp area, how the 2027 budget fares in a fragmented parliament, and whether Spanish assets keep distinguishing themselves from France ahead of the November 29 election.
SUI dnes vzrostl o 4,43 % na 1,23 USD, zatímco trh sleduje rezistenci na 1,27 USD. Mysten Labs staví Sui na globálních platbách, stablecoinech a AI transakcích.
Sui price has climbed 4.43% to $1.23 as Mysten Labs co-founder Adeniyi Abiodun outlined a strategy centered on global payments, stablecoins and AI-agent transactions, while traders watch $1.27 as the next technical hurdle.
Summary
SUI rose 4.43% to $1.23 today as traders watched $1.27 for potential bullish breakout confirmation. Sui has processed more than $1 trillion in stablecoin transfers since August 2025, foundation says. Google lists Mysten Labs among collaborators behind AP2, its open protocol for AI-driven payments systems. USDsui launched in March through Stripe-owned Bridge, giving Sui a native dollar for payments applications. Analysts see $1.27 as immediate resistance, while a $2 target remains conditional on breakout confirmation. Wu Blockchain published the interview on Oct. 5, with Abiodun arguing that Sui should be viewed as payment infrastructure capable of moving money globally instead of simply another Layer 1 blockchain.
CoinGecko data showed SUI near $1.23 during the session, with a market value close to $5 billion and roughly $878 million in 24-hour trading volume. The token had traded between approximately $1.17 and $1.26 during the day.
Abiodun said Sui’s long-term ambition was to compete with traditional payment infrastructure, going as far as saying its goal over the next several years is to “replace SWIFT.” The statement represents Mysten Labs’ long-term view and does not amount to a forecast that Sui will displace the global bank messaging network.
Sui price is closing in on the $1.27 level On the weekly chart, SUI is trading above the upper Bollinger Band near $1.19, while the 20-week middle band sits around $0.83 and the lower band near $0.46.
Price moving above the upper band shows stronger upside momentum compared with its recent weekly range, though it leaves SUI extended above its 20-week average. The immediate $1.19-$1.25 area remains important because SUI is testing the upper band and recent weekly highs.
Sui price chart, source: TradingView The Relative Strength Index stands at 58.71, above its signal average near 44.19. RSI has recovered above the neutral 50 level but remains below the commonly watched overbought threshold of 70.
Crypto analyst Ali Martinez said on Oct. 2 that SUI had repeatedly formed parallel consolidation channels before breaking higher since Sept. 12. He identified $1.27 as the next level to watch, saying an hourly close above it “could confirm another bullish breakout.”
Price has since moved closer to that threshold without clearly breaking it. CoinGecko showed the token reaching a 24-hour high near $1.26, leaving Martinez’s $1.27 trigger just above the current market.
A second analyst, Celal Kucuker, said a bull flag was approaching resistance. He argued that a break of the pattern during October could bring $2 into view.
$SUI
The bull flag is getting close to a breakout.
If the red resistance line breaks this month, $2 could come quickly.
In a bull market, $10+ looks technically very achievable from here. pic.twitter.com/7TpnoTLCw4
— Celal Kucuker (@CelalKucuker) October 4, 2026 Kucuker’s longer-term call for prices above $10 was explicitly tied to a future bull-market scenario. It remains an analyst projection, not a confirmed target supported by current price action.
For now, $1.27 is the closer test. A sustained move above it would place SUI beyond the level Martinez identified, while a return below roughly $1.19 would move price back inside the weekly Bollinger Band.
Stablecoins are becoming central to Sui’s payment push Abiodun described stablecoins as one of the strongest current uses for blockchain payments because they can operate continuously and settle outside conventional banking hours.
Sui Foundation said in May that the network had processed more than $1 trillion in stablecoin transfer volume since August 2025. The same update introduced gasless transfers for supported stablecoins, allowing qualifying peer-to-peer transactions to execute without users holding SUI for gas.
The feature initially covered assets including USDsui, USDC, SuiUSDe, AUSD, FDUSD, USDB and USDY. Sui’s documentation says eligible transfers can use a zero gas price and budget when they meet the network’s allowlist requirements.
USDsui gives the network its own native dollar asset. Sui Foundation announced its mainnet launch on March 4 through Bridge, the stablecoin infrastructure company owned by Stripe. The token was built for payments, decentralized finance and cross-border transactions.
As previously reported, Sui’s USDsui launch brought a native stablecoin to its payment and DeFi ecosystem after the network processed more than $111 billion in stablecoin transfers during January alone.
Abiodun said USDsui had reached roughly $75 million and named stablecoin liquidity as one metric Mysten Labs will watch when measuring future network adoption.
Recent integrations have extended the payment strategy beyond DeFi. Daya integrated Sui as settlement infrastructure in September, using gasless stablecoin transfers across products serving businesses and developers in Nigeria. The company plans to expand into South Africa, Ghana and Kenya.
RedotPay provides another payment connection, though its official April announcement is narrower than the translated interview suggested. Sui Foundation said RedotPay added support for SUI and native USDC on Sui, giving users access to assets through a payment network that supports Apple Pay and Google Pay. The official release does not identify USDsui as part of that initial integration.
AI agents form the second part of Sui’s strategy Abiodun expects AI agents to become a major source of blockchain transactions as software begins making payments, purchasing services and moving funds without a person manually initiating every transfer.
His view has some support from Sui’s work with Google. Google announced the Agent Payments Protocol, or AP2, in September 2025 and listed Mysten Labs among more than 60 payments and technology organizations helping develop the open standard.
AP2 is designed to let AI agents initiate payments under verifiable user authorization across different payment systems. Google’s list includes companies such as Mastercard, PayPal, Coinbase, Revolut and Worldpay alongside Mysten Labs.
Sui joined Google’s AP2 effort around programmable payments for AI agents, placing the blockchain among projects testing how autonomous software could interact with digital money.
Sui’s current AI infrastructure combines several products. Walrus handles decentralized storage, Seal manages programmable access controls and Nautilus supports verifiable computing, while Sui coordinates transactions and policies on-chain.
Abiodun argued that such tools could help AI systems prove where information came from and whether it was changed before an agent makes a decision or payment.
Sui tested that type of automated activity in July through programmable tunnels. The foundation reported a peak of 6,086,766 transactions per second during a public experiment involving AI agents, games, payments and chat. The result came from off-chain programmable channels that settle back to Sui mainnet, not normal base-layer transaction throughput.
Sui still faces a gap between payments growth and DeFi TVL Abiodun acknowledged the decline in Sui’s total value locked during the interview while arguing that stablecoin use, institutional integrations and network activity deserve attention alongside TVL.
Current DefiLlama data place Sui DeFi TVL near $550 million, with stablecoin market capitalization close to $482 million. The tracker recorded roughly 25.3 million network transactions over the latest 24-hour period.
The interview referenced a previous TVL level of approximately $4 billion before a decline toward $1 billion. The $4 billion figure could not be matched to the current DefiLlama dataset reviewed for this report, so it remains attributed to the interview.
Governance remains another part of Sui’s recent history. After the $223 million Cetus exploit in May 2025, validators coordinated around frozen attacker funds and later voted on a protocol upgrade to recover them.
Sui Foundation reported that validators representing 90.9% of stake supported the recovery proposal, with the foundation’s stake excluded from the vote. Approved funds were moved to a multisignature wallet for return under Cetus’ recovery plan.
Abiodun said Mysten Labs and the Sui Foundation cannot independently order validators to freeze addresses, describing such actions as decisions that require validator coordination.
Price traders are now watching a much shorter-term question. SUI is sitting near $1.23 after its latest gain, while the weekly RSI remains below overbought territory and $1.27 stands just above the current trading range.
Martinez’s setup requires an hourly close above $1.27 before his proposed breakout is confirmed. Kucuker’s $2 scenario requires a separate bull-flag resistance break during October, while his $10-plus forecast depends on the much less certain condition of a future bull market.
Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.
Společnost Snap-on za poslední tři měsíce klesla o 10,26 %, i když Tigress Financial zvýšila cílovou cenu na 485 USD a potvrdila doporučení Buy. Analytik očekává 31,5% potenciál růstu během 12 měsíců.
A top Wall Street analyst just raised his price target on this Dividend Aristocrat even as the stock keeps sliding, and his reasoning centers on a business segment most investors are overlooking entirely.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Snap-on (NYSE:SNA | SNA Price Prediction) trades at $368.82. The average price target among analysts is $416.56, which leaves 12.9% of implied upside.
Snap-on makes premium tools, diagnostics and equipment for auto technicians and industrial customers, selling through a franchise van network and financing purchases via its own credit arm. It is a Dividend Aristocrat that recently raised its quarterly payout to $2.44 from $2.14.
The most optimistic analyst is far more bullish than the average. Ivan Feinseth of Tigress Financial Partners has the highest target on the Street at $485, raised from $445, with a reiterated Buy. That target implies 31.5% upside, well above the consensus.
A Strong Second Quarter Still Led to a 10% Slide Over three months the stock fell 10.26%, from $411.07 to $368.90, after trading near its 52-week high of $420.41. Shares were at $406.17 when second-quarter results came out. The headline numbers were good. EPS was $4.96 against a $4.9531 estimate, revenue beat by 9.42%, and gross margin rose to 51.4% from 50.5%.
Weakness appeared in the details. Financial Services originations dropped 4.1%. Tools Group operating margin slid to 22.6% from 23.8%, and Repair Systems margin fell to 24% from 25.6% as OEM dealerships pulled back. Management noted technicians are “cash rich” but “confidence poor,” avoiding large financed purchases like tool storage. Snap-on’s franchise model depends on credit-funded buying.
Shares now sit below both the 50-day average of $390.18 and the 200-day average of $379.38.
What Tigress Sees That the Market Is Ignoring Tigress says demand from technicians holds up, pricing power protects margins, and high-margin diagnostic software is growing. Commercial & Industrial organic sales rose 11.0%, with operating margin expanding 330 bps to 16.8%. Management noted a data center business that is “heating up now.”
Two acquisitions add to that story. Hi-Force expands the torque business, and Diesel Laptops brings Snap-on’s diagnostics model to trucks. Snap-on paid $99.1 million for Diesel Laptops, and management called the deal EPS accretive.
Overall, analysts are split. Of 11 analysts, three rate it Strong Buy, two Buy, five Hold and one Strong Sell. Tigress’s raise is the key recent move, and its timeframe is 12 months.
Tool Peers Slipped Too, but Snap-on Lagged the Leader Tool peers weakened over the past month, but Snap-on started from a smaller year-to-date gain.
Stanley Black & Decker (NYSE:SWK) lost 4.88% over the month but is still up 26.78% this year. At $91.34 against a $101.09 target, it offers 10.7% implied upside. Analysts mostly rate it Hold, with four Buy and 11 Hold ratings. Analysts see less upside there than at Snap-on.
Illinois Tool Works (NYSE:ITW) fell 3.51% in the past week and is up 8.77% this year. At $262.90 against a $300.64 target, it offers 14.4% upside. Analysts are more bearish on it, with four Sell or Strong Sell ratings out of 16.
On consensus targets, Illinois Tool Works has the most upside. Snap-on stands out only because of the Tigress target, which is an estimate and not guaranteed.
A Dividend Aristocrat Trailing the S&P 500 at 17x Forward Earnings At $368.82, Snap-on trades 12.9% below the 11-analyst consensus of $416.56. This year the stock is up 9.12%, while the S&P 500 is up 12.86%. Over the past month, Snap-on fell 3.07% and the index rose 0.59%.
The valuation is modest. Shares trade at 19x trailing earnings and 17x forward earnings, compared with 22x forward for Illinois Tool Works. The $9.76 annual dividend yields 2.57%.
Snap-on’s Rebound Hinges on Technician Confidence Returning The bull case strengthens if originations steady and the shift toward quick-payback products keeps raising volumes, while Commercial & Industrial margins hold near 16.8%. In that case, earnings growth plus a rising dividend gives the stock a credible path back above $416. The bear case gains weight if technicians stay “confidence poor” and keep avoiding financed purchases. Credit-funded buying is the core of Snap-on’s model, and OEM dealership weakness would keep weighing on Repair Systems margins.
The outlook leans positive, though with limited expectations. At 17x forward earnings, Snap-on trades below Illinois Tool Works’ 22x. The consensus target is a reasonable 12-month goal. Getting to Tigress’s $485 would require a turn in technician view, and so far there is little evidence of one.
Contact [email protected] for any questions or corrections.
Company has provided four rounds of bill credits while continuing investments in PFAS treatment and water quality improvements across Indiana
, /PRNewswire/ -- Indiana American Water announced that it is providing a fourth bill credit to customers this month following the company's receipt of proceeds from settlements reached with manufacturers of per- and polyfluoroalkyl substances (PFAS). With this latest credit, Indiana American Water will have returned a total of over $25.5 million to customers statewide of PFAS settlement distributions.
Since November 2025, eligible water customers will have received nearly $75 per account in PFAS settlement credits. For the average residential customer, that amount exceeds the cost of a typical monthly water bill, based on average usage of 4,000 gallons per month and an average monthly bill of approximately $55.
Credit
Timing
Amount Per Customer
First Credit
November 2025
$13.20
Second Credit
January 2026
$39.43
Third Credit
July-August 2026
$10.64
Fourth Credit
October 2026
$11.65
Total
$74.92
The credits distribute settlement proceeds Indiana American Water received from PFAS manufacturers through a customer bill credit mechanism approved by the Indiana Utility Regulatory Commission (IURC). This streamlined approach allows settlement funds to be returned quickly, equitably and transparently through automatic bill credits that are applied equally among eligible tariffed water customer accounts. The company plans to continue providing additional bill credits as future settlement payments are received and approved for distribution.
"Indiana American Water remains committed to returning these settlement proceeds directly to our customers while continuing to invest in the long-term protection of safe, clean, reliable and affordable drinking water across Indiana," said Barry Suits, president of Indiana American Water. "These credits provide a direct customer benefit from the settlements, while our company continues making significant investments in monitoring, treatment technologies and infrastructure improvements designed to address contaminants of emerging concern such as PFAS. We believe customers should receive the benefit of these settlement funds as quickly and efficiently as possible."
The credits are not based on whether PFAS has ever been detected in a customer's water supply, and Indiana American Water remains committed to meeting all state and federal drinking water standards while proactively addressing evolving PFAS regulations.
Indiana American Water has been a leader in PFAS treatment and water quality investments in Indiana. In January 2026, the company announced operation of Indiana's first drinking water treatment system specifically designed to remove PFAS at its Charlestown Water Treatment Plant. The company also has advanced PFAS treatment projects underway in Terre Haute and is evaluating additional treatment investments in other communities as part of its broader strategy to address emerging contaminants and comply with future regulatory requirements.
PFAS are a group of manufactured chemicals that have been used in consumer products and industrial applications for decades. Indiana American Water, along with numerous other water utilities nationwide, participated in multi-district litigation (MDL) proceedings seeking damages from manufacturers of PFAS chemicals. Settlement agreements provide payments over multiple years, allowing utilities to return proceeds to customers as funds are received.
Customers interested in learning more about PFAS, including what these compounds are, how they are regulated and the steps Indiana American Water is taking to address them, can visit the company's PFAS information webpage at Indiana American Water PFAS Information. Customers can also view annual Water Quality Reports for their local community, which provide detailed information about drinking water quality, testing and compliance with state and federal standards.
About American Water
American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886 and celebrating 140 years in 2026, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to approximately 14 million people with regulated operations in 14 states and on 19 military installations. American Water's approximately 7,000 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders. For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.
About Indiana American Water
Indiana American Water, a subsidiary of American Water, is the largest regulated water utility in the state, providing high-quality and reliable water and wastewater services to approximately 1.5 million people.
Leonardo DRS založila DRS UK a spustila místní výrobu taktických radarů ve Spojeném království. Cílí na podporu poptávky po proti-UAS, protivzdušné obraně a aktivní ochraně.
New DRS UK capability will support growing demand for counter-UAS, air defence and active protection system applications | Source: Leonardo DRS, Inc.
ARLINGTON, Va., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Leonardo DRS, Inc. (Nasdaq: DRS) announced the establishment of DRS UK, a new subsidiary created to support the company’s business in the United Kingdom, along with the launch of local production of tactical radars in the UK.
The newly purpose-built production site expands DRS’s manufacturing footprint and creates a dedicated local presence to support UK defence customers, industry partners and system integrators. The company said the investment is intended to strengthen long-term support for UK programmes and provide greater flexibility to meet evolving operational requirements.
DRS tactical radars are designed to detect, track and classify a wide range of airborne and ground threats, including unmanned aircraft systems (UAS) and rockets, artillery and mortars (RAM). The radars support counter-UAS, air defence, force protection and active protection system applications.
DRS said more than 10,000 radar panels have been deployed worldwide with operational service with the United States Armed Forces, NATO allies and other international customers.
“Establishing DRS UK and launching a full local tactical radar capability, strengthens our ability to support customers and partners with the proximity, responsiveness and manufacturing capacity needed to meet evolving operational requirements,” said John Baylouny, president and chief executive officer of Leonardo DRS. “This investment enables closer collaboration with UK industry partners and integrators to deliver counter-UAS, air defence and force protection capabilities that help protect the warfighter.”
“Our investment in UK-based manufacturing for advanced sensing technologies reinforces the industrial capability, supply chain resilience and skilled workforce needed to support critical defence priorities,” said Max Cohen, senior vice president and general manager overseeing DRS’s tactical radar portfolio. “By establishing this local capacity, we are creating high-value engineering and manufacturing opportunities while positioning DRS UK to support future export growth and deliver greater value to customers across the UK and Europe.”
The UK operation will serve as a strategic hub for DRS’s tactical radar business in the UK and Europe, the company said.
About Leonardo DRS
Leonardo DRS, Inc. (Nasdaq: DRS) is at the forefront of developing transformative defense technologies using its proven agility and delivering innovative solutions for U.S. national security customers and allies worldwide. We specialize in rapidly providing high-performance, multi-domain capabilities across next-generation advanced sensing, network computing, force protection, and electric power and propulsion. Our reputation as a trusted provider is built on a continuous focus on practical innovation, delivering quality, and meeting our customers’ most demanding mission requirements. For further information on our complete range of capabilities, visit www.LeonardoDRS.com.
Forward-Looking Statements
This communication contains statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Those statements reflect current expectations, assumptions and estimates of future performance and economic conditions. The company cautions investors that any forward-looking statements which include contract values, contract performance and our development and production of products are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters expressed in or implied by such forward-looking statements.
Curaleaf zvýšil nabídku na převzetí Aurora Cannabis na 5,00 USD za akcii, což je o 25 % více než dříve. Nabídka nyní zahrnuje 1,00 USD v hotovosti a 0,4013 akcie Curaleaf.
Increases total implied consideration by 25% to US$5.00 per Aurora Share, representing a premium of 86% to Aurora's Unaffected Share Price
Increases Cash consideration by 33% to US$1.00 per Aurora Share, which represents approximately 20% of the consideration mix
Increases Share Consideration to 0.4013 Curaleaf shares per Aurora Share and increases the Cap Price by 20% to US$6.00 per share
Enhanced proposal developed solely from publicly available information; Curaleaf remains committed to engaging with Aurora in a formal due diligence process and urges Aurora's Board to engage in good faith discussions regarding the Enhanced Offer
Enhanced Offer continues to provide Aurora Shareholders with the opportunity to become owners of the premium global cannabis platform and participate in the significant long-term upside of the combined company
, /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today announced that it will file a Notice of Variation and Change to increase its offer (the "Enhanced Offer") to acquire all of the issued and outstanding common shares (the "Aurora Shares") of Aurora Cannabis Inc. ("Aurora") for consideration consisting of subordinate voting shares of Curaleaf (the "Curaleaf Shares") and cash.
Under the terms of the Enhanced Offer, Aurora shareholders would receive total implied consideration of US$5.00 per Aurora Share, comprised of 0.4013 Curaleaf Shares (the "Share Consideration") plus US$1.00 cash (the "Cash Consideration", and collectively with the Share Consideration, the "Amended Consideration") based on Curaleaf's U.S. dollar equivalent closing share price of C$14.21 (C$1.00 = US$0.7015) on October 2, 2026. Based on Aurora's 30-day volume weighted average price ("VWAP") of US$2.75 as of August 10, 2026 (the day before Curaleaf announced its intention to make its initial Offer (the "Unaffected Share Price"), the Enhanced Offer represents a premium of 86% to Aurora's Unaffected Share Price. Excluding the value of the cash and cash equivalents that Aurora has on its balance sheet, including its subsequent equity issuances pursuant to its at-the-market ("ATM") program issued during its fiscal first quarter, the Enhanced Offer represents a premium of 217% to the ex-cash Unaffected Share Price.
The Enhanced Offer will also increase the Offer's maximum consideration per Aurora Share from US$5.00 to US$6.00 (the "Cap Price"). The Cap Price would represent a premium of 118% to Aurora's Unaffected Share Price and a 295% premium to the ex-cash Unaffected Share Price.
Boris Jordan, Chairman of the Board and Chief Executive Officer of Curaleaf, stated:
"Over the past several weeks, we have met with a significant percentage of Aurora's shareholder base, all of whom are supportive of the strategic rationale for the deal. This increased offer reflects careful consideration and shareholder input, demonstrating our continued commitment to reaching a successful outcome.
"Importantly, we are enhancing our proposal despite Aurora's refusal to engage and provide access to customary due diligence. We view this as a significant good-faith step that demonstrates our conviction in the merits of a combination and the value creation opportunity it represents.
"We have demonstrated our willingness to act in the best interest of shareholders. While this is not how we would expect to engage in a sale process, we are prepared to act because we believe strongly in the value creation opportunity. Importantly, if Aurora is providing diligence access to other parties, shareholders deserve a fair and open process that includes Curaleaf."
A combination of Curaleaf and Aurora would create the global cannabis leader, with operations across 17 countries, more than US$1.5 billion of last-twelve-month ("LTM") revenue, nearly US$350 million of LTM Adjusted EBITDA and at least US$40 million of expected annual cost synergies. Aurora shareholders would retain exposure to Aurora's international business while gaining ownership in Curaleaf's leading U.S. platform and future regulatory upside.
The combined company would be a larger, more diversified global cannabis platform with a pro forma market capitalization in excess of US$3 billion, with its scale, diversity and enhanced liquidity providing a significantly lower cost of capital than Aurora has today, providing Aurora shareholders with greater opportunities to capitalize on the global cannabis sector.
Curaleaf will be filing a Notice of Variation, Change and Extension (the "Notice of Variation and Change") to its Offer to Purchase and Circular and related offer materials to reflect the Enhanced Offer with the applicable Canadian securities regulatory authorities and a new Registration Statement on Form F-80 with the U.S. Securities and Exchange Commission. The Notice of Variation and Change is expected to be filed promptly. Aurora shareholders and other interested parties can find additional information regarding Curaleaf's Enhanced Offer, including materials and instructions on how to tender their shares, at grow.curaleaf.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.
Although we do not believe required, as a sign of our commitment to the Enhanced Offer, the Notice of Variation and Change will also include the pro forma financial statements that Aurora suggests should be provided. The Notice of Variation and Change will also extend the Expiry Time under the Offer from 5:00pm (Mountain Time) on December 1, 2026 to 11:59pm (Mountain Time) on December 4, 2026.
IMPORTANT INFORMATION
This document does not constitute an offer to buy or the solicitation of an offer to sell any securities. The Offer by Curaleaf to purchase all outstanding common shares of Aurora is made solely by the Offer to Purchase and Circular dated August 18, 2026, as amended by the Notice of Variation and Change and as may be further amended or supplemented.
SECURITY HOLDERS ARE URGED TO READ THE NOTICE OF VARIATION AND CHANGE AS WELL AS THE OFFER TO PURCHASE AND CIRCULAR, THE REGISTRATION STATEMENTS ON FORM F-80, THE TENDER OFFER STATEMENT ON SCHEDULE 14D-1F, AND ALL OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Free copies are available at www.sedarplus.ca, www.sec.gov or by contacting the Information Agent, Carson Proxy Advisors, at 1-800-530-5189 (toll-free), 416-751-2066 (local/text), or [email protected].
NOTICE TO U.S. SHAREHOLDERS
The enforcement by investors of civil liabilities under the federal securities laws may be affected adversely by the fact that the subject company is located in a foreign country, and that some or all of its officers and directors are residents of a foreign country.
Investors should be aware that the bidder or its affiliates, directly or indirectly, may bid for or make purchases of the issuer's securities subject to the offer or of the issuer's related securities, or of the bidder's securities to be distributed or of the bidder's related securities, during the period of the tender offer, as permitted by applicable Canadian laws or provincial laws or regulations.
Curaleaf has filed with the SEC a Registration Statement on Form F-80 under the U.S. Securities Act of 1933 and a Tender Offer Statement on Schedule 14D-1F under the U.S. Securities Exchange Act of 1934 and will promptly be filing amendments to both to reflect the Enhanced Offer. The Offer is being conducted in accordance with Section 14(e) of the Exchange Act and Regulation 14E.
THE OFFER AND THE OFFEROR SHARES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY U.S. STATE SECURITIES COMMISSION, NOR HAS ANY SUCH AUTHORITY PASSED UPON THE ACCURACY OR ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The Curaleaf Shares to be issued under the Offer have not been registered or otherwise qualified for offer and sale in certain U.S. states where shareholders may reside. No offer is made in those states except to qualifying Exempt Institutional Investors as described in the Offer to Purchase and Circular.
FORWARD-LOOKING INFORMATION
This document contains "forward-looking information" within the meaning of applicable Canadian securities laws and "forward-looking statements" within the meaning of applicable U.S. securities laws. Such statements relate to, among other things, the expected benefits, timing, and effects of the Offer, the timing for filing of the Notice of Variation and Change, and anticipated synergies from a combination of Curaleaf and Aurora. Forward-looking statements can often be identified by words such as "believes," "expects," "anticipates," "may," "will," or similar expressions.
Actual results may differ materially due to risks including: changes in general economic conditions; failure to satisfy conditions to the Offer; failure to realize anticipated synergies; fluctuations in foreign exchange and interest rates; regulatory changes; and other risks described under "Risk Factors" in the Offer to Purchase and Circular. The safe harbor for forward-looking statements does not apply to statements made in connection with a tender offer. Security holders should not place undue reliance on forward-looking information. Curaleaf disclaims any obligation to update forward-looking information except as required by law.
AURORA INFORMATION
Information concerning Aurora herein is based solely on Aurora's publicly available filings and other public sources. Aurora has not reviewed this document. Neither Curaleaf nor its officers or directors assumes responsibility for the accuracy or completeness of such information.
ADDITIONAL INFORMATION
The disposition of Common Shares and the acquisition of Curaleaf shares may have U.S. and Canadian tax consequences; shareholders should consult their own tax advisors and review the tax disclosure contained in the Offer to Purchase and Circular which are available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Contacts
Media Contact
Kekst CNC
[email protected]
Investor Contact
Curaleaf Holdings, Inc.
[email protected]
Shareholder Contact
Carson Proxy Advisors
North American Toll Free Phone: 1-800-530-5189
Local (Collect outside North America): 416-751-2066
Email: [email protected]
PNC zveřejní čtvrtletní výsledky před otevřením trhu ve čtvrtek; analytici čekají zisk 4,89 USD na akcii a tržby 6,61 miliardy USD. Společnost také oznámila čtvrtletní dividendu 2,00 USD na akcii.
The PNC Financial Services Group, Inc. (NYSE:PNC) will release its third-quarter earnings report before the opening bell on Thursday, Oct. 15.
Analysts expect the Pittsburgh, Pennsylvania-based company to report quarterly earnings of $4.89 per share, up from $4.35 per share in the year-ago period. The consensus estimate for PNC’s quarterly revenue is $6.61 billion. It reported $5.92 billion last year, according to Benzinga Pro.
On Oct. 2, PNC declared a quarterly cash dividend of $2.00 per share on common stock
PNC shares rose 0.1% to close at $221.03 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
JP Morgan analyst Vivek Juneja maintained the stock with an Overweight rating and cut the price target from $269.5 to $258 on Oct. 2, 2026. This analyst has an accuracy rate of 57%. Evercore ISI Group analyst John Pancari maintained the stock with an Outperform rating and cut the price target from $285 to $265 on Oct. 1, 2026. This analyst has an accuracy rate of 61%. Truist Securities analyst John McDonald maintained the stock with a Hold rating and lowered the price target from $254 to $252 on Oct. 1, 2026. This analyst has an accuracy rate of 65%. Argus Research analyst Stephen Biggar maintained a Buy rating and raised the price target from $250 to $280 on July 16, 2026. This analyst has an accuracy rate of 72%. RBC Capital analyst Gerard Cassidy maintained the stock with an Outperform rating and boosted the price target from $235 to $273 on July 16, 2026. This analyst has an accuracy rate of 75%. Considering buying PNC stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Leidos a Altaris dokončily vytvoření společného podniku s Analogic zaměřeného na bezpečnostní screening na letištích, hranicích a kritické infrastruktuře po celém světě. Leidos si ponechá významný menšinový podíl.
, /PRNewswire/ -- Leidos (NYSE: LDOS) and investment firm Altaris have completed their previously announced transaction to form a scaled U.S.-based joint venture (JV) for advancing security screening at airports, borders and critical infrastructure worldwide.
Operating under the Analogic brand, the new company combines complementary security screening technologies, engineering expertise and advanced manufacturing capabilities. Leidos will retain a significant minority ownership stake in the company, maintaining its interests in a critical national security market.
"This JV creates an American innovator with the technology, talent and scale to address rapidly evolving global security screening needs," said Leidos Chief Executive Officer Tom Bell. "Its launch also sharpens our focus on the growth engines driving our NorthStar 2030 strategy."
In parallel with the mission of the Analogic JV, Leidos will continue its work across the broader aviation ecosystem, including modernizing airports and air traffic systems to help move people safely and efficiently around the world.
"The strategic combination of these two businesses into one reinforces our commitment to the important national security missions and markets we serve," Bell said.
About Leidos
Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Headquartered in Reston, Virginia, with approximately 50,000 global employees, Leidos reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026. For more information, visit www.leidos.com.
About Analogic
Analogic, headquartered in Salem, New Hampshire, is a global provider of advanced imaging, detection, automation, and power technology solutions. The company designs, develops, manufactures, and supports a comprehensive portfolio of solutions for aviation security, ports and borders, critical infrastructure, healthcare, and industrial markets worldwide. Backed by decades of innovation and a global installed base, Analogic combines advanced imaging, artificial intelligence, precision power, automation, and lifecycle support capabilities to help customers meet evolving operational and regulatory requirements. For more information, visit www.analogic.com.
About Altaris
Altaris is an investment firm with an exclusive focus on acquiring and building companies in the healthcare industry. Since its inception in 2003, Altaris has invested in more than 50 companies across a range of healthcare subsectors, with a consistent goal of delivering value to the healthcare system and generating attractive financial returns for investors. Altaris is headquartered in New York City and manages $9+ billion of equity capital. For more information, visit www.altariscap.com.
Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including, but not limited to: ; the future operational and financial performance of the new joint venture company; the ability of the new joint venture company to successfully integrate the SES business and Analogic at all or otherwise in accordance with any anticipated timeline; the ability of the new joint venture company to service its indebtedness; developments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, future delays in the U.S. government budget process, or the U.S. government's failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession; uncertainties in tax due to new tax legislation or other regulatory developments; deterioration of economic conditions or weakening in credit or capital markets; uncertainty in the consequences of current and future geopolitical events; inflationary pressures and fluctuations in interest rates; delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our company; our ability to effectively compete and win contracts with the U.S. government and other customers; our ability to respond rapidly to emerging technology trends, including the use of artificial intelligence; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by U.S. government and commercial organizations in environmental impact and remediation projects; the effects of an epidemic, pandemic or similar outbreak may have on our business, financial position, results of operations and/or cash flows; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; our ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price contracts and other contracts; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; cybersecurity, data security or other security threats, system failures or other disruptions of our business; our compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer, disposal and other processing, technology protection and personal information; the damage and disruption to our business resulting from natural disasters and the effects of climate change; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks; our ability to manage risks associated with our international business; our ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations; our ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements; our ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; our ability to successfully integrate acquired businesses; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks described in our Securities and Exchange Commission filings.
Media Contact:
Victor Melara
Senior Media Relations Manager
703.431.4612
[email protected]
WASHINGTON and NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Carlyle Group Inc. (NASDAQ: CG) announced today that it will release financial results for the third quarter 2026 on Thursday, November 5, 2026, and host a conference call at 8:30 a.m. EST. The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available after the call’s completion.
Chief Executive Officer Harvey Schwartz, Chief Financial Officer Justin Plouffe, and Head of Public Investor Relations Daniel Harris, will review the results during the call.
The earnings release will be available through all Carlyle channels, including the Earnings Releases section of ir.carlyle.com and the firm’s X and LinkedIn accounts.
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $485 billion of assets under management as of June 30, 2026, Carlyle’s purpose is to connect people, ideas, and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,500 people in 28 offices across four continents.
Contacts
Public Investor Relations
Daniel Harris
+1 (212) 813-4527 [email protected]
New offerings bring beverage culture's biggest trends to life through distinctive new flavors, expanded energy choices and updates to iconic brands
, /PRNewswire/ -- Keurig Dr Pepper (NASDAQ: KDP) today unveiled a first look at its 2027 beverage innovation pipeline ahead of the 2026 National Association of Convenience Stores (NACS) Show. The lineup delivers what consumers want most: familiar favorites, reimagined; a bigger, bolder energy lineup; and refreshed iconic brands.
Photo Credit: Keurig Dr Pepper
Photo Credit: Keurig Dr Pepper
Photo Credit: Keurig Dr Pepper
Photo Credit: Keurig Dr Pepper
"Beverages are one of the strongest drivers of traffic and basket growth for convenience retailers, and innovation is what keeps shoppers engaged," said Jeff Tabor, Chief Customer Officer at Keurig Dr Pepper. "Our 2027 pipeline brings together breakthrough energy varieties, culturally relevant flavors and meaningful investments in some of the industry's most iconic brands. Backed by our broad portfolio and route-to-market capabilities, these innovations are designed to create excitement, spark discovery and help retailers capture incremental sales across the beverage category."
Familiar Favorites, Reimagined
KDP's research shows that younger consumers are exploring a wider range of beverage categories and flavors, while remaining drawn to the nostalgia and familiarity of brands they know and love. Carbonated Soft Drinks remain the largest non-alcoholic beverage segment, and innovation continues to drive category dollar growth. Building on a track record that includes delivering the #1 CSD innovation in each of the past three years1, KDP is introducing the following fresh twists on familiar favorites, all of which are available in both Regular and Zero Sugar varieties:
Dr Pepper® Ice Cream Float blends Dr Pepper's signature 23 flavors with a creamy vanilla ice cream flavor and rich notes of caramel and butterscotch for an everyday treat take on the beloved float. Launching nationwide as a permanent offering, the flavor will be available in cans and 20 oz. bottles beginning February 2027, with fountain and frozen dispensed formats arriving mid-year.
7UP® Miami Vice™ combines refreshing lime-lemon, sweet strawberry daiquiri, and creamy pina colada flavors for a tropical soda experience inspired by the classic frozen cocktail. The limited-time offering arrives nationwide in June 2027.
7UP® Shirley Temple, one of the brand's most successful recent flavor platforms, returns for the holiday season as a limited-time offering. Featuring the nostalgic flavors of cherry and pomegranate, the fan-favorite flavor will roll out with expanded immediate-consumption availability through a new 20 oz. package in 2027.
Canada Dry® Raspberry Lemonade combines the flavors of raspberry and lemonade with the crisp refreshment of Canada Dry for a bright, seasonal twist beginning in Spring 2027. A Bigger, Bolder Energy Lineup for 2027
Energy remains one of the fastest-growing areas in beverages, with innovation and limited-time offerings driving nearly three-quarters of category growth2. In 2027, KDP will distribute more than 25 new items across its energy brand portfolio, spanning permanent additions, limited-time releases, distinctive collaborations and new formats designed to meet growing demand for flavor exploration and variety. Highlights from the Company's owned energy brand, GHOST®, and energy brand partners include:
Building on the success of its partnership with KDP, GHOST® - now a $1 billion brand at retail - will make GHOST® Energy x 7UP® and GHOST® Energy x A&W® permanent offerings in 2027 following the popularity and strong retail performance of the 2026 limited-time releases. The brand will also launch GHOST® Energy Sour Strips Appleberry™, a sweet-and-sour blend of green apple and strawberry, nationwide in January, followed by the limited-time GHOST® Energy Blueberry Cream, a first-to-market flavor requested by consumers that pairs tangy blueberry with sweet, creamy vanilla for a nostalgic yogurt-inspired taste.
Bloom Energy™ will introduce a new lineup of iconic treats, featuring three flavors inspired by childhood favorites. Strawberry Shortie, available beginning in October 2026, combines sweet swirls of strawberry and vanilla cream flavors reminiscent of a classic ice cream truck treat, while Cotton Candy and Lemon Freezie, arriving in January 2027, deliver playful takes on blue cotton candy and frozen lemonade respectively.
C4 Energy® will expand its zero-sugar Cereal's Most Wanted lineup in January 2027, introducing Cocoa Loco in 16-ounce cans and launching new 8.4-ounce mini can formats for Cereal Killer, Jacked Apple Crunch and Buzzin' Honey O's. The great Breakfast Heist of 2027 is upon us. Refreshing Iconic Brands
While consumers are exploring more flavors than ever, they continue to return to the brands they know and trust. KDP is investing in iconic brands like 7UP and Sunkist with updates that enhance taste, evolve with changing consumer preferences and strengthen their presence across the physical and digital shelf.
7UP®recently unveiled its most significant brand evolution in more than 15 years, featuring a consumer-preferred lime-forward formula, refreshed packaging, a modernized logo and an updated visual identity across select varieties. The refresh reflects a renewed investment in the iconic brand and reinforces 7UP's distinctive position within the category.
Sunkist® will introduce updated graphics and a refreshed recipe in Q1 2027. The renovation builds on the brand's signature citrus flavor with an improved orange taste for a more fruit-forward experience for today's consumer. In addition to the innovations featured in this release, attendees at the 2026 NACS Show in Las Vegas will get an exclusive preview of upcoming consumer-inspired innovations from across KDP's portfolio of owned and partner brands, including Snapple, Electrolit, Polar, La Colombe, Vita Coco and more.
About Keurig Dr Pepper
Keurig Dr Pepper (Nasdaq: KDP) is a leading beverage company with more than 150 owned, licensed and partner brands that meet a wide range of needs and occasions. Our North American refreshment beverage business holds leadership positions across carbonated soft drinks, water, juice and mixers with a portfolio of iconic brands such as Dr Pepper®, Canada Dry®, Mott's®, A&W®, Peñafiel®, GHOST®, 7UP®, Snapple®, Clamato® and Core Hydration®. Our global coffee business spans more than 100 markets and includes the leading Keurig® single‑serve brewing system in the U.S. and Canada, along with powerhouse brands such as Peet's, L'OR and Jacobs, and other regional coffee leaders. Our more than 50,000 employees aim to enhance the experience of every beverage and coffee occasion while making a positive impact for people, communities and the planet. Learn more at www.keurigdrpepper.com and follow us @KeurigDrPepper on LinkedIn and Instagram.
Media Contact:
Xenja Lindberg
[email protected]
1 Source: Circana Total US Multi-Outlet + Convenience, Calendar Year 2025, 2024 and 2023
2 Source: Circana POS Energy Drink Aisle, 2024 vs. 2025.
Baker Hughes podepsala dvě dohody s PDVSA, Lindsayca, Fulcrum LNG a New Stratus Energy na rozvoj venezuelské plynárenské a energetické infrastruktury. Cílem je rozšířit těžbu, zpracování i budoucí export LNG.
An alliance agreement was signed with PDVSA, Lindsayca and Fulcrum LNG, Inc. to restore energy infrastructure for gas production An MOU with New Stratus Energy Inc. was also recently signed to support the future development of in-country oil and gas resources CARACAS, Venezuela, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, Monday announced the signing of two strategic agreements to accelerate the revitalization of Venezuela’s energy infrastructure across the natural gas value chain and expansion of the country’s energy production.
In Caracas, the company signed a strategic alliance agreement with PDVSA, Lindsayca and Fulcrum LNG, Inc. to revitalize and expand the country’s natural gas infrastructure. Baker Hughes also recently signed a separate Memorandum of Understanding (MOU) with New Stratus Energy Inc. to support the development of future oil and gas prospects.
Together, these agreements establish an enterprise deal framework that can connect upstream resource development, midstream infrastructure, gas monetization, and LNG commercialization. This creates a pathway to unlock Venezuela's significant natural gas potential.
“A central objective of these partnerships is the development of an integrated gas value chain capable of transforming Venezuela's substantial natural gas resources into reliable domestic supply and future export opportunities, including the potential to export the first LNG molecules produced in Venezuela,” said Lorenzo Simonelli, chairman and CEO of Baker Hughes. “Venezuela holds tremendous potential to become a significant contributor to the evolving global energy landscape, and these agreements are designed to bring world-class resource opportunities, project development, energy infrastructure & technologies, and financing expertise together to realize this.”
“This strategic alliance with PDVSA is a historic opportunity to maximize the use and value of Venezuela's natural gas resources, and it reflects the capabilities and expertise of Fulcrum, Lindsayca and Baker Hughes in developing fully integrated gas value chains, from upstream production to end markets,” said Jesus Bronchalo, CEO of Fulcrum LNG, Inc.
"In the near term, we will work closely with PDVSA to identify and execute the infrastructure developments and upgrades needed to meet its internal gas requirements, while pursuing opportunities to supply natural gas to the domestic market to support reliable power generation for Venezuela and its people. Over the medium and long term, we will evaluate the development and financing of new open-access midstream and LNG infrastructure that gives PDVSA and other upstream operators solutions to monetize their gas, positioning Venezuela to become a key player in the global gas and LNG industry and helping meet growing world energy demand," Bronchalo said.
About the agreements
Under the alliance with PDVSA, Lindsayca and Fulcrum, the companies will combine Baker Hughes' broad portfolio of industrialized energy solutions for oil and gas field development, gas infrastructure and LNG solutions, Lindsayca's engineering, procurement, construction, and operational capabilities, and Fulcrum's midstream and LNG project development, financing and market access. The collaboration will focus on developing project specific agreements, advancing critical infrastructure required to process, transport, commercialize, and export natural gas, for the first time in the history of Venezuela.
The alliance is a cooperation framework. Any specific project will be subject to separate definitive agreements, each party’s internal approvals, and applicable U.S. sanctions and export control requirements, including authorizations issued by the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC).
Through the MOU with New Stratus Energy, Baker Hughes will support the development of future oil and gas prospects. The partnership will leverage Baker Hughes' integrated portfolio of subsurface, drilling, production, processing, digital, emissions abatement, power generation, oil and gas monetization, and liquefied natural gas (LNG) technologies to maximize resource recovery opportunities and accelerate future project developments.
Baker Hughes has supported Venezuela’s energy sector for more than 60 years. Its installed base in country includes more than 1,200 oil production systems, the largest artificial lift footprint, significant flexible pipe infrastructure, and approximately 240 turbomachinery units across 23 sites.
About Baker Hughes
Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward – making it safer, cleaner and more efficient for people and the planet. Visit us at bakerhughes.com.
About Lindsayca Inc.
Lindsayca Inc. is a U.S. company headquartered in Houston, specializing in engineering, procurement, modular fabrication, construction, commissioning, and operation of energy infrastructure. Through Lindsay C.A., established in Venezuela in 1986, it brings four decades of experience developing gas, oil, and power generation projects in the country. Its track record combines international project execution capabilities with knowledge of Venezuela’s operating environment, specialized talent, and local engineering and fabrication resources. In alliance with PDVSA, Baker Hughes, and Fulcrum LNG, Inc., Lindsayca contributes this experience to transform Venezuela’s natural gas potential into productive infrastructure, restore power generation capacity, and strengthen the domestic energy supply. Its participation is focused on developing an integrated value chain that culminates in the production and export of liquefied natural gas (LNG), helps position Venezuela in international markets, and creates jobs, opportunities for domestic suppliers, and development for its communities.
About Fulcrum LNG, Inc.
Fulcrum LNG, Inc. is a U.S.-based independent developer of midstream natural gas and liquefied natural gas (LNG) infrastructure in international markets. Together with its world-class consortium partners, Fulcrum applies the same flexible business model used to develop gas infrastructure on the U.S. Gulf Coast. Fulcrum develops, finances, and operates shared, open-access midstream gas infrastructure, including LNG facilities, with private capital and independently of upstream producers. This approach removes the infrastructure financing burden from host governments and upstream operators, provides alternative gas monetization solutions and greater optionality, and brings more gas to domestic and export markets. Fulcrum has a broad portfolio of opportunities, primarily in Latin America and the Atlantic Basin.
Cognizant spustil novou divizi Cognizant Activate pro transformaci středně velkých firem pomocí AI s ročními výnosy 1 až 5 miliard USD. Cílí na rychlejší nasazení řešení v oblasti dat, umělé inteligence, kyberbezpečnosti, cloudu a podnikových aplikací.
New business unit designed to deliver enterprise-grade AI transformation to emerging enterprises that generate $1 billion to $5 billion in annual revenue, building toward Global 2000 scale, through a dedicated, right-sized operating model built for speed
, /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading AI builder and technology services provider, today announced the launch of Cognizant Activate, a new business unit designed to help emerging enterprises harness AI and accelerate transformation. Cognizant Activate brings the depth of Cognizant's AI Builder capability, proven with the world's largest companies, together with a purpose-built operating model tailored to the speed, priorities and decision-making dynamics of emerging enterprises.
Cognizant is an AI Builder company www.cognizant.ai Emerging enterprises with high growth face many of the same pressures as large enterprises, including legacy technology, rising cybersecurity risk and the need to adopt AI ahead of competitors, but they require solutions that are faster to deploy and right-sized for their scale.
Cognizant Activate is expected to deliver platform-aligned, pre-configured solution kits spanning data and AI, cybersecurity, enterprise applications, cloud modernization and managed services. The business unit will operate with vertically integrated teams and a single engagement lead accountable from the first conversation through delivery. It will launch with an initial focus on financial services, healthcare, manufacturing and retail/CPG sectors, where Cognizant has deep domain expertise and an established presence serving emerging enterprises. Cognizant Activate will also draw on Cognizant's ecosystem partnerships to accelerate time-to-value for clients.
"The companies shaping tomorrow's economy are moving fast and thinking boldly, and they need a partner who will treat their transformation as consequential, not incremental," said Ravi Kumar S, Chief Executive Officer of Cognizant. "Cognizant Activate brings the same AI Builder capability that is helping to transform some of the world's largest enterprises to emerging enterprises, right-sized for their speed and scale. This is how our clients activate growth with AI."
Cognizant Activate is built around the idea that emerging enterprises aren't looking for a scaled-down version of an enterprise engagement. They want a partner that can build AI into how they operate today, not add it as a future roadmap item. Cognizant's approach combines pre-built AI accelerators, compressed implementation timelines and commercial models designed for high-growth economics.
"Emerging enterprises with high growth want enterprise-grade capability without enterprise-level complexity and cost," said Mohammad Haque, Global Head of Intelligent Enterprise Platforms and Large Deals of Cognizant. "Cognizant Activate gives them access to our global delivery network, platform certifications and decades of industry expertise, delivered through a model built specifically for their speed and ambition."
About Cognizant
Cognizant (Nasdaq: CTSH) is an AI builder and technology services provider, building the bridge between AI investment and enterprise value by building full-stack AI solutions for our clients. Our deep industry, process and engineering expertise enables us to build an organization's unique context into technology systems that amplify human potential, realize tangible returns and keep global companies ahead in a fast-changing world. See how at www.cognizant.ai or @cognizant.
For more information, contact:
Katrina Cheung
[email protected]
Coco Robotics a Deliveroo spouštějí exkluzivní partnerství pro robotické doručování ve Velké Británii, začnou v Canary Wharf v Londýně a poté se rozšíří do dalších měst. Jde o debut Coco na britském trhu a první využití autonomních doručovacích vozidel Deliveroo ve Velké Británii.
The partnership marks Coco Robotics' UK debut as it accelerates expansion across Europe
The rollout is due to begin in London's Canary Wharf before expanding to several other towns and cities in the coming months
The partnership follows the successful collaboration between Coco, DoorDash and Wolt in the U.S. and other geographies
, /PRNewswire/ -- Coco Robotics, one of the largest sidewalk delivery operators across the U.S. and Europe, and Deliveroo, a brand within DoorDash's global portfolio, are set to bring robot deliveries to towns and cities across the UK through a new strategic partnership.
Coco Robotics will launch in multiple locations, beginning with Canary Wharf in London this October, before launching in Milton Keynes, Leeds, Stockton on Tees and Nottingham in the coming weeks and months.
A Coco Robotics delivery robot in London The launches have been welcomed by local authorities across the UK in a positive sign of support for the innovative new service and job creation the partnership will bring. Coco is also in discussions with other councils across both London and the UK.
Consumers will initially be able to order from the likes of Patty&Bun, independent family-run brands like bakery Signorelli and cafe and restaurant Beam, in Wood Wharf, Canary Wharf, before the service area expands to include a wider pool of merchants at a later stage, including Ole & Steen, Royal China and Din Tai Fung. In Milton Keynes, consumers will be able to order from Smoke and Pepper amongst others when the service rolls out.
The multi-city rollout marks Coco's entry into the UK, extending the company's broader expansion across Europe. The launch will be backed by local investment in UK operational infrastructure, creating new skilled jobs in operations, maintenance and logistics across each region, supported by new depot and charging facilities.
The partnership represents a significant milestone in Deliveroo's autonomous delivery journey, marking its first use of autonomous delivery vehicles in the UK. The move reflects the company's strategy to develop a multi-modal last-mile delivery approach by scaling new delivery methods for consumers and merchants, building on learnings from other geographies.
While the majority of orders will continue to be fulfilled by Deliveroo's extensive rider network, Coco's fully electric robots are suited to short-distances and navigating urban environments, offering additional flexibility to local businesses on Deliveroo's platform to fulfill more orders.
Built to travel safely and navigate busy urban environments, Coco's robots operate at walking pace, moving safely along sidewalks while carrying orders directly to customers. Each delivery is zero-emission and reduces urban congestion.
Through its partnership with BlindSquare, Coco will also share real-time data on sidewalk hazards identified by its robots, so that the company can update its app to help alert blind and partially sighted pedestrians to obstacles ahead.
Zach Rash, CEO and co-founder of Coco Robotics: "We're thrilled to be bringing Coco to the UK with Deliveroo as our launch partner, building on our existing partnership with DoorDash. The interest here has been incredible, and we're committed to building something that creates lasting value for local merchants and the communities they serve. As we expand further across the UK, we look forward to giving more businesses another reliable delivery option and more communities access to the kind of infrastructure that makes delivery work better for everyone."
Miki Kuusi, CEO at Deliveroo and Head of DoorDash International: "London is where Deliveroo was born, so it feels fitting that we're launching our first UK autonomous delivery service with Coco Robotics here before expanding our exclusive partnership to more towns and cities nationwide, building on our partnership in other geographies."
"We see huge potential in autonomous delivery and we are looking forward to working with Coco to bring more flexibility to our delivery network, helping local restaurants and shops meet increasing consumer demand. We firmly believe that robot and drone technology should benefit High Street businesses of all sizes, helping them remain competitive and meet consumers in new ways."
Ilkka Pirttimaa, Founder, BlindSquare: "This isn't theoretical anymore. We're seeing firsthand how Coco's real-time sidewalk data delivers tangible safety improvements for our users in every city where we operate together. Coco's robots are essentially a real-time accessibility mapping network, feeding hazard data, discarded e-scooters, temporary construction, straight into BlindSquare's self-voicing app, giving blind and partially sighted pedestrians the crucial seconds they need to navigate safely. London is historic, dynamic, and often challenging to navigate. Bringing this safety layer here is a major step forward, and it's what autonomous technology should look like in a city. Coco's robots don't just share the sidewalk, they help make it more accessible for everyone."
Mayor of the East Midlands, Claire Ward, said: "The East Midlands is determined to be a leader in the adoption of new technologies, and Coco's UK launch is exactly the kind of opportunity that reflects our ambitions for the region. We look forward to working with Coco Robotics to explore the potential for autonomous delivery and the benefits it could bring to businesses, residents and visitors."
Ben Houchen, Mayor of Tees Valley: "Teesside, Darlington and Hartlepool have built a reputation for turning innovation into reality, and Coco Robotics choosing our region as one of its first UK launches is another major vote of confidence in everything we're building here. This project will bring more cutting-edge tech, new investment and good-quality opportunities for local people — further proof that Teesside is one of the best places in the country to grow and invest in industries of the future."
Jacinta Rowsell, Managing Director of Operations at Canary Wharf Group: "It's exciting to be the first UK launch for Coco and Deliveroo's autonomous delivery partnership. Canary Wharf is built on an ambitious vision, one which supports and encourages growth and innovation, and our partnership with Coco is a great example of this."
DoorDash and Wolt partner with Coco across multiple cities across the globe, including Los Angeles, San Jose, Chicago, Miami, Washington D.C. and Helsinki. Deliveroo, Wolt and DoorDash are also exploring different forms of autonomous vehicles across multiple geographies, and DoorDash continues to invest in autonomous delivery solutions. The companies have established partnerships with multiple leading aerial drone and ground-based robot operators, and DoorDash has developed its own in-house autonomous delivery robot, Dot, which is operating across the greater Phoenix area in Arizona.
How Coco robots work
Coco robots operate at a walking pace and use onboard sensors, cameras, and AI-driven navigation to move along sidewalks. The system processes real-time environmental data at the edge, without relying on cloud connectivity, allowing the robot to perceive and respond to its surroundings as conditions change. Each robot is designed to operate within the existing flow of pedestrian and urban traffic rather than requiring dedicated infrastructure.
Deployment in any new location is always phased and aligned with local regulations. Coco's control software enforces location-specific speed limits and routing policies, and supervising operators are trained on local rules and street conditions. The robot is designed to move predictably and yield where appropriate. The objective is to complement urban mobility systems, not interfere with them.
About Coco Robotics
Coco Robotics is one of the largest robot delivery fleets across the U.S. and Europe, combining autonomous robots, real-world operations data, and advanced AI to power smarter, more efficient city logistics. Founded in 2020, Coco has completed more than 500,000 zero-emission deliveries across the U.S. and Europe for more than 4,500 restaurants and retailers. The fleet continuously learns from millions of miles of real-world operations, giving Coco instant adaptability to new cities and environments. Coco partners with leading delivery platforms including Deliveroo, DoorDash, and Wolt to bring autonomous delivery services to businesses and consumers around the world. For more information, visit cocodelivery.com.
About Deliveroo
Deliveroo is changing the way people eat and shop by bringing the neighbourhood to your door, unlocking a wealth of hyperlocal choice across restaurants, grocery and retail, with fast and reliable delivery, at the right price. Founded in 2013 by William Shu and Greg Orlowski, Deliveroo joined forces with DoorDash (NASDAQ: DASH) in 2025. Together, we operate in more than 40 countries. You can read more on the Deliveroo website.
Forward-Looking Statements
This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events, and such statements in this communication include, but are not limited to, expectations regarding the opportunity and expected benefits of the Deliveroo and Coco Robotics partnership and the expected plans for the launch and expansion of such partnership; and expectations regarding DoorDash's strategy and plans regarding autonomous delivery. Expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. For information on potential risks and uncertainties that could cause actual results to differ from any results predicted, please see DoorDash's Annual Report on Form 10-K for the year ended December 31, 2025 and its quarterly reports on Form 10-Q, each filed with the U.S. Securities and Exchange Commission.
Credo Technology vykázala sedmý po sobě jdoucí kvartál s tříciferným růstem tržeb; klíčové bude, zda optické tržby ve fiskálním roce 2027 překročí 600 milionů USD.
Credo Technology just posted its seventh consecutive quarter of triple-digit revenue growth, yet analysts still set targets well below where this volatile stock has already traded. One specific milestone in its optical business could force a dramatic rethink of where…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Credo Technology (NASDAQ:CRDO | CRDO Price Prediction) sells the connectivity that keeps AI clusters talking. Its lineup covers active electrical cables, optical DSPs, retimers and now silicon photonics. Revenue hit a record $479 million last quarter, up 115% year over year.
Shares are up 54.22% year to date but still trade well below the $308.67 52-week high. One number could change the long-term story: more than $600 million of optical revenue in fiscal 2027. So can Credo hit $350 in 2027?
What’s Holding Credo Back Right Now The biggest risk is volatility: Credo carries a beta of 3.228. Shares traded at $282.82 in mid-August and fell to $161.49 by mid-September, though recent gains of +13.24% week-over-week show a rebound.
GAAP gross margin slipped to 64.5% from 68.2% sequentially due to acquisition amortization. Goodwill jumped to $986.4 million. The largest customer accounted for 33% of revenue and the second-largest for 28%. Inventory rose to $313.1 million, and share-based compensation reached $87.98 million.
Analysts Are Bullish, but Their Targets Trail the Estimates The consensus target is $281.09. The stock carries 4 Strong Buy, 14 Buy, 1 Hold, plus 0 Sell ratings from analysts. The model’s base case is $270.13, or 18.44% upside. The scenario range runs from a bear case of $212.44 to a bull case of $335.88. Model confidence is high, at 0.9 on a 1.0 scale.
The fiscal 2028 EPS estimate has rose to $9.7049 from $8.8475 90 days ago. Over the last 30 days there were 14 upward revisions and 1 downward. Analyst sentiment is 95% bullish, yet the model may be underweighting the optical ramp.
Here’s What It Takes for Credo to Reach $350 A climb to $350 from $228.07 means a gain of 53.5%.
Given forward EPS of $7.1551, $350 amounts to a significantly higher forward multiple than the base case of $270.13, calling for additional multiple expansion.
That expansion is justified because management expects fiscal 2027 revenue growth above 85% and a non-GAAP net margin “in the vicinity of 50%”. Zero-flap optics, silicon photonics PICs and optical DSPs are each expected to top $100 million.
CEO Bill Brennan said: “Fiscal 27, I think, is just a stepping stone for where we’re going with our optical business.” OmniConnect could add “thousands of dollars of Credo content per GPU” starting in fiscal 2028.
A slowdown in hyperscaler capex poses the biggest risk, landing hard on a business where three to four customers each make up more than 10% of revenue.
The flip side is that the same expansion is lifting a whole bench of suppliers beyond the chipmakers (we covered seven of them, from power to cooling to networking, in a free report).
Where Credo Trades Today vs Its Earnings Power At $228.07, Credo’s forward multiple is reasonable for a company posting its seventh consecutive quarter of triple-digit growth. The stock is trading between its 52-week low of $86.48 and a high of $308.67.
Since January 2022, the stock has gained 1,804.81%. If the optical business delivers, today’s multiple leaves room for the rerating the bull case depends on.
$350 Is a Stretch, but Here’s Why It’s Possible Hitting $350 requires a 53.5% gain. It’s a stretch, but within reach for a stock this volatile.
Optical revenue must clear $600 million, the first 1.6T DSP revenue must arrive on schedule, and Q2 revenue must meet the $525 million to $535 million guidance. A sharp cut in AI infrastructure spending would undermine the thesis. We’ve outlined the blueprint for how Credo could reach $350 in 2027.
Contact [email protected] for any questions or corrections.
Insmed oznámil, že finanční ředitelka Sara Bonsteinová odstoupí 30. října a firma zahájila hledání nástupce. Zároveň potvrdila celoroční výhled na rok 2026.
—Company Announces Third-Quarter 2026 Financial Results Conference Call to Be Held on Thursday, October 29, 2026—
, /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that Sara Bonstein will step down as Chief Financial Officer (CFO). Ms. Bonstein will continue to serve as CFO until October 30, 2026, to ensure a smooth transition through the Company's reporting of its third-quarter 2026 financial results and she will participate in the earnings call on Thursday, October 29, 2026. Insmed has commenced a search to identify the Company's next CFO.
"We are grateful for Sara's many contributions over the past almost seven years and her dedicated leadership overseeing our finance organization during a time when Insmed raised more than $4.2 billion in capital," said Will Lewis, Chair and Chief Executive Officer of Insmed. "We are now well positioned to reach cash flow positivity next year with what we view as a clear path toward sustained top-line growth and bottom-line profitability."
"Serving as Insmed's CFO has been a privilege of my career," said Ms. Bonstein. "I am thankful for our team and all we achieved together during my time with the Company. I am confident in Insmed's future, especially given our successful launch of BRINSUPRI coupled with our exciting pipeline. After considerable reflection, now is an ideal time for me to pursue my ambition for a broader leadership role."
Lewis continued, "Sara has been a steadfast partner in building Insmed into the company we are today, and we wish her well as she pursues her next leadership opportunity. Insmed has undergone a major transformation in recent years to become a global diversified biotech company with a robust portfolio of first- or best-in-class therapies with the potential to deliver meaningful impact for patients with serious diseases. With BRINSUPRI and ARIKAYCE on track to deliver meaningful revenue this year, and with substantial growth expected in the years ahead through our commercial portfolio and diverse therapeutic pipeline, we remain focused on delivering on our long-term ambitions. We are committed to ensuring our finance operations continue supporting Insmed's success in our next phase of growth, and we have partnered with a leading executive search firm to identify our next CFO."
Ms. Bonstein's transition is not related to any disagreement between Ms. Bonstein and the Company on any matter relating to the Company's accounting practices, financial statements, internal controls, or operations.
Reaffirms Full-Year 2026 Guidance
As Insmed continues to build on its operational excellence and momentum, the Company reaffirms its full-year 2026 financial guidance of revenue in the range of $1.25 billion to $1.40 billion for BRINSUPRI® (brensocatib) and $450 million to $470 million for ARIKAYCE® (amikacin liposome inhalation suspension).
Third-Quarter 2026 Earnings Conference Call
Insmed announced today that it will release its third-quarter 2026 financial results on Thursday, October 29, 2026.
Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, October 29, 2026, to discuss financial results and provide a business update.
Shareholders and other interested parties may participate in the conference call by dialing (833) 461-5787 (U.S.) and (585) 542-9983 (international) and referencing access code 603611044. The call will also be webcast live on the Company's website at www.insmed.com.
A replay of the conference call will be accessible approximately 2 hours after its completion through November 5, 2026, by dialing (833) 309-1852 (U.S.) and (929) 828-5978 (international) and referencing access code 603611044. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.
About ARIKAYCE
ARIKAYCE® is approved in the United States as ARIKAYCE (amikacin liposome inhalation suspension), in Europe as ARIKAYCE Liposomal 590 mg Nebuliser Dispersion, and in Japan as ARIKAYCE inhalation 590 mg (amikacin sulfate inhalation drug product). Current international treatment guidelines recommend the use of ARIKAYCE for appropriate patients. ARIKAYCE is a novel, inhaled, once-daily formulation of amikacin, an established antibiotic that was historically administered intravenously and associated with severe toxicity to hearing, balance, and kidney function. Insmed's proprietary PULMOVANCE™ liposomal technology enables the delivery of amikacin directly to the lungs, where liposomal amikacin is taken up by lung macrophages where the infection resides, while limiting systemic exposure. ARIKAYCE is administered once daily using the Lamira® Nebulizer System manufactured by PARI Pharma GmbH (PARI).
About PARI Pharma and the Lamira® Nebulizer System
ARIKAYCE is delivered by a novel inhalation device, the Lamira® Nebulizer System, developed by PARI. Lamira® is a quiet, portable nebulizer that enables efficient aerosolization of ARIKAYCE via a vibrating, perforated membrane. Based on PARI's 100-year history working with aerosols, PARI is dedicated to advancing inhalation therapies by developing innovative delivery platforms to improve patient care.
BOXED WARNING AND IMPORTANT SAFETY INFORMATION FOR ARIKAYCE IN THE U.S.
WARNING: RISK OF INCREASED RESPIRATORY ADVERSE REACTIONSARIKAYCE has been associated with an increased risk of respiratory adverse reactions, including hypersensitivity pneumonitis, hemoptysis, bronchospasm, and exacerbation of underlying pulmonary disease that have led to hospitalizations in some cases.
Hypersensitivity Pneumonitis has been reported with the use of ARIKAYCE in the clinical trials. Hypersensitivity pneumonitis (reported as allergic alveolitis, pneumonitis, interstitial lung disease, allergic reaction to ARIKAYCE) was reported at a higher frequency in patients treated with ARIKAYCE plus background regimen (3.1%) compared to patients treated with a background regimen alone (0%). Most patients with hypersensitivity pneumonitis discontinued treatment with ARIKAYCE and received treatment with corticosteroids. If hypersensitivity pneumonitis occurs, discontinue ARIKAYCE and manage patients as medically appropriate.
Hemoptysis has been reported with the use of ARIKAYCE in the clinical trials. Hemoptysis was reported at a higher frequency in patients treated with ARIKAYCE plus background regimen (17.9%) compared to patients treated with a background regimen alone (12.5%). If hemoptysis occurs, manage patients as medically appropriate.
Bronchospasm has been reported with the use of ARIKAYCE in the clinical trials. Bronchospasm (reported as asthma, bronchial hyperreactivity, bronchospasm, dyspnea, dyspnea exertional, prolonged expiration, throat tightness, wheezing) was reported at a higher frequency in patients treated with ARIKAYCE plus background regimen (28.7%) compared to patients treated with a background regimen alone (10.7%). If bronchospasm occurs during the use of ARIKAYCE, treat patients as medically appropriate.
Exacerbations of underlying pulmonary disease has been reported with the use of ARIKAYCE in the clinical trials. Exacerbations of underlying pulmonary disease (reported as chronic obstructive pulmonary disease (COPD), infective exacerbation of COPD, infective exacerbation of bronchiectasis) have been reported at a higher frequency in patients treated with ARIKAYCE plus background regimen (14.8%) compared to patients treated with background regimen alone (9.8%). If exacerbations of underlying pulmonary disease occur during the use of ARIKAYCE, treat patients as medically appropriate.
Anaphylaxis and Hypersensitivity Reactions: Serious and potentially life-threatening hypersensitivity reactions, including anaphylaxis, have been reported in patients taking ARIKAYCE. Signs and symptoms include acute onset of skin and mucosal tissue hypersensitivity reactions (hives, itching, flushing, swollen lips/tongue/uvula), respiratory difficulty (shortness of breath, wheezing, stridor, cough), gastrointestinal symptoms (nausea, vomiting, diarrhea, crampy abdominal pain), and cardiovascular signs and symptoms of anaphylaxis (tachycardia, low blood pressure, syncope, incontinence, dizziness). Before therapy with ARIKAYCE is instituted, evaluate for previous hypersensitivity reactions to aminoglycosides. If anaphylaxis or a hypersensitivity reaction occurs, discontinue ARIKAYCE and institute appropriate supportive measures.
Ototoxicity has been reported with the use of ARIKAYCE in the clinical trials. Ototoxicity (including deafness, dizziness, presyncope, tinnitus, and vertigo) were reported with a higher frequency in patients treated with ARIKAYCE plus background regimen (17%) compared to patients treated with background regimen alone (9.8%). This was primarily driven by tinnitus (7.6% in ARIKAYCE plus background regimen vs 0.9% in the background regimen alone arm) and dizziness (6.3% in ARIKAYCE plus background regimen vs 2.7% in the background regimen alone arm). Closely monitor patients with known or suspected auditory or vestibular dysfunction during treatment with ARIKAYCE. If ototoxicity occurs, manage patients as medically appropriate, including potentially discontinuing ARIKAYCE.
Nephrotoxicity was observed during the clinical trials of ARIKAYCE in patients with MAC lung disease but not at a higher frequency than background regimen alone. Nephrotoxicity has been associated with the aminoglycosides. Close monitoring of patients with known or suspected renal dysfunction may be needed when prescribing ARIKAYCE.
Neuromuscular Blockade: Patients with neuromuscular disorders were not enrolled in ARIKAYCE clinical trials. Patients with known or suspected neuromuscular disorders, such as myasthenia gravis, should be closely monitored since aminoglycosides may aggravate muscle weakness by blocking the release of acetylcholine at neuromuscular junctions.
Embryo-Fetal Toxicity: Aminoglycosides can cause fetal harm when administered to a pregnant woman. Aminoglycosides, including ARIKAYCE, may be associated with total, irreversible, bilateral congenital deafness in pediatric patients exposed in utero. Patients who use ARIKAYCE during pregnancy, or become pregnant while taking ARIKAYCE should be apprised of the potential hazard to the fetus.
Contraindications: ARIKAYCE is contraindicated in patients with known hypersensitivity to any aminoglycoside.
Most Common Adverse Reactions: The most common adverse reactions in Trial 1 at an incidence ≥5% for patients using ARIKAYCE plus background regimen compared to patients treated with background regimen alone were dysphonia (47% vs 1%), cough (39% vs 17%), bronchospasm (29% vs 11%), hemoptysis (18% vs 13%), ototoxicity (17% vs 10%), upper airway irritation (17% vs 2%), musculoskeletal pain (17% vs 8%), fatigue and asthenia (16% vs 10%), exacerbation of underlying pulmonary disease (15% vs 10%), diarrhea (13% vs 5%), nausea (12% vs 4%), pneumonia (10% vs 8%), headache (10% vs 5%), pyrexia (7% vs 5%), vomiting (7% vs 4%), rash (6% vs 2%), decreased weight (6% vs 1%), change in sputum (5% vs 1%), and chest discomfort (5% vs 3%).
Drug Interactions: Avoid concomitant use of ARIKAYCE with medications associated with neurotoxicity, nephrotoxicity, and ototoxicity. Some diuretics can enhance aminoglycoside toxicity by altering aminoglycoside concentrations in serum and tissue. Avoid concomitant use of ARIKAYCE with ethacrynic acid, furosemide, urea, or intravenous mannitol.
Overdosage: Adverse reactions specifically associated with overdose of ARIKAYCE have not been identified. Acute toxicity should be treated with immediate withdrawal of ARIKAYCE, and baseline tests of renal function should be undertaken. Hemodialysis may be helpful in removing amikacin from the body. In all cases of suspected overdosage, physicians should contact the Regional Poison Control Center for information about effective treatment.
U.S. INDICATION
LIMITED POPULATION: ARIKAYCE® is indicated in adults, who have limited or no alternative treatment options, for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen in patients who do not achieve negative sputum cultures after a minimum of 6 consecutive months of a multidrug background regimen therapy. As only limited clinical safety and effectiveness data for ARIKAYCE are currently available, reserve ARIKAYCE for use in adults who have limited or no alternative treatment options. This drug is indicated for use in a limited and specific population of patients.
This indication is approved under accelerated approval based on achieving sputum culture conversion (defined as 3 consecutive negative monthly sputum cultures) by Month 6. Clinical benefit has not yet been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Limitation of Use:
ARIKAYCE has only been studied in patients with refractory MAC lung disease defined as patients who did not achieve negative sputum cultures after a minimum of 6 consecutive months of a multidrug background regimen therapy. The use of ARIKAYCE is not recommended for patients with non-refractory MAC lung disease.
Patients are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088. You can also call the Company at 1-844-4-INSMED.
Please see Full Prescribing Information.
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines — including two approved therapies to treat chronic, debilitating lung diseases — as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology & Inflammation, and Neuro & Other Rare. The Company's research engine is advancing a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, RNA end-joining, and synthetic rescue, in the pursuit of future pipeline candidates.
Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.
Forward-Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. "Forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995, are statements that are not historical facts and involve a number of risks and uncertainties. Words herein such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "predicts," "intends," "potential," "continues," and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) may identify forward-looking statements.
The forward-looking statements in this press release are based upon the Company's current expectations and beliefs, and involve known and unknown risks, uncertainties and other factors, which may cause the Company's actual results, performance and achievements and the timing of certain events to differ materially from the results, performance, achievements or timings discussed, projected, anticipated or indicated in any forward-looking statements. Such risks, uncertainties and other factors include, among others, the following: failure to continue to successfully commercialize ARIKAYCE in the U.S., Europe, or Japan or failure to successfully commercialize BRINSUPRI in the U.S., Europe, or Japan, or to maintain U.S., European, or Japanese approval for ARIKAYCE or BRINSUPRI; our inability to obtain full approval of ARIKAYCE from the FDA or our failure to obtain regulatory approval to expand ARIKAYCE's indication to a broader patient population; failure to obtain, or delays in obtaining, regulatory approvals for our product candidates in the U.S., Europe or Japan, for ARIKAYCE outside of the U.S., Europe, and Japan, including separate regulatory approval for the Lamira® Nebulizer System in each market and for each usage, or for BRINSUPRI outside of the U.S., Europe, and Japan; failure to successfully commercialize our product candidates, if approved by applicable regulatory authorities, or to maintain applicable regulatory approvals for such product candidates, if approved; uncertainties or changes in the degree of market acceptance of our marketed products or, if approved, our product candidates, by physicians, patients, third-party payors and others in the healthcare community; our inability to obtain and maintain adequate reimbursement from government or third-party payors for our marketed products or, if approved, our product candidates, or acceptable prices for our marketed products or, if approved, our product candidates; inaccuracies in our peak sales estimates for our marketed products and our product candidates; inaccuracies in our estimates of the size of the potential markets for our marketed products and our product candidates or in data we have used to identify physicians, expected rates of patient uptake, duration of expected treatment, or expected patient adherence or discontinuation rates; failure of third parties on which we are dependent to manufacture sufficient quantities of our marketed products and our product candidates for commercial or clinical needs, as applicable, to conduct our clinical trials, or to comply with our agreements or laws and regulations that impact our business; risks and uncertainties associated with, and the perceived benefits of, our senior secured loan with certain funds managed by Pharmakon Advisors, LP and our royalty financing with OrbiMed Royalty & Credit Opportunities IV, LP, including our ability to maintain compliance with the covenants in the agreements for the senior secured loan and royalty financing and the impact of the restrictions on our operations under these agreements; our inability to create or maintain an effective direct sales and marketing infrastructure or to partner with third parties that offer such an infrastructure for distribution of our marketed products or any of our product candidates that are approved in the future; failure to successfully conduct future clinical trials for our marketed products or our product candidates and our potential inability to enroll or retain sufficient patients to conduct and complete the trials or generate data necessary for regulatory approval of our product candidates; development of unexpected safety or efficacy concerns related to our marketed products or our product candidates; risks that our clinical studies will be delayed, that serious side effects will be identified during drug development, or that any protocol amendments submitted will be rejected; failure to successfully predict the time and cost of development, regulatory approval and commercialization for novel gene therapy products; risk that interim, topline or preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available or may be interpreted differently if additional data are disclosed, or that blinded data will not be predictive of unblinded data; risk that our competitors may obtain orphan drug exclusivity for a product that is essentially the same as a product we are developing for a particular indication; our inability to attract and retain key personnel or to effectively manage our growth; our inability to successfully integrate our acquisitions and appropriately manage the amount of management's time and attention devoted to integration activities; risks that our acquired technologies, products and product candidates will not be commercially successful; inability to adapt to our highly competitive and changing environment; inability to access, upgrade or expand our technology systems or difficulties in updating our existing technology or developing or implementing new technology; risk that we are unable to maintain our significant customers; risk that healthcare legislation or other government action materially adversely affects our business; business or economic disruptions due to catastrophes or other events, including natural disasters or public health crises; risk that our current and potential future use of AI and machine learning may not be successful; deterioration in general economic conditions in the U.S., Europe, Japan and globally, including the effect of prolonged periods of inflation, affecting us, our suppliers, third-party service providers and potential partners; risk that we could become involved in costly intellectual property disputes, be unable to adequately protect our intellectual property rights or prevent disclosure of our trade secrets and other proprietary information, and incur costs associated with litigation or other proceedings related to such matters; restrictions or other obligations imposed on us by agreements related to our marketed products or our product candidates, including our license agreements with PARI and AstraZeneca AB, and failure to comply with our obligations under such agreements; the cost and potential reputational damage resulting from litigation to which we are or may become a party, including product liability claims; risk that our operations are subject to a material disruption in the event of a cybersecurity attack or issue; changes in laws and regulations applicable to our business, including any pricing reform and laws that impact our ability to utilize certain third parties in the research, development or manufacture of our product candidates, and failure to comply with such laws and regulations; our history of operating losses, and the possibility that we never achieve or maintain profitability; goodwill impairment charges affecting our results of operations and financial condition; inability to repay our existing indebtedness and uncertainties with respect to our ability to access future capital; and delays in the execution of plans to build out an additional third-party manufacturing facility approved by the appropriate regulatory authorities and unexpected expenses associated with those plans.
The Company may not actually achieve the results, plans, intentions or expectations indicated by the Company's forward-looking statements because, by their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. For additional information about the risks and uncertainties that may affect the Company's business, please see the factors discussed in Item 1A, "Risk Factors," in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and any subsequent Company filings with the Securities and Exchange Commission (SEC).
The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date of this press release. The Company disclaims any obligation, except as specifically required by law and the rules of the SEC, to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.
Contact:
Investors:
Sara Bonstein
Chief Financial Officer
[email protected]
Společnost SAIC dokončila akvizici Information Security Corporation, čímž rozšířila své schopnosti v oblasti zero-trust, postkvantové kryptografie a šifrování. Finanční podmínky transakce nebyly zveřejněny.
RESTON, Va., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC), a leading mission integrator supporting defense, space, intelligence, and civilian agencies, today announced it has completed the acquisition of Information Security Corporation (ISC).
For more than three decades, ISC has delivered public key infrastructure (PKI), encryption, and credential management software to some of the most security-conscious organizations in government and industry, providing the critical cryptographic building blocks for confidentiality, integrity, and availability of sensitive data. Engineered with a forward-looking focus on automation and crypto-agility, ISC’s product suite helps customers modernize their cryptographic infrastructure and transition to post-quantum cryptography. The suite spans PKI and data protection solutions, including CertAgent, which has been on the National Security Agency’s Commercial Solutions for Classified (CSfC) Components List for more than a decade.
“This strategic tuck-in acquisition reflects our disciplined approach to investing in technology and capabilities that address the nation’s most critical challenges,” said Jim Reagan, Chief Executive Officer of SAIC. “Integrating ISC’s mission-proven cryptographic technologies with SAIC’s pedigree of delivering and operating robust zero-trust architectures, provides our intelligence and defense customers with the security and scalability to protect against rapidly evolving threats.”
“Joining SAIC marks an exciting new chapter for ISC and our employees,” said Jonathan Schulze-Hewett, Vice President of Development at ISC. “For more than three decades, our team has built innovative products to solve some of our customers’ most difficult security challenges. Joining SAIC gives us the opportunity to build on that work and bring ISC’s technology to more customers and more missions.”
ISC's technology is deeply embedded across the U.S. intelligence community and Department of War, supporting identity, authentication, and data protection in some of the government's most sensitive environments.
Financial terms were not disclosed. SAIC was supported by KPMG and ISC was advised by TideLock Partners.
About SAIC
SAIC® is a premier mission integrator focused on advancing the power of technology and innovation to serve and protect our world. Our robust portfolio of offerings across the defense, space, intelligence, and civilian markets includes secure high-end solutions in mission IT, enterprise IT, engineering services, and professional services. We integrate emerging technology, rapidly and securely, into mission critical operations that modernize and enable critical national imperatives.
We are approximately 23,000 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has annual revenues of approximately $7.3 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.
Forward-Looking Statements
Certain statements in this release contain or are based on “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,” and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at www.saic.com or on the SEC’s website at www.sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.
Four packaged food stocks sit on the same grocery shelves, but their dividends tell completely different stories about which companies are quietly rebuilding and which ones are still in danger of the next cut.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The center of the grocery store has been a hard place to own stocks. Conagra Brands (NYSE:CAG | CAG Price Prediction) has lost 48.84% of its value over five years, and General Mills (NYSE:GIS) and Campbell’s (NASDAQ:CPB) have also fallen hard. J.M. Smucker (NYSE:SJM) has gone the other way. All four sell off the same shelves, but each one leaves income investors with a very different dividend check and a very different level of safety.
General Mills: 127 Years of Payments and an Ultra-High Yield With a Catch General Mills yields about 7.6% on its $2.44 annualized dividend at a share price of $32.02. It qualifies as an ultra-high-yield stock, but consider where that yield came from. The quarterly payout has been $0.61 since 2025, while the shares are down 27.83% year to date and 35.86% over five years. When the price falls and the dividend stays the same, the yield rises on its own. In this case the high yield reflects doubt in the market, with the payout itself unchanged.
Its dividend history is strong. General Mills is in its 127th consecutive year of continuous dividends, and the quarterly rate went from $0.59 to $0.60 to $0.61 before leveling off. Coverage is lower. Against fiscal 2027 adjusted EPS guidance of $3.00 to $3.20, the dividend uses roughly 76% to 81% of earnings. Fiscal 2026 free cash flow was $1.63B. In the seasonally light first quarter, free cash flow came to $207.3 million, while dividends paid were $330.5M. Leverage is running “just a touch” above four times net debt to EBITDA, against a three-times target that management says will take “at least a couple years” to reach.
Bull case: The company’s pressures have names. Stretched shoppers are waiting for promotions, smaller insurgent brands are taking fruit snack share, and Wilderness dry dog food is shrinking. Management is responding with $750 million of fiscal 2027 cost savings, $3 billion in total by fiscal 2030, and new products that grew from 3% to 5% of net sales. Organic sales held flat last quarter, and adjusted EPS of $0.75 beat the $0.72 consensus.
Risk: Adjusted operating profit is guided down 8% to 13% in constant currency this fiscal year, which leaves very little room for the payout to grow.
Campbell’s: A 36% Dividend Cut That Rebuilds Coverage Campbell’s yields about 5.1% on its new $1 annualized dividend at $19.62. Trailing yield screens show a bigger number because they still include the old $0.39 checks. If you buy at today’s price, the reset rate is what you will collect. The shares are down 25.13% year to date and 41.77% over five years.
The board cut the quarterly payout to $0.25, a 36% reduction, to speed up debt reduction. Before that, the dividend rose in small steps: $0.35 from 2017, $0.37 from late 2021 and $0.39 from 2025. Coverage is now much better. The new rate uses about 56% to 61% of fiscal 2027 adjusted EPS guidance of $1.65 to $1.80. Fiscal 2026 free cash flow was $678 million, against $470 million of dividends at the old rate. The balance sheet is the pressure point: total liabilities are $11.49B against equity of $3.85B, and a $500 million bond comes due in March.
Chief executive Mick Beekhuizen called the cut “a difficult decision, but it’s an unfortunately necessary decision that we needed to take.”
Bull case: Rao’s, Goldfish, Pepperidge Farm and Swanson give Campbell’s real pricing power, and Meals & Beverages organic sales grew 3%. A new $500M cost-savings program runs through fiscal 2030, and the company plans price increases on roughly 60% of its portfolio.
Risk: Snacks are getting worse. Segment operating earnings fell 34% in the fourth quarter, and the company took $117M in impairments on its Cape Cod and Kettle Brand trademarks.
Conagra Brands: Half the Dividend, Full Focus on Debt Conagra yields about 5.2% on its $0.70 annualized payout at $13.36. Income investors should know that “held flat” describes a level that was already cut. The quarterly dividend dropped from $0.35 to $0.175, a 50% reduction, and the latest declaration kept it at that level. Trailing screens still show the old payments. The shares are down 18.46% year to date.
The lower rate is easy to cover. It uses about 47% to 50% of fiscal 2027 adjusted EPS guidance of $1.40 to $1.50. Fiscal 2026 free cash flow was $978.7 million, against $669.7 million of dividends at the old rate. First-quarter free cash flow was negative $127.9M because of legal payments and a seasonal inventory build. Leverage was 3.99 times, and management plans to pay down about $250 million of debt this year. The dividend history shows steady increases, from $0.2125 between 2018 and 2020 up to $0.35 from 2023, before the cut.
“Our target is three times,” CFO Dave Marberger said. “We are maniacally focused on getting there as soon as possible.”
Bull case: First-quarter adjusted EPS of $0.41 beat the $0.28 consensus, and Ardent Mills equity earnings rose 71.8%. Frozen volumes are falling, and higher gas prices are cutting into convenience-store snack traffic. Management is responding by trimming SKUs across a single-serve meal portfolio of more than 400 SKUs, dropping Celeste Pizza and raising marketing spend to 3% of net sales.
Risk: Costs are rising faster than planned. Cost of goods inflation is running near 7%, and transportation inflation is double the company’s original plan.
J.M. Smucker: Outlier in the Aisle With a Growing Payout Smucker yields about 3.8% on its $4.48 forward dividend at $117.21. Here the yield math runs in reverse. The stock is up 23.46% year to date, 13.15% over the past year and 16.46% over five years. A rising price has kept the yield modest even as the payout keeps growing.
This is the strongest dividend of the four. The quarterly rate rose from $1.10 to $1.12, and it has increased every year since 2017, when it was $0.75. The forward payout uses only about 41% to 43% of raised fiscal 2027 adjusted EPS guidance of $10.50 to $11.00. Full-year free cash flow guidance went up to about $1.1B, and first-quarter free cash flow alone was $337.3M. Smucker already reached its three-times leverage target in the quarter and plans to pay down roughly $500 million of debt. Management said, “We remain committed to the quarterly dividend, which we recently announced an increase.”
Bull case: Coffee has pricing power. U.S. Retail Coffee grew 13% to $807.8M, and Café Bustelo grew 23%. Uncrustables growth guidance was raised to high single digits, with new capacity coming online in McCalla, Alabama. Even after the rally, the stock trades at about 12 times forward earnings.
Risk: The headline beat had help. First-quarter adjusted EPS of $3.24 included a $0.84 per share benefit from one-time tariff refunds, and Hostess sales fell 7%.
Coverage and Debt Separate the Payouts That Hold The dividends in this group that can hold share three things: a payout well below earnings, free cash flow that grows, and leverage already near target. Smucker has all three. Campbell’s and Conagra cut their payouts to rebuild coverage. General Mills offers the highest yield of the group, but it also has the weakest earnings coverage, and its stock price has done the most to push that yield up. The same warning signs that preceded the Campbell’s and Conagra cuts tend to show up well before a board acts, and we catalogued them in a free guide to spotting dividend traps. In packaged food, the yields that held up came from companies that kept growing their cash flow.
Contact [email protected] for any questions or corrections.
BridgeBio uvedla, že BBP-418 ve studii FORTIFY v 12. měsíci normalizoval HS troponin I u 100 % léčených pacientů s LGMD2I/R9 oproti 40 % na placebu. Léčba také zlepšila nebo stabilizovala LVEF u 54 % pacientů versus 25 % na placebu.
- In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with BBP-418 returned to the normal range by Month 12 versus 40% in the placebo arm (p=0.0248); HS troponin I, a blood marker of heart muscle injury, declined more with BBP-418 than placebo (LS mean difference -17.8 ng/L; 95% CI: -35.1 to -0.5; p=0.0443)
- 54% of BBP-418-treated individuals had stable or improved LVEF at Month 12 versus 25% in the placebo arm (p=0.0262)
- In data presented separately, BBP-418 treatment of LGMD2I/R9 in FORTIFY increased mean glycosylated αDG by Month 3 to the levels of asymptomatic heterozygous FKRP carriers, who do not exhibit disease; this result was sustained through Month 12
- Taken together, these findings support the potential of BBP-418 to act as a disease modifying therapy by addressing the condition at its source
- BBP-418 is under FDA Priority Review with a PDUFA target action date of November 27, 2026
PALO ALTO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a biopharmaceutical company focused on developing medicines for genetic conditions, today presented new exploratory cardiac data from the 12-month interim analysis of FORTIFY, the Phase 3 clinical trial of oral BBP-418 in individuals living with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9) (FKRP-related). The data were presented in an oral presentation at the 31st annual Congress of the World Muscle Society in Hiroshima, Japan by Volker Straub, M.D., Ph.D. of Newcastle University, UK.
“Cardiac involvement is a major driver of morbidity and mortality in LGMD2I/R9, which is why it remains one of the greatest concerns for people living with the condition, families and treating physicians. Historically, we have been able to monitor the heart and manage complications, but we have not been able to address the underlying cause of the disease," said Dr. Straub. “What stands out in this analysis is how consistent it is: high-sensitivity troponin I fell and, in those who entered the study with elevated levels, it normalized; ejection fraction stabilized; and this happened alongside walking farther and breathing better. It’s encouraging to see that the therapeutic approach seems to work across the whole muscular system, including the heart.”
Cardiomyopathy affects approximately 30% of individuals with LGMD2I/R9 and approximately 60% of those with other FKRP genotypes, and is progressive, with an annual loss of approximately 0.4% of left ventricular ejection fraction (LVEF). In FORTIFY, 22.9% of participants (25/109) had elevated high-sensitivity (HS) troponin I at baseline and 17.1% (18/105) had an LVEF below 50%. Exploratory cardiac findings at Month 12 showed:
HS troponin I is a blood test used to detect injury to heart muscle. 100% of the participants treated with BBP-418 returned to the normal range for HS troponin l by Month 12 versus 40% in the placebo arm (p=0.0248); HS troponin I declined more with BBP-418 than placebo (LS mean difference -17.8 ng/L; 95% CI: -35.1 to -0.5; p=0.0443)At Month 12, 54% of participants treated with BBP-418 had stable or improved LVEF, a measurement of how much blood the heart's main chamber pushes out with each beat, compared with 25% of those on placebo (p=0.0262)Both HS troponin I and LVEF will continue to be monitored in the ongoing FORTIFY study
A consistent pattern across the FORTIFY interim analysis is the proportion of treated individuals reaching normal or near-normal levels on markers of the disease e.g., 38% of patients whose CK reached normal levels. In addition to the HS troponin I finding, in which 100% of evaluable BBP-418-treated participants with elevated levels at baseline returned to the normal range by Month 12, separate data presented at WMS 2026 by Anne Katrine Kjemsø Jensen, a medical student in the laboratory of John Vissing M.D., D.M.Sci., Copenhagen Neuromuscular Center of Rigshospitalet, DK, quantified αDG glycosylation in 34 asymptomatic heterozygous FKRP carriers. Results showed:
Asymptomatic carriers showed significantly reduced glycosylation versus healthy controls, thereby establishing a reference point for the level associated with normal muscle function (34% of control)In FORTIFY, BBP-418 treatment increased mean glycosylated αDG above carrier levels by Month 12, suggesting that BBP-418 can restore glycosylated αDG to asymptomatic levelsWhile many therapies in progressive neuromuscular disease aim to slow decline, BBP-418 was developed to target LGMD2I/R9 at its source, and the pattern of biomarker normalization observed to date, alongside functional improvement from baseline rather than stabilization, is consistent with the potential for BBP-418 to be a disease modifying therapy
In the Phase 3 FORTIFY trial, BBP-418 met all primary and secondary endpoints at the pre-specified 12-month interim analysis, showing treated individuals improving while placebo recipients declined across every key measure. These results were presented as a late-breaking oral presentation at the 2026 MDA Clinical and Scientific Conference, which are available here.
BridgeBio believes BBP-418 is positioned to become the first and only approved therapy for individuals living with LGMD2I/R9, addressing a significant unmet need in this disease and potentially representing the first approval of a therapy for any form of LGMD. Approximately 7,000 individuals currently live with LGMD2I/R9 and other addressable α-dystroglycanopathies in the U.S. and Europe. BBP-418 is under FDA Priority Review with a PDUFA target action date of November 27, 2026. The Company is also engaging regulatory agencies to identify an expedited path to approval for BBP-418 in Europe.
BBP-418 has previously received Orphan Drug, Fast Track, and Rare Pediatric Disease Designations from the FDA and Orphan Drug Designation from the European Medicines Agency (EMA). BBP-418 received Priority Review from the FDA, highlighting the potential for BBP-418 to address unmet need in LGMD2I/R9. Consistent with Rare Pediatric Designation from the FDA, if BBP-418 is approved, BridgeBio may qualify for a Priority Review Voucher. The Company intends to initiate clinical studies of BBP-418 in LGMD2I/R9 for individuals less than 12 years of age in the first half of 2027 and in LGMD2M/R13 and LGMD2U/R20 in the near future.
About Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
LGMD2I/R9 is a monogenic autosomal recessive disease caused by partial loss of function mutations in the fukutin-related protein (FKRP) gene, and FKRP mutations impair glycosylation of alpha-dystroglycan (αDG), a protein associated with stabilizing muscle cells. Clinical manifestations typically present as a skeletal myopathy affecting the lower and then upper limbs, which is commonly later accompanied by pulmonary muscle and cardiac muscle involvement. Individuals who harbor a homozygous L276I genotype typically develop disease manifestations during late childhood with progression to loss of independent ambulation (25%), assisted ventilation (10%), and cardiomyopathy (30%) in adulthood. Cardiomyopathy is progressive, with an annual loss of 0.4% of left ventricular ejection fraction (LVEF). Individuals with other FKRP genotypes typically have an earlier childhood onset with a more severe clinical course, rapid loss of mobility by 20 years of age, more frequent cardiac involvement (60%), and eventual pulmonary decline by 30 years of age in nearly all cases.
About BBP-418
BBP-418 is an investigational oral glycosylation substrate therapy with potential to be the first and only therapy for LGMD2I/R9. BBP-418 is designed to saturate the partially functional FKRP enzyme with substrate thereby enhancing residual FKRP function and restoring glycosylation of αDG. Through restoration of αDG glycosylation, BBP-418 may stabilize or improve muscle function, including gross motor, ambulatory, and cardiopulmonary function.
About BridgeBio
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, YouTube, and TikTok.
BridgeBio Forward-Looking Statements
This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), which are usually identified by the use of words such as “anticipates,” “believes,” “continues,” “estimates,” “expects,” “hopes,” “intends,” “may,” “plans,” “projects,” “remains,” “seeks,” “should,” “will,” and variations of such words or similar expressions. BridgeBio intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements include statements regarding the potential clinical significance and therapeutic implications of data regarding BBP-418, including the potential for BBP-418 to act as a disease-modifying therapy for LGMD2I/R9, restore or normalize disease biomarkers, and stabilize or improve cardiac, gross motor, ambulatory and pulmonary function; the potential for BBP-418 to become the first and only approved therapy for individuals living with LGMD2I/R9 and potentially the first approved therapy for any form of LGMD; the timing and likelihood of potential regulatory approval and commercialization of BBP-418, including the PDUFA target action date of November 27, 2026; BridgeBio’s interactions with regulatory authorities regarding a potential expedited path to approval for BBP-418 in Europe; BridgeBio’s potential eligibility to receive a Priority Review Voucher if BBP-418 is approved; the continued evaluation of cardiac and other clinical measures in the ongoing FORTIFY study; and BridgeBio’s plans to initiate additional clinical studies of BBP-418, including in individuals with LGMD2I/R9 less than 12 years of age and in individuals with LGMD2M/R13 and LGMD2U/R20. Although the Company believes that its plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable, the Company can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks, uncertainties and assumptions, including, but not limited to, initial and ongoing data from the Company’s preclinical studies and clinical trials not being indicative of final data; the exploratory and non-alpha-controlled nature of certain analyses described in this press release and the small sample sizes on which certain of those analyses are based; that observed biomarker changes, including normalization of HS troponin I, glycosylated αDG or other disease markers, may not be replicated in additional analyses or studies or predict or translate into long-term clinical benefit, sustained improvement in cardiac or other muscle function, or prevention of disease progression; that BBP-418 may not demonstrate the anticipated efficacy, safety, therapeutic benefit or disease-modifying potential in ongoing or future clinical studies; that the design, enrollment, conduct, timing and success of ongoing and planned clinical trials may differ from current expectations; that the FDA or other regulatory authorities may not approve BBP-418 on the anticipated timeline or at all, may not agree with BridgeBio’s regulatory approval strategies, clinical trial designs, conduct or methodologies, or the sufficiency of data submitted, or may require additional data, studies or other information; that BBP-418 may not become the first and only approved therapy for LGMD2I/R9 or the first approved therapy for any form of LGMD; that BridgeBio may not identify or obtain an expedited path to approval for BBP-418 in Europe; that BridgeBio may not qualify for or receive a Priority Review Voucher; that plans to initiate additional clinical studies, including studies in individuals less than 12 years of age or in other forms of LGMD, may be delayed, modified or may not occur as expected; the potential size of the target patient populations BBP-418 is designed to treat not being as large as anticipated; the impacts of current macroeconomic and geopolitical events, including changing conditions from hostilities in Ukraine and the Middle East, increasing rates of inflation and changing interest rates, on business operations and expectations, as well as those risks set forth in the Risk Factors section of the Company’s most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K and the Company’s other filings with the U.S. Securities and Exchange Commission. Moreover, the Company operates in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of the Company’s management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, BridgeBio assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
SEATTLE and WASHINGTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sabey Corporation ("Sabey") and National Real Estate Advisors, LLC ("National") today announced that Ares Secondaries funds (“Ares”) have expanded their investment in Sabey Data Center Properties, LLC ("SDCP"), an owner, developer, and operator of data centers across the United States. The additional commitment builds on Ares' minority equity investment in SDCP announced in July 2026, bringing its total investment to more than $500 million.
SDCP is a fully integrated data center platform that owns and operates hyperscale and enterprise data center campuses located in top-tier United States data center markets totaling 275 megawatts (MW), with an expansion pipeline expected to reach approximately 737 MW by 2033.
"This follow-on investment reflects continued conviction in SDCP's long-term value proposition and growth trajectory," said Kevin Verdi, Executive Vice President & Chief Investment Officer at National Real Estate Advisors. "We remain focused on disciplined growth and delivering the digital infrastructure needed to support the next generation of cloud and AI demand."
"We are pleased to deepen our relationship with Ares as we continue executing on our long-term growth strategy,” Tim Mirick, President of Sabey Data Center Properties, added. “This additional commitment reflects confidence in the strength of our platform and our ability to develop and operate the mission-critical infrastructure our customers rely on."
“We are pleased to expand our investment in SDCP and build on our relationship with the Sabey and National teams as we continue to see significant runway for growth,” said Jamie Sunday, Co-Head of Real Estate Secondaries at Ares.
The additional investment further aligns three long-term partners committed to supporting SDCP's continued growth and expanding the platform's ability to serve customers across an increasingly data-driven economy.
To learn more about Sabey Corporation, visit https://sabey.com/.
To learn more about SDCP, visit: https://sabeydatacenters.com.
About Sabey Data Center Properties (SDCP)
With a portfolio of more than four million square feet of mission-critical space, Sabey Data Centers is one of the largest privately owned multi-tenant data center owners/developers/operators in the United States. Sabey specializes in scalable, custom-built data center solutions recognized for their efficiency, low total cost of ownership, operational maturity and sustained uptime. Sabey provides sustainable data center services to many of the world's top financial, technology and healthcare companies. The company is a joint venture between Sabey Corporation and National Real Estate Advisors, LLC, acting as the investment manager on behalf of its institutional clients.
To learn more about Sabey Data Centers, please visit sabeydatacenters.com.
About Sabey Corporation
Sabey is a privately held commercial real estate development and investment company established in 1971 specializing in data center, medical and life sciences, education, government and military properties. Headquartered in Tukwila, Sabey employs more than 270 people.
About National Real Estate Advisors, LLC
National Real Estate Advisors, LLC ("National") is an investment manager developing, operating, and managing commercial real estate and infrastructure projects across the United States.
Since 2000, National has built diversified investment portfolios currently concentrated primarily in multifamily, data centers, healthcare-related, and mixed-use facilities. The firm manages separate accounts and commingled investment vehicles on behalf of investors, applying a disciplined investment process and development-led approach to value creation.
National is an independently operated subsidiary of the National Electrical Benefit Fund ("NEBF"), a pension trust with assets that are managed by National on a discretionary basis. For more information, please visit www.natadvisors.com.
About Ares Management Corporation
Ares Management Corporation (NYSE: ARES) is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, real estate, private equity and infrastructure asset classes. We seek to advance our stakeholders' long-term goals by providing flexible capital that supports businesses and creates value for our investors and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of June 30, 2026, Ares Management Corporation's global platform had over $671 billion of assets under management, with operations across North America, South America, Europe, Asia Pacific and the Middle East. For more information, please visit www.ares.com.
C.H. Robinson koupí RXO v hotovostně-akciové transakci za implikovanou hodnotu 5,8 mld. USD. Spojená společnost čeká do dvou let od uzavření synergie kolem 300 mil. USD.
EDEN PRAIRIE, Minn. & CHARLOTTE, N.C.--(BUSINESS WIRE)--C.H. Robinson Worldwide, Inc. (“C.H. Robinson”) (Nasdaq: CHRW) and RXO Inc. (NYSE: RXO) (“RXO”), a Fortune 1000 provider of asset-light tech-enabled transportation solutions, today announced that they have entered into a definitive agreement (the “Merger Agreement”) under which C.H. Robinson will acquire RXO in a stock-and-cash transaction for an implied value of $5.8 billion and will create a combined company with an enterprise value of over $25 billion.
This transaction is a natural next step in our transformation, allowing us to create a more scaled, resilient North American third-party logistics provider positioned to offer exceptional customer service and redefine the future of our industry.
Share The acquisition of RXO brings together two complementary networks and diversifies and strengthens C.H. Robinson’s multi-modal platform to accelerate its growth and increase its penetration across all modes and segments. Combining both companies’ robust trucking brokerage and managed transportation businesses, along with C.H. Robinson’s global forwarding and RXO’s strengths in expedited and last mile, will create a more comprehensive offering for customers across a larger and denser network. Through the implementation of its proven Lean AI operating model across RXO’s business, C.H. Robinson expects to realize approximately $300 million of net run-rate cost synergies within two years post-close. The companies expect these productivity improvements to create a more resilient platform to drive profitable growth with enhanced operating leverage and improved margins regardless of the freight market environment.
“This transaction is a natural next step in our transformation, allowing us to create a more scaled, resilient North American third-party logistics provider positioned to offer exceptional customer service and redefine the future of our industry,” said Dave Bozeman, C.H. Robinson President and Chief Executive Officer. “Like C.H. Robinson, RXO is a customer-focused company with expertise and talent that will allow us to expand our capabilities to better support customers of all sizes on their most complex challenges. By applying our proven Lean AI model to RXO’s business, we expect to significantly enhance productivity to unlock compelling cost synergies. We are confident our experienced team and disciplined execution plan will allow us to seamlessly integrate our organizations and position the combined company to capture the expected synergies, drive innovation and deepen customer relationships to enhance profitable growth and shareholder value.”
Drew Wilkerson, RXO Chairman and Chief Executive Officer, said, “Joining C.H. Robinson represents an exciting next chapter for our company, our employees and our customers. We have built a strong business by staying relentlessly focused on our customers, operating with agility and delivering solutions that help them navigate an increasingly complex supply chain. By bringing together our complementary capabilities, talented teams and shared commitment to service, we will be able to offer customers greater scale, broader capabilities and even more value. I’m incredibly proud of what our team has built and excited about the opportunities ahead as part of C.H. Robinson.”
Adam R. Karr, President and Portfolio Manager at Orbis Investments, said, “Orbis is RXO’s largest shareholder and has owned the Company since it became independent. We know the business and the team well, and we fully support this transaction. It gives RXO shareholders substantial cash today and continued ownership in a combined platform with significant upside.”
Strategic & Financial Benefits
Unlocks compelling cost synergy opportunities through C.H. Robinson’s Lean AI operating model – C.H. Robinson expects to unlock significant productivity improvements and drive operating margin expansion as it applies its proven Lean AI operating model to RXO’s business. The transaction is expected to deliver approximately $300 million of net run-rate cost synergies within two years following the transaction close, through cost-to-serve opportunities, operating efficiencies, shared-services savings and third-party spend optimization. The anticipated synergies will allow the combined company to increase operating leverage and drive significant shareholder value creation. The acquisition will also significantly expand C.H. Robinson’s proprietary datasets, enhancing the speed and precision of its AI-driven sales, matching and procurement capabilities. Increases scale in a large and fragmented market – The addition of RXO will improve C.H. Robinson’s network density and expand its capabilities, enhancing penetration across verticals and increasing volumes. The combined company’s complementary platform and diversified customer exposure will increase market visibility and enhance its ability to drive growth through market cycles. Diversifies and strengthens offerings to support customers’ end-to-end needs – The transaction will bring together C.H. Robinson’s global, multi-modal solutions with RXO’s capabilities in North American brokerage, expedited and last mile to deliver more tailored solutions, creating opportunities to deepen relationships, increase wallet share and win new enterprise customers. The companies’ complementary commercial capabilities and diverse customer base will also create compelling cross-selling opportunities. Strengthens financial profile to support deleveraging – C.H. Robinson expects the transaction to be accretive to adjusted EPS1 within nine months of the transaction close and mid-teens accretive to adjusted EPS in 2028. Additionally, the anticipated productivity improvements are expected to increase cash flow generation to support rapid de-leveraging to C.H. Robinson’s target leverage range of 1.75x to 2.25x net debt to LTM adjusted EBITDA by the end of 2028, with flexibility to continue growth investments. C.H. Robinson expects to maintain its solid investment grade credit ratings and intends to pause share repurchases until it reaches its target leverage ratio after the transaction closes. Transaction Details
Under the terms of the merger agreement, RXO stockholders will receive $17.25 per share in cash and 0.0856 shares of C.H. Robinson common stock for each RXO share they own, representing an implied total consideration of $30.25 per share.2 The transaction represents a premium of 27% to RXO’s 90-day volume-weighted average price and 29% to RXO’s closing price on Friday, October 2, 2026. Under the terms of the merger agreement, RXO stockholders may elect to receive either (i) the standard mixed consideration consisting of $17.25 in cash and 0.0856 shares of C.H. Robinson common stock, (ii) all-cash consideration of $30.25 per share or (iii) all-stock consideration of 0.1992 shares of C.H. Robinson common stock, in each case subject to proration and adjustment procedures designed to ensure that, in the aggregate, approximately 57% of the merger consideration is paid in cash and 43% is paid in shares of C.H. Robinson common stock. RXO stockholders are expected to own 11% of the combined company upon transaction close.
The merger agreement, which was unanimously approved by the Boards of both companies, is expected to close in the first half of 2027 and is subject to customary closing conditions, including regulatory approval and approval by RXO’s stockholders. In connection with the execution of the Merger Agreement, MFN Partners LP has agreed, among other things, to vote all of its shares of RXO (which represents approximately 17%) in favor of the transaction and adoption of the Merger Agreement, and, subject to certain exceptions, not to transfer its shares.
C.H. Robinson will finance the cash consideration with new debt financing and has entered into a fully underwritten commitment for a bridge facility with Morgan Stanley Senior Funding, Inc. Upon completion of the transaction, C.H. Robinson will integrate RXO primarily into its NAST division.
For additional information regarding the transaction, including resources for customers, carriers, employees and investors, please visit www.CHRobinsonAcquiresRXO.com.
Advisors
Morgan Stanley & Co. LLC is acting as financial advisor to C.H. Robinson, Gibson, Dunn & Crutcher LLP is serving as its legal counsel and Joele Frank, Wilkinson Brimmer Katcher is serving as its strategic communications advisor. Goldman Sachs & Co. LLC is serving as financial advisor to RXO and Paul, Weiss, Rifkind, Wharton & Garrison LLP is serving as its legal counsel.
Conference Call and Webcast Information:
C.H. Robinson will host a conference call at 8:00 a.m. Eastern Time today to discuss the announcement. A slide presentation and a simultaneous live audio webcast of the conference call may be accessed through C.H. Robinson’s website at investor.chrobinson.com.
About C.H. Robinson
C.H. Robinson is the global leader in Lean AI supply chains. For more than a century, companies everywhere have looked to us to reimagine how goods move. Now, as we redefine what’s next for the industry, that same drive fuels our commitment to Building Tomorrow’s Supply Chains, Today™. Trusted by 75,000 customers and 450,000 contract carriers, we manage 37 million shipments annually, representing $23 billion in freight. We deliver tailored solutions across the world via truckload, less-than-truckload, ocean, air, and more. With our unique combination of human insight and Lean AI working as one, supply chains move faster, smarter, and more sustainably. As a responsible global citizen, we proudly contribute millions to the causes that matter most to our employees. For more information, visit us at chrobinson.com (Nasdaq: CHRW).
About RXO
RXO (NYSE: RXO) is a leading provider of asset-light transportation solutions. RXO offers tech-enabled truck brokerage services together with complementary solutions including managed transportation and last mile delivery. The company combines massive capacity and cutting-edge technology to move freight efficiently through supply chains across North America. The company is headquartered in Charlotte, N.C. Visit RXO.com for more information and connect with RXO on LinkedIn, Facebook, Instagram, X and YouTube.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Exchange Act. Statements that are not historical facts, including statements about beliefs, expectations, targets or goals, the expected timing of the closing of the proposed transaction, the anticipated benefits of the proposed transaction, including synergies, and expected future financial position, total addressable market and results of operations, are forward-looking statements. These statements are based on plans, estimates, expectations and/or goals at the time the statements are made, and readers should not place undue reliance on them. Some of these forward-looking statements can be identified by the use of forward-looking words such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “projects,” “strategy,” or “anticipates,” or the negative of those words or other comparable terminology. C.H. Robinson’s and RXO’s results may differ materially from the experience and results anticipated in such statements. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions including, but not limited to, the following factors: the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; the risk that the conditions to the closing of the proposed transaction are not satisfied, including the risk that required approvals of the transaction from the stockholders of RXO or from regulators are not obtained; litigation or regulatory action relating to the transaction; the risk that the proposed transaction may not be completed on the anticipated terms, in a timely manner or at all; uncertainties as to the timing of the consummation of the proposed transaction and the ability of each party to consummate the proposed transaction; risks that the proposed transaction disrupts the current plans or operations of C.H. Robinson or RXO; the effect of the announcement of the proposed transaction on the ability of C.H. Robinson or RXO to retain and hire key personnel; competitive responses to the proposed transaction; unexpected costs, charges or expenses resulting from the transaction; the risk that C.H. Robinson is unable to obtain the anticipated debt financing in connection with the proposed transaction on the anticipated timing or terms, or at all; potential adverse effects on the market price of RXO’s and/or C.H. Robinson’s common stock, credit ratings, or operating results; fluctuations in the market value of the merger consideration, which may vary from its value as of the date of the Merger Agreement or the date of this communication, as a result of changes in the market price of C.H. Robinson common stock; potential adverse reactions or changes to relationships with employees, customers, suppliers, distributors and other business partners resulting from the announcement, pendency or completion of the proposed transaction; restrictions during the pendency of the proposed transaction on RXO’s ability to pursue certain business opportunities or strategic transactions; the potential acquisition being more expensive to complete than anticipated, including as a result of unexpected factors or events, significant transaction costs or unknown liabilities; the combined company’s ability to achieve the synergies expected from the proposed transaction, as well as delays, challenges and expenses associated with integrating the combined company’s existing businesses or realizing the anticipated benefits of the proposed transaction; competitive factors, including but not limited to pricing pressures, industry consolidation, entry of new competitors into the industries in which C.H. Robinson and RXO operate, as well as new product and marketing initiatives by C.H. Robinson’s and RXO’s competitors; risks associated with cyber-attacks, information security and data privacy; diversion of management’s time and attention from C.H. Robinson’s and RXO’s ongoing business operations due to the proposed transaction; disruptions resulting from key management changes; unknown liabilities and uncertainties regarding general economic, market sector, competitive, legal, regulatory, tax and geopolitical conditions; and legislative, regulatory, economic, competitive or technological developments. Other factors that might cause such a difference include those discussed in C.H. Robinson’s and RXO’s filings with the SEC, which include their Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and in the registration statement on Form S-4 (including the proxy statement/prospectus) to be filed in connection with the proposed transaction. For more information, see the section entitled “Risk Factors” and the forward-looking statements disclosure contained in C.H. Robinson’s and RXO’s Annual Reports on Form 10-K and in other filings. Forward-looking statements should not be relied on as predictions of future events, and these statements are not guarantees of performance or results. The forward-looking statements included in this communication are made only as of the date hereof and, except as required by applicable law, C.H. Robinson and RXO undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Additional Information about the Proposed Transaction and Where to Find It
In connection with the proposed transaction, C.H. Robinson intends to file with the SEC a registration statement on Form S-4 that will include a preliminary proxy statement of RXO that also constitutes a preliminary prospectus of C.H. Robinson. C.H. Robinson and RXO also each plan to file other relevant documents with the SEC regarding the proposed transaction. After the registration statement is declared effective, the definitive proxy statement/prospectus will be mailed to stockholders of RXO. This communication is not a substitute for the registration statement, the proxy statement/prospectus or any other document that C.H. Robinson or RXO may file with the SEC in connection with the proposed transaction. INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT ON FORM S-4, PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.
Investors and stockholders will be able to obtain free copies of these documents (if and when available), and other documents containing important information about C.H. Robinson and RXO, once such documents are filed with the SEC through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by C.H. Robinson will be available free of charge on C.H. Robinson’s website at investor.chrobinson.com/financials/sec-filings. Copies of the documents filed with the SEC by RXO will be available free of charge on RXO’s website at investors.rxo.com.
Participants in the Solicitation
C.H. Robinson, RXO and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from RXO’s stockholders in respect of the proposed transaction. Information about the directors and executive officers of C.H. Robinson, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in (i) the C.H. Robinson’s proxy statement for its 2026 Annual Meeting of Shareholders, which was filed with the SEC on March 24, 2026, including under the sections captioned “Proposal 1: Election of Directors,” “Compensation of Directors,” “Compensation Discussion and Analysis,” “Executive Compensation Tables,” “Security Ownership of Certain Beneficial Owners and Management,” and “Related Party Transactions,” (ii)the C.H. Robinson Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 13, 2026, including under the section captioned “Information about our Executive Officers” in Part I, Item 1, and (iii) Item 5.02 of the C.H. Robinson’s Current Report on Form 8-K filed with the SEC on June 2, 2026. Information about the directors and executive officers of RXO , including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in (i) RXO’s proxy statement for its 2026 Annual Meeting of Stockholders, which was filed with the SEC on March 30, 2026, including under the sections captioned “Proposal 1: Election of Directors,” “Director Compensation,” “Certain Relationships and Related Party Transactions,” “Security Ownership of Certain Beneficial Owners and Management,” and “Compensation Discussion and Analysis,” and (ii) RXO’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 9, 2026, including under the section captioned “Information about our Executive Officers” in Part I, Item 1. To the extent holdings of RXO’s securities by its directors or executive officers have changed since the applicable “as of” date described in its 2026 proxy statement, such changes have been or will be reflected on Initial Statements of Beneficial Ownership of Securities on Form 3, Statements of Changes in Beneficial Ownership on Form 4 or Annual Statements of Changes in Beneficial Ownership on Form 5 filed with the SEC, including (i) the Form 4s filed by Mr. Wilkerson on May 4, 2026 and May 19, 2026; (ii) the Form 4 filed by Mr. Morris on May 18, 2026; and (iii) the Form 4 filed by Mr. Firestone on August 25, 2026.
Other information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed transaction when such materials become available. Investors and stockholders should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from C.H. Robinson and RXO using the sources indicated above.
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Comstock Resources zveřejní výsledky za 3. čtvrtletí 2026 po uzavření trhu 4. listopadu 2026. Následně uspořádá konferenční hovor 5. listopadu v 10:00 CT.
FRISCO, TX, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. (NYSE:CRK) plans to release its third quarter 2026 results on November 4, 2026 after the market closes and host its quarterly conference call at 10:00 a.m. CT on November 5, 2026 to discuss the third quarter results.
Parties interested in participating in the conference call telephonically will need to register at https://register-conf.media-server.com/register/BI962f0a6609044819bcc431a45cfea339. Upon registering to participate in the conference call, participants will receive the dial-in number and a personal PIN number to access the conference call. On the day of the call, please dial in at least 15 minutes in advance to ensure a timely connection to the call.
~~~
The conference call will also be broadcast live in listen-only mode and can be accessed via the website URL: https://edge.media-server.com/mmc/p/e9dram3p.
~~~
A replay of the third quarter 2026 conference call will be available for twelve months beginning at 1:00 p.m. CT on November 5, 2026. The replay of the conference can be accessed using the webcast link: https://edge.media-server.com/mmc/p/e9dram3p
About Comstock Resources:
Comstock Resources is a leading independent natural gas producer with operations focused on the development of the Haynesville Shale in North Louisiana and East Texas.
A slide show presentation on the financial results will be available on Comstock's website at www.comstockresources.com. Click on “Quarterly Results” to view the slide show.
Applied Optoelectronics dokončila svůj at-the-market program emise akcií za 600 milionů USD a prodala 5 694 845 akcií za průměrnou cenu 105,36 USD. Čistý výnos činil 587 999 985,89 USD.
, /PRNewswire/ -- Applied Optoelectronics, Inc. (NASDAQ: AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power AI, today announced that it has completed its previously disclosed $600 million "at-the-market" equity offering program (the "ATM Program").
AOI disclosed on August 21, 2026 that it filed a prospectus supplement with the U.S. Securities and Exchange Commission to offer and sell shares of its common stock having an aggregate offering price of up to $600,000,000. The Company sold a total of 5,694,845 shares at an average sales price of $105.36 per share, representing proceeds to the Company of $587,999,985.89, net of commissions and fees.
"We are pleased to have successfully completed our third at-the-market equity offering program this year, which strengthens our balance sheet and supports our ability to address growing demand for high-speed optical connectivity in AI data centers," said Dr. Thompson Lin, AOI's Founder, President and Chief Executive Officer. "We intend to use these proceeds to continue to make investments in the business, including new equipment and machinery for production and research and development use, as we continue to scale our advanced manufacturing capacity. We thank our shareholders for their continued support of AOI and welcome our new shareholders."
The Company currently intends to use the net proceeds from the ATM Program for general corporate purposes, which may include, among other things, debt repayment, working capital, and capital expenditures, primarily in support of its manufacturing expansion efforts for data center optical devices.
Forward-Looking Information
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "could," "would," "target," "seek," "aim," "predicts," "think," "objectives," "optimistic," "new," "goal," "priorities," "strategy," "potential," "is likely," "will," "expect," "momentum," "plan" "project," "permit," "positions" or by other similar expressions that convey uncertainty of future events or outcomes. These statements include management's beliefs and expectations regarding the use of proceeds from the ATM Program and planned investments in manufacturing capacity. Such forward-looking statements reflect the views of management at the time such statements are made. These forward-looking statements involve risks and uncertainties, as well as assumptions and current expectations, which could cause the company's actual results to differ materially from those anticipated in such forward-looking statements. These risks and uncertainties include but are not limited to: reduction in the size or quantity of customer orders; change in demand for the company's products due to industry conditions; changes in manufacturing operations; volatility in manufacturing costs; delays in shipments of products; disruptions in the supply chain; change in the rate of design wins or the rate of customer acceptance of new products; the company's reliance on a small number of customers for a substantial portion of its revenues; potential pricing pressure; a decline in demand for our customers' products or their rate of deployment of their products; general conditions in the internet datacenter, cable television (CATV) broadband, telecom, or fiber-to-the-home (FTTH) markets; changes in the world economy (particularly in the United States and China); changes in the regulation and taxation of international trade, including the imposition of tariffs; changes in currency exchange rates; the negative effects of seasonality; and other risks and uncertainties described more fully in the company's documents filed with or furnished to the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2025 and our Quarterly report on Form 10-Q for the quarter ended June 30, 2026. More information about these and other risks that may impact the company's business are set forth in the "Risk Factors" section of the company's quarterly and annual reports on file with the Securities and Exchange Commission. You should not rely on forward-looking statements as predictions of future events. All forward-looking statements in this press release are based upon information available to us as of the date hereof, and qualified in their entirety by this cautionary statement. Except as required by law, we assume no obligation to update forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in the company's expectations.
About AOI
Applied Optoelectronics, Inc. (AOI) is a leading developer and manufacturer of advanced optical and HFC networking products that are the building blocks for AI datacenters, CATV and broadband fiber access networks around the world. AOI supplies this critical infrastructure to tier-one customers across cloud computing, CATV broadband, telecom, and FTTH markets. The company has R&D facilities in Atlanta, GA, and engineering and manufacturing facilities at its corporate headquarters in Sugar Land, TX, as well as in Taipei, Taiwan and Ningbo, China. For additional information, visit www.ao-inc.com.
Pagaya Technologies v září klesla o 20 %, protože investoři se obávají dopadu vysokých sazeb a volatility dluhopisového trhu na její úvěrový byznys. Ve 2. čtvrtletí výnosy vzrostly o 19 % na 387 milionů USD a čistý zisk o 172 % na 45 milionů USD.
Shares of Pagaya Technologies (PGY +3.10%) stock fell 20% in September, according to data provided by S&P Global Market Intelligence. Investors are worried about how high interest rates and bond market volatility will impact the credit evaluation company.
The AI way to lend moneyPagaya operates a credit platform driven by artificial intelligence (AI) and machine learning. It teams up with client lenders, who have Pagaya's platform integrated into their systems, to assess borrower risk quickly and more accurately than traditional models. Client partners can then approve more loans without adding risk.
Image source: Getty Images.
The platform acts as a middleman, approving these loans and then selling them as asset-backed securities (ABS) to partnering funders. The software-based model is agile and low-cost, and Pagaya takes a fee from each loan. Each incremental loan from the same provider comes without marketing and acquisition costs, and the company's growth strategy involves adding new client partners as well as driving higher engagement with existing partners.
Pagaya already works with a stellar client list of 35 partners that includes Visa (V +0.23%), U.S. Bank (USB +0.26%), and SoFi Technologies (SOFI -0.44%). It has a long pipeline of new customers that are joining the platform, and its goal is to add two to four large clients annually, focusing on large banks and auto dealers.
Pagay isn't the only name in this space, but it has an advantage in its funding model. It has relationships with 170 institutional investors and has the funding before any loans are issued. It's the top issuer of personal ABS loans in the U.S., with a triple-A rating across categories.
Can it keep up high growth?Pagaya has been reporting consistent growth and increasing profits. In the second quarter, total revenue increased 19% year over year to $387 million, and net income increased 172% to $45 million. Volume increased 33%, so there's been no shortage of new loans to approve, so far, despite the high-interest rate environment. Growth was driven by auto loans.
Premium Feature
Moneyball Superscore
68/100
Today's Change
(
3.10
%) $
0.54
Current Price
$
17.98
However, it's highly exposed to the credit industry, which has been troubled by higher borrowing costs. One area where the pressure is showing is in fee revenue less production costs (FRLPC) margin, an industry profitability metric. FRLPC increased 16% over last year in the quarter, but the margin decreased by 0.61 percentage points to 4.2%, based in part on the increased cost of capital.
Pagaya stock isn't for the risk-averse investor, but for those with a high appetite for risk, Pagaya stock looks like a bargain today. At the lower price, it trades at under 14 times trailing 12-month earnings, which is cheap for a high-growth AI stock.
Osisko Gold hlásí ze zóny Lowhee v projektu Cariboo Gold nové výsledky vrtů s 7,28 g/t Au na 16,15 m a 7,13 g/t Au na 11,60 m. Výsledky mají posílit důvěru v převod zdrojů na zásoby a další mineralizaci.
HIGHLIGHTS 3,933 m of new infill drilling in 36 holes from the Lowhee Zone 1290 m level. Highlight intercepts include:7.28 g/t Au over 16.15 m (~105 m vertical depth), including 173.66 g/t Au over 0.60 m, 6.80 g/t Au over 0.50 m, 5.39 g/t Au over 0.50 m, and 3.58 g/t Au over 0.50 m7.13 g/t Au over 11.60 m (~61 m vertical depth), including 62.06 g/t Au over 0.50 m, 31.88 g/t Au over 0.80 m, 18.85 g/t Au over 0.50 m, 7.13 g/t Au over 0.85 m, 6.47 g/t Au over 0.90 m, and 2.23 g/t Au over 0.85 m
TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) ("Osisko Gold" or the "Company") is pleased to announce new results from its ongoing definition infill drilling program on 10-15 metre ("m") target spacing totaling 3,933 m in 36 holes drilled from the 1290 m level in the Lowhee Zone of the Company's flagship, permitted, 100%-owned Cariboo Gold Project (the "Project"), currently under construction in central British Columbia, Canada.
Chris Lodder, President, stated, "Ongoing underground infill drilling continues to strengthen our confidence in the Lowhee Zone of the Cariboo Gold deposit. Intercepts outside the modelled reserve stopes also suggest potential for resource conversion and upside mineralization, reinforcing the Cariboo Gold Project's potential as underground development advances into new zones."
Corporate Updates
In connection with the ongoing construction of the Cariboo Gold Project, the Company, through its wholly-owned subsidiary, Barkerville Gold Mines Ltd., has awarded the continuing underground mine development and related works contract to current contractor JDS Energy & Mining Inc. ("JDS") effective October 5, 2026.The Company also announces that it has granted an aggregate of (i) 72,700 stock options of the Company (the "Options"), and (ii) 553,700 restricted share units of the Company ("RSUs") to certain newly hired senior officers and non-executive employees (collectively, the "Incentive Awards"), pursuant to the Company's omnibus equity incentive plan ("Omnibus Plan"). The Incentive Awards are designed to align the interests of the recipients with those of shareholders and support the execution of the Company's long-term growth strategy. The Options are exercisable at a price of C$4.00 per common share of the Company (based on the October 2, 2026, closing price on the TSX Venture Exchange) and will expire on October 5, 2031. The Options will vest in three equal installments over the next three years. The RSUs will cliff vest on October 5, 2029, and are subject to time and performance conditions. DRILL ASSAY HIGHLIGHTS
This news release contains assays from thirty-six (36) diamond drillholes ("DD") completed in four fans totaling 3,933 m drilled to the northwest from the L1290-ORE-000 drill station with depths ranging from 81.20 to 150.50 m (see Table 1 and Figures 5-9). All holes were collared in HQ (63.5 millimetre diameter). Estimated true widths of intercepts are provided in Table 1. Select photon assay highlights include:
7.28 grams per tonne ("g/t") gold ("Au") over 16.15 m at ~105 m vertical depth in BMU-26-121, including: 173.66 g/t Au over 0.60 m, and6.80 g/t Au over 0.50 m, and5.39 g/t Au over 0.50 m, and3.58 g/t Au over 0.50 m 7.13 g/t Au over 11.60 m at ~61 m vertical depth in BMU-26-075 (Figure 1), including: 62.06 g/t Au over 0.50 m, and31.88 g/t Au over 0.80 m, and18.85 g/t Au over 0.50 m, and7.13 g/t Au over 0.85 m, and6.47 g/t Au over 0.90 m, and2.23 g/t Au over 0.85 m 9.40 g/t Au over 8.50 m at ~72 m vertical depth in BMU-26-076, including: 78.39 g/t Au over 0.65 m, and41.31 g/t Au over 0.55 m, and3.77 g/t Au over 0.55 m, and3.06 g/t Au over 0.50 m 29.30 g/t Au over 2.10 m at ~62 m vertical depth in BMU-26-096 (Figure 2), including: 111.38 g/t Au over 0.55 m 10.26 g/t Au over 5.75 m at ~56 m vertical depth in BMU-26-076, including: 60.62 g/t Au over 0.80 m, and7.84 g/t Au over 0.50 m, and5.28 g/t Au over 0.50 m, and4.82 g/t Au over 0.50 m 4.04 g/t Au over 14.35 m at ~78 m vertical depth in BMU-26-098, including: 29.57 g/t Au over 1.00 m, and20.35 g/t Au over 1.00 m, and7.06 g/t Au over 0.50 m 9.98 g/t Au over 5.70 m at ~91 m vertical depth in BMU-26-118, including: 72.45 g/t Au over 0.60 m, and8.75 g/t Au over 0.75 m, and6.38 g/t Au over 0.50 m, and3.16 g/t Au over 0.50 m 11.17 g/t Au over 3.05 m at ~65 m vertical depth in BMU-26-119, including: 50.82 g/t Au over 0.50 m, and14.38 g/t Au over 0.50 m 2.71 g/t Au over 9.95 m at ~63 m vertical depth in BMU-26-097, including: 19.51 g/t Au over 0.95 m, and6.95 g/t Au over 0.50 m, and4.87 g/t Au over 0.50 m 4.10 g/t Au over 6.50 m at ~40 m vertical depth in BMU-26-047, including: 17.25 g/t Au over 0.50 m, and14.98 g/t Au over 0.50 m, and9.18 g/t Au over 0.50 m, and6.33 g/t Au over 0.50 m, and2.51 g/t Au over 0.50 m Complete assay highlights, including true width estimates, are presented in Table 1. Vertical depths are measured from modelled topographic surface to the interval mid-point. Drill hole locations and orientations are listed in Table 2. Intervals not recovered were assigned zero grade. Top cuts have not been applied to high grade assays.
Cut-off assay composites from ongoing infill drilling at the 1290 Level, presented in plan in Figure 5 and in cross section in Figures 6-9, show a degree of spatial correlation with modelled reserve stopes; intercepts outside these areas suggest potential for resource conversion and upside mineralization.
FIGURE 1: 7.13 g/t Au over 11.60 m at ~61 m vertical depth in BMU-26-075
FIGURE 2: Visible gold with pyrite under hand lens in composite interval with 29.30 g/t Au over 2.1 m at ~62 m vertical depth in BMU-26-096
FIGURE 3: Cariboo Gold Project deposit map with Location of Lowhee Zone and Cow Portal underground access.
FIGURE 4: Location and overview of ongoing Lowhee Zone underground definition infill diamond drilling.
FIGURE 5: Lowhee Zone select underground drilling highlights (plan view).
FIGURE 6: L1290-ORE-F09 select underground drill assay highlights (this release) with previously released surface and underground diamond drilling results in cross section by fan. New results from adjacent fans within slice (20 m looking 029°) omitted for visual clarity.
FIGURE 7: L1290-ORE-F10 select underground drill assay highlights (this release) with previously released surface and underground diamond drilling results in cross section by fan. New results from adjacent fans within slice (20 m looking 039°) omitted for visual clarity.
FIGURE 8: L1290-ORE-F11 select underground drill assay highlights (this release) with previously released surface and underground diamond drilling results in cross section by fan. New results from adjacent fans within slice (20 m looking 046°) omitted for visual clarity.
FIGURE 9: L1290-ORE-F12 select underground drill assay highlights (this release) with previously released surface and underground diamond drilling results in cross section by fan. New results from adjacent fans within slice (20 m looking 050°) omitted for visual clarity.
Geological mapping and geochemical sampling were carried out on Barkerville Mountain from 2017-2018, with the Lowhee Zone identified as a high-priority drill target. From 2019 to 2022, a total of 167 surface drill holes were completed, totaling 54,494.5 m.
The Lowhee Zone is accessed through the Cow portal on the northwestern flank of Barkerville Mountain (Figure 3 and Figure 4). Cow portal construction was completed in Q4 2024 and development of the underground ramp into the Lowhee Zone commenced in Q1 2025. The probable mineral reserves estimate for the Lowhee Zone (with an effective date of April 10, 2025) includes 104,491 ounces of contained Au (923,162 tonnes grading 3.52 g/t Au) and represents approximately 5% of the total contained gold in the estimated probable mineral reserves for the Cariboo Gold Project.
ABOUT CARIBOO GOLD PROJECT
The Cariboo Gold Project is a permitted, 100%-owned feasibility-stage project currently under construction located in the historic Wells-Barkerville mining camp of central British Columbia, Canada. Spanning approximately 186,740 hectares, the Company's land package includes 443 mineral titles and covers an area that extends approximately 77 kilometres from northwest to southeast. In late 2024, the Project was granted the Mines Act and Environmental Management Act (British Columbia) permits, marking the successful completion of the permitting process for key approvals. On September 14, 2026, the Company announced a formal positive decision to proceed with the construction of the Project, with an expected first gold pour in Q1 2029 and commercial production in H2 2029.
Technical Reports
Scientific and technical information relating to the Cariboo Gold Project and the 2025 feasibility study on the Cariboo Gold Project is supported by the technical report, titled "NI 43-101 Technical Report, Feasibility Study for the Cariboo Gold Project, District of Wells, British Columbia, Canada" and dated June 11, 2025 (with an effective date of April 25, 2025) (the "Cariboo Technical Report").
For readers to fully understand the information in the Cariboo Technical Report, reference should be made to the full text of the Cariboo Technical Report in its entirety, including all assumptions, parameters, qualifications, limitations and methods therein. The Cariboo Technical Report is intended to be read as a whole, and sections should not be read or relied upon out of context. The Cariboo Technical Report was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects ("NI 43-101") and is available electronically on SEDAR+ (www.sedarplus.ca) and on EDGAR (www.sec.gov) under Osisko Gold's issuer profile and on the Company's website at www.osiskogold.ca.
Qualified Persons
The scientific and technical information in this news release has been reviewed, verified and approved by Scott Smith, P. Geo., Vice President, Exploration of Osisko Gold, a "qualified person" within the meaning of NI 43-101. Verification includes core photo and three-dimensional review of logged drillhole data and assays consistent with the Company's standard procedures.
Quality Assurance (QA) – Quality Control (QC)
All drill core was whole core sampled in on-site logging facilities following daily QAQC checks for logging and sampling errors. Quality control (QC) samples are inserted at regular intervals in the sample stream, including blanks and reference materials with all sample shipments to monitor laboratory performance. Samples are bagged, labelled, sealed with numbered security tags.
Samples are taken by expeditor from the logging facilities direct to MSALABS's analytical facility in Prince George, B.C., Canada, for preparation and analysis. MSALABS is independent of the Company. The MSALABS facility is accredited to the ISO/IEC 17025 standard for gold assays, and all analytical methods include quality control materials at set frequencies with established data acceptance criteria. The entire sample is dried, crushed, and split into sealed containers. Analysis for gold is by gamma ray analysis using the Chrysos PhotonAssay (PA1408X). Samples are bombarded with gamma rays and the resulting signal is sent to the detectors.
ABOUT OSISKO GOLD GROUP INC.Osisko Gold Group Inc. is a North American gold development company focused on past-producing mining camps with district-scale potential. The Company's objective is to become an intermediate gold producer through the development of its flagship, fully permitted, 100%-owned Cariboo Gold Project, currently under construction in central British Columbia, Canada. The Project is situated within the Company's broader Cariboo regional land package, which hosts numerous prospective exploration targets and provides opportunities for future discoveries. Its Cariboo project pipeline is complemented by the Tintic Project, located in the historic East Tintic mining district in Utah, U.S.A., a brownfield property with significant exploration potential, extensive historical mining data, and access to established infrastructure. Osisko Gold is focused on developing long-life mining assets in mining-friendly jurisdictions while maintaining a disciplined approach to capital allocation, development risk management, and mineral inventory growth.For further information, visit our website at www.osiskogold.ca or contact:
Sean Roosen
Chairman and CEO
Email: [email protected]
Tel: +1 (514) 940-0685Philip Rabenok
Vice President, Investor Relations
Email: [email protected]
Tel: +1 (437) 423-3644
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking information" (within the meaning of applicable Canadian securities laws) and "forward-looking statements" (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended) (collectively, "forward-looking statements"). Such forward-looking statements are identified with words such as "may", "will", "would", "could", "anticipate", "believe", "expect", "plan", "intend", "potential", "estimate", "propose", "project", "outlook", "foresee", "objective", "strategy", variants of these words or the negative or comparable terminology, as well as terms usually used in the future and the conditional. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including the assumptions, qualifications, limitations or statements pertaining to: the utility and significance of the underground infill drilling results and the interpretation thereof; the interpretation and accuracy of intercepts outside modelled reserve stopes to suggest potential for resource conversion and upside mineralization (if at all); the potential for upside at depth and along strike of the known mineral resource footprint (if any); the interpretation and accuracy of spatial geometries, geological structure and local variability modeling and assumptions in regard to potential reserve or resource revisions (if at all); the ability and utility of exploration and infill drilling to inform resource modeling, mine planning, production stope design procedures and parameters, refinement of infill drill requirements, and the appropriate drill spacing for future infill drilling (if at all); the results (if any) of further exploration work and ability of the Company to define and expand mineral resources beyond current mineral resource estimates; mineral resource category conversion; the prospectivity of exploration in targets outside of currently defined mineral reserves and/or mineral resources; the performance of the underground mine development and related works contract with JDS and the advancement of underground development into new zones; the anticipated construction of the Cariboo Gold Project, including the expected timing of first gold pour and commercial production; the vesting, exercise and settlement of the Incentive Awards, including the satisfaction of applicable time and performance conditions; assumptions, qualifications and parameters underlying the Cariboo Technical Report (including, but not limited to, the mineral resources, mineral reserves, production profile, mine design and project economics); the results of the Cariboo Technical Report as an indicator of quality and robustness of the Cariboo Gold Project; the ability of the Company to achieve the estimates outlined in the Cariboo Technical Report in the timing contemplated (if at all); the future development and operations at the Cariboo Gold Project; management's perceptions of historical trends, current conditions and expected future developments; the utility and significance of historic data, including the significance of the district hosting past producing mines; the ability of exploration work (including drilling and sampling) to accurately predict mineralization; the ability of the Company to complete its exploration and development objectives for its projects in the timing contemplated and within expected costs (if at all); the ability to adapt to changes in gold prices, estimates of costs, estimates of planned exploration and development expenditures; the Company's strategy and objectives relating to the Cariboo Gold Project as well as its other projects; the assumptions, qualifications and limitations relating to the Cariboo Gold Project being permitted; the exploration potential and prospectivity (if any) of its properties; 'regulatory framework remaining defined and understood as well as other considerations that are believed to be appropriate in the circumstances, and any other information herein that is not a historical fact may be "forward looking information". Actual results could differ materially due to a number of factors, including, without limitation: 'risks relating to third-party approvals, including the issuance of permits by governments; risks relating to the performance of contractors, including JDS; capital market conditions and the Company's ability to access capital on terms acceptable to the Company for the contemplated exploration, development and construction at the Company's properties; risks related to the exploration, development, construction and operation of the Cariboo Gold Project, including delays and cost overruns; risks related to geological modeling and resource estimation; health, safety and security incidents; regulatory delays or changes in regulatory framework and applicable laws; labour shortages or disputes; general economic and market conditions and business conditions in the mining industry; fluctuations in commodity prices and currency exchange rates, as well as those risks and factors disclosed in the Company's most recent annual information form, financial statements and management's discussion and analysis as well as other public filings on SEDAR+ (www.sedarplus.ca) and on EDGAR (www.sec.gov).
Although the Company believes the expectations conveyed by the forward-looking statements are reasonable based on information available as of the date hereof, no assurances can be given as to future results, levels of activity and achievements. The Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by law. Forward-looking statements are not guarantees of performance and there can be no assurance that these forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
Photos accompanying this announcement are available at:
Harrow dokončila akvizici TYRVAYA od Viatris za 30 milionů USD v hotovosti s potenciálem až 100 milionů USD. TYRVAYA je první a jediný nosní sprej na suché oko schválený FDA.
First and Only FDA-Approved Nasal Spray for Dry Eye Disease Adds a Differentiated, Drop-Free Treatment Option to Harrow’s Growing Ocular Surface Franchise | Source: Harrow, Inc.
NASHVILLE, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has closed its previously announced acquisition of TYRVAYA® (varenicline solution) nasal spray 0.03 mg from Viatris Inc., a global healthcare company. At closing, Harrow acquired worldwide rights to TYRVAYA, except for Japan. Viatris retained the rights to commercialize TYRVAYA in Japan and agreed to pay Harrow royalties on any future net sales there. Consistent with the terms announced in August, Harrow paid $30 million in cash at closing and may pay up to $70 million in contingent milestone payments tied to TYRVAYA’s net sales, for potential total consideration of up to $100 million. The closing payment was funded with cash on hand.
TYRVAYA is a cholinergic agonist indicated for the treatment of the signs and symptoms of dry eye disease (DED) and is the first and only FDA-approved nasal spray for DED. Unlike topical ophthalmic therapies, TYRVAYA is administered through the nose and is thought to activate the trigeminal parasympathetic pathway to stimulate basal tear production. TYRVAYA is approved in the U.S., China, and Taiwan, with marketing applications pending in additional markets.
The addition of TYRVAYA meaningfully expands Harrow’s position in the large and growing U.S. dry eye market and complements VEVYE®, Harrow’s flagship prescription therapy for DED. With two highly differentiated branded prescription products, Harrow believes it can give eyecare professionals greater flexibility to individualize treatment based on their patients' needs and preferences.
“Today marks an important step forward for Harrow and for the physicians and patients we serve,” said Mark L. Baum, Chief Executive Officer of Harrow. “Dry eye disease is complex and multifactorial, and there is no single treatment approach that works for every patient. VEVYE and TYRVAYA approach dry eye differently and give eyecare professionals two distinct tools from one organization committed to serving this market. VEVYE remains the cornerstone of our dry eye franchise, while TYRVAYA gives us an established, complementary prescription brand with a unique route of administration and an existing base of physicians who know and use the product.”
Baum added, “We see a significant commercial opportunity ahead. TYRVAYA comes to Harrow with meaningful physician awareness, an established prescription base, and years of real-world clinical experience. By combining that foundation with Harrow’s expanding Ocular Surface commercial organization, market access capabilities, and focus on patient access and affordability, we believe we can introduce TYRVAYA to many more eyecare professionals and patients while also expanding awareness of VEVYE among existing TYRVAYA prescribers.”
TYRVAYA will be available to eyecare professionals through Harrow's commercial organization immediately after closing. As part of the acquisition, Harrow expects approximately 40 experienced personnel from Viatris, with established knowledge of TYRVAYA and the dry eye market, to join and augment Harrow’s existing Ocular Surface commercial team. Harrow expects to onboard these new colleagues during the fourth quarter of 2026. Harrow’s expanded Ocular Surface team will support both VEVYE and TYRVAYA as the integration progresses.
Harrow believes the combination of two differentiated dry eye brands and a larger, experienced field organization create several attractive commercial opportunities:
Expanded prescriber reach: The approximately 40 personnel expected to join Harrow will materially increase the size of Harrow’s Ocular Surface team, expanding its reach and frequency of engagement with ophthalmologists and optometrists who manage dry eye disease.Broader portfolio engagement: TYRVAYA brings an established prescriber base and meaningful familiarity among eyecare professionals. Bringing VEVYE and TYRVAYA together creates opportunities to deepen engagement across both brands and expand utilization across Harrow’s dry eye portfolio.Commercial efficiency: Both VEVYE and TYRVAYA utilize PhilRx as their primary specialty pharmacy and will be supported by a single Ocular Surface commercial organization, allowing Harrow to leverage shared commercial, market access, patient-support, and operational infrastructure across both brands. Harrow expects TYRVAYA to contribute more than $30 million in revenue in 2027. With commercial integration beginning in the fourth quarter of 2026, Harrow believes TYRVAYA’s established prescription base, physician awareness, and experienced commercial team, combined with Harrow’s dedicated Ocular Surface infrastructure, provide a strong foundation for growth in 2027 and beyond.
“TYRVAYA is a product I have used extensively in my dry eye practice, and its nasal route of administration makes it a truly differentiated treatment option,” said Laura Periman, MD, a board-certified ophthalmologist at Periman Eye Institute. “For patients who struggle with eye drops or contact lens wearers who want an option that does not require removing their lenses, TYRVAYA can fit very well into their treatment routine. I have seen firsthand the value of stimulating a patient’s own tear production, and I am pleased to see TYRVAYA become part of Harrow, a company deeply committed to eyecare and patient access.”
“VEVYE has become an important option in my dry eye practice because of the clinical benefits it can provide, and TYRVAYA is another therapy I know well and have prescribed for years,” said Paul Karpecki, OD, Director of Cornea and External Disease at Kentucky Eye Institute. “The two products approach dry eye very differently: VEVYE is applied directly to the ocular surface, while TYRVAYA is administered nasally and stimulates natural tear production through a distinct mechanism. Having therapies with different mechanisms and routes of administration gives me greater flexibility to individualize treatment based on each patient’s needs. I’m pleased to see both products together at Harrow, giving physicians more options for patients with this chronic disease.”
Eyecare professionals can send TYRVAYA prescriptions using their electronic medical record (EMR) software directly to Harrow’s dedicated pharmacy partner, PhilRx. Prescriptions can also be sent to any retail pharmacy. TYRVAYA is fully stocked in the wholesale distribution channel, including McKesson, Cardinal, and Cencora, and can be shipped to any retail pharmacy, generally within 24 hours of order placement.
Interested patients should ask their trusted eyecare professional whether TYRVAYA and VEYVE are right for them.
VEVYE® (cyclosporine ophthalmic solution) 0.1%
INDICATIONS AND USAGE
VEVYE® (cyclosporine ophthalmic solution) 0.1% is indicated for the treatment of the signs and symptoms of dry eye disease.
Important Safety Information
WARNINGS AND PRECAUTIONS
Potential for Eye Injury and Contamination: To avoid the potential for eye injury and/or contamination, patients should not touch the bottle tip to the eye or other surfaces.
Use with Contact Lenses: VEVYE® should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following the administration of VEVYE®.
ADVERSE REACTIONS
In clinical trials with 738 subjects receiving at least 1 dose of VEVYE®, the most common adverse reactions were instillation site reactions (8%) and temporary decreases in visual acuity (3%).
Please see full Prescribing Information for VEVYE.
INDICATIONS AND USAGE
TYRVAYA (varenicline solution) nasal spray is a cholinergic agonist indicated for the treatment of the signs and symptoms of dry eye disease.
Important Safety Information
ADVERSE REACTIONS
The most common adverse reaction reported in 82% of patients was sneezing. Events that were reported in 5–16% of patients were cough, throat irritation, and instillation-site (nose) irritation.
Please see full Prescribing Information for TYRVAYA.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and diseases of the retina. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com and connect with us on LinkedIn.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such “forward-looking statements.” Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include, among others, risks related to: liquidity or results of operations; our ability to successfully implement our business plan, develop and commercialize our products, product candidates and proprietary formulations in a timely manner or at all, identify and acquire additional products, manage our pharmacy operations, service our debt, obtain financing necessary to operate our business, recruit and retain qualified personnel, manage any growth we may experience and successfully realize the benefits of this acquisition and any other acquisitions and collaborative arrangements we may pursue; competition from pharmaceutical companies, outsourcing facilities and pharmacies; general economic and business conditions, including inflation and supply chain challenges; regulatory and legal risks and uncertainties related to our pharmacy operations and the pharmacy and pharmaceutical business in general, including the ongoing communications with the U.S. Food and Drug Administration relating to compliance and quality plans at our outsourcing facility in New Jersey; physician interest in and market acceptance of our current and any future formulations and compounding pharmacies generally. These and additional risks and uncertainties are more fully described in Harrow’s filings with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2025, and other filings with the SEC. Such documents may be read free of charge on the SEC’s web site at sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by law, Harrow undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.
Investor & Media Contact:
Mike Biega
Vice President of Investor Relations and Communications [email protected]
617-913-8890
France’s Schneider Electric shares tumbled about 9% on Monday after the company announced plans to acquire US industrial software group PTC for $22.6 billion, with investors likely questioning the hefty premium and the debt burden needed to fund the deal.
Schneider said it expects to complete the all-cash acquisition in the third quarter of 2027 at $205 per PTC share.
The offer represents a 42.3% premium to PTC’s last closing price and marks the largest acquisition in Schneider’s history.
The transaction is a major expansion of Schneider’s software ambitions, but its scale has raised concerns about valuation, financing and the ability to deliver promised synergies.
The $205-per-share offer values PTC at roughly 20–21 times its expected 2027 EBITDA before synergies, a multiple that some investors consider stretched.
PTC’s valuation had fallen as low as 13.1 times next-12-month earnings this year, according to FactSet.
Schneider said the transaction is priced at 13 times earnings after taking synergies into account.
However, much of that benefit comes from projected revenue synergies, which can be more difficult to realise than cost savings.
“AI disruption fears are still weighing on software valuations, which allows acquiring PTC at a decade-low valuation but could still weigh on [Schneider] post-deal,” Jefferies analysts led by Lucas Ferhani said.
Citi analysts described the transaction as Schneider’s “largest deal yet,” but said it should not come as a surprise given the company’s earlier pursuit of acquisitions including Aveva and Bentley Systems.
“The deal may be seen as opportunistic — ‘SaaSpocalypse’ fears have led to the de-rating of many industrial software companies on AI disruption fears — and the onus will be on Schneider to show how the combined software and hardware offering fortifies its moat,” the analysts said.
They added that, given the size of the transaction, investors should seek greater disclosure around the details of the “enlarged software business within Schneider.”
Schneider will finance the acquisition through a combination of new equity and debt.
It plans to raise €5 billion to €6 billion through an Accelerated Bookbuild Offering of new shares, alongside €16 billion to €17 billion in new debt.
The financing is likely to increase Schneider’s leverage significantly and could create near-term earnings dilution for existing shareholders.
JPMorgan analysts said, “Large-scale M&A is typically unwelcome in the first instance by European investors, although Schneider Electric's deals have typically proven strategically astute, if debatable from a valuation standpoint."
JPMorgan reiterated its Overweight rating and €345 price target on Schneider, while acknowledging that the PTC deal represents roughly 12% of the French company’s market capitalisation.
The bank expects the acquisition to become accretive to sales and EBITDA over time.
Schneider expects the combined business to deliver €250 million in annual run-rate cost savings by the third year after closing.
It is also targeting about €800 million in revenue synergies.
The PTC acquisition builds on Schneider’s growing push into industrial software and artificial intelligence.
The company agreed in June to acquire Cognite Holding, a privately held provider of AI software and industrial data.
Schneider has also undergone a broader transformation in recent years.
Once primarily associated with electrical components such as fuses and circuit breakers, it now supplies critical infrastructure for data centres, including cooling systems, server racks and power distribution equipment.
Surging data-centre investment, particularly in the US, has become an increasingly important growth driver for Schneider and is helping offset weaker demand in some traditional electrical-equipment markets.
PTC provides software used to design, manufacture and service products across multiple industries.
Its portfolio has also benefited from growing interest in AI-powered industrial tools.
UBS ponechává na Cerebras Systems doporučení Buy a cílovou cenu 291,64 USD, což implikuje 75,2% růst. Firma zároveň zvýšila výhled tržeb z hlavní činnosti na rok 2026 na 880–890 milionů USD.
Cerebras stock cratered to a post-IPO low while rivals like NVIDIA and AMD surged, yet one of the world's largest banks just doubled down with a price target that implies the market is deeply, fundamentally wrong about this AI chip…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cerebras Systems (NASDAQ:CBRS) currently trades at $166.43. The average analyst price target is $291.64, which implies 75.2% upside.
Cerebras makes wafer-scale AI chips and runs the Cerebras Inference Cloud, a service built for very fast AI inference. Its customers include OpenAI, AWS, G42, Figma (NYSE:FIG) and GSK (NYSE:GSK | GSK Price Prediction). It has also signed a multi-year OpenAI deal for 750 MW of inference compute valued at more than $20B.
UBS, one of the world’s largest banks, has set the most bullish price target at $330.00. That works out to 98.3% upside, so UBS expects the stock to roughly double. Either the market is missing a hypergrowth story or analysts are anchored to the excitement around the IPO.
Hot IPO Hits a Post-IPO Low Cerebras fell 19.5% in five sessions and hit a post-IPO low. Shares now trade below the IPO price and are down 46.5% from the first-day close of $311.07.
Second-quarter results showed the crack. GAAP revenue of $180.11M missed the $193.55M consensus, though core revenue grew 103%. Core gross margin slipped to 40.6% from 46.5% the prior quarter. Third-quarter guidance calls for 38% to 40% margin.
The selloff is specific to Cerebras. During the same week, NVIDIA (NASDAQ:NVDA) gained 3.95%.
Why UBS Still Expects the Stock to Double UBS analyst Timothy Arcuri repeated his Buy rating and $330.00 target. His thesis: the WSE-3 chip delivers up to 6x the inference performance of GPU clusters; demand for inference workloads avoiding HBM memory bottlenecks keeps growing; and sovereign AI contracts like G42 partnerships provide revenue visibility several quarters out.
The backlog supports this. Cerebras has $25.4 billion in remaining performance obligations, excluding AWS and other hyperscalers. Management raised 2026 core revenue guidance to $880 to $890 million and expects to more than triple core revenue in 2027. The average 2027 revenue estimate is $2.95 billion, with average 2027 EPS rising to $1.2737 from $0.9573 90 days ago. Over the past 30 days there were nine up revisions and no cuts.
The catalysts have dates attached. Disaggregated inference with Helios racks from Advanced Micro Devices (NASDAQ:AMD) launches in the fourth quarter and promises 5x more throughput. AWS Bedrock availability follows in early 2027, with revenue from other hyperscalers starting in mid-2027. Management says gross margin bottoms in the third quarter and then moves toward 60% plus.
The analyst ratings are skewed:
Strong Buy: 3 Buy: 7 Hold: 1 Sell: 0 Arcuri asked on the earnings call whether OpenAI and AWS could make up about two-thirds of next year’s revenue. The CEO replied that OpenAI “will stay a big part next year.” Price targets carry real uncertainty.
Cerebras Falls While Its Chip Rivals Rally Cerebras is falling on its own while its biggest rivals rally.
NVIDIA is up 25.74% year to date at $233.95. Its average target of $327.70 implies 40.1% upside, with 10 Strong Buys, 48 Buys, 2 Holds and 1 Sell.
AMD is up 196% year to date at $633.91, above its $619.51 target. It has 5 Strong Buys, 39 Buys and 11 Holds.
Cerebras has the largest analyst-implied upside in the group. That gap reflects execution risk that its larger, profitable rivals don’t carry.
Down 46.5% Since Debut as the S&P 500 Gains 12.86% This Year At $166.43, Cerebras has 75.2% upside to the $291.64 consensus target held by 11 analysts. The stock is close to its 52-week low of $160.81 and far below its high of $386.34.
Cerebras is down 46.5% since its debut. Meanwhile, the S&P 500 is up 12.86% year to date. Cerebras trades at 58.09 times sales and 217x forward earnings.
A Rare Discount Comes With OpenAI Strings Attached The bull case improves if AWS and the AMD partnership start bringing in revenue on schedule and gross margin bottoms in the third quarter as promised. The backlog already locks in years of growth, and the 2027 estimates keep rising.
The bear case improves if OpenAI moves more work to NVIDIA or if new data centers come online late. When one customer dominates the backlog, it carries more risk than the headline figure suggests. More lockup releases could also keep pressure on the stock.
The evidence leans bullish. The discount looks too steep for a company whose revenue is about to triple, the kind of early signal we cataloged in a free playbook on spotting the next NVIDIA. Still, OpenAI concentration is the risk I’d track most closely in every earnings report.
Contact [email protected] for any questions or corrections.
Polský antimonopolní úřad podezřívá Google ze zneužití dominantního postavení při vyjednávání plateb s vydavateli obsahu. Úřad tvrdí, že firma neposkytla dostatek dat pro férová jednání.
Poland's antitrust watchdog said on Monday it suspected Alphabet's (GOOGL.O) Google of abusing its dominant market position while negotiating content payments with domestic media publishers.
The Office of Competition and Consumer Protection, known by its Polish abbreviation UOKiK, said the charges relate to how Google negotiates remuneration for displaying articles and snippets in its search results, Google News and Discover services.
The companies named in the statement are Alphabet Inc, Google LLC, Google Ireland Limited and Google Poland, none of which immediately responded to a Reuters request for comment.
UOKiK alleges Google failed to provide publishers with the necessary data to properly assess offers, leading to an information imbalance that prevented fair negotiations on payment for content.
"Big tech companies cannot place themselves above the law," UOKiK President Tomasz Chrostny said in the statement, adding the lack of data led to negotiations becoming illusory and tending towards Google imposing terms.
The dispute stems from a 2024 Polish copyright law amendment that implemented an EU directive under which online services may use press publishers' content in return for remuneration.
The maximum fine for abusing a dominant market position may amount to 10% of a company's turnover, the regulator said.
It added the investigation was separate from the European Commission probe opened in December 2025 into whether Google used publishers' content in its AI services without adequate compensation or giving them the ability to object.
The Polish probe, which focuses on Google Search, Google News and Discover services, is being carried out independently following an agreement with the Commission, UOKiK said.
In December 2024, Polish e-commerce group Allegro's price comparison platform Ceneo sued Alphabet for 2.33 billion zlotys ($568 million) in damages for alleged anti-competitive behaviour.
Azimuth Capital Investment Management zvýšila ve 2. čtvrtletí podíl ve společnosti Amazon.com o 23,5 % na 130 567 akcií. Hodnota pozice činila 31,1 milionu USD.
Azimuth Capital Investment Management LLC lifted its position in Amazon.com, Inc. (NASDAQ:AMZN – Free Report) by 23.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 130,567 shares of the e-commerce giant’s stock after acquiring an additional 24,833 shares during the quarter. Amazon.com makes up approximately 1.1% of Azimuth Capital Investment Management LLC’s portfolio, making the stock its 15th largest position. Azimuth Capital Investment Management LLC’s holdings in Amazon.com were worth $31,119,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in AMZN. Bank of America Corp DE bought a new stake in Amazon.com in the 2nd quarter worth about $22,218,775,000. Bank of New York Mellon Corp bought a new position in shares of Amazon.com during the 2nd quarter worth approximately $16,341,405,000. Invesco Ltd. lifted its position in shares of Amazon.com by 3.3% during the 4th quarter. Invesco Ltd. now owns 59,604,857 shares of the e-commerce giant’s stock worth $13,757,993,000 after buying an additional 1,879,630 shares in the last quarter. Legal & General Group Plc bought a new position in shares of Amazon.com during the 2nd quarter worth approximately $12,831,376,000. Finally, Amundi boosted its stake in shares of Amazon.com by 14.1% in the 1st quarter. Amundi now owns 61,400,503 shares of the e-commerce giant’s stock worth $12,787,883,000 after buying an additional 7,590,952 shares during the last quarter. Hedge funds and other institutional investors own 72.20% of the company’s stock.
Analyst Ratings Changes Several equities analysts have recently issued reports on the company. Bank of America upped their target price on Amazon.com from $310.00 to $320.00 and gave the company a “buy” rating in a report on Friday, July 31st. HSBC reissued a “buy” rating and issued a $310.00 price objective on shares of Amazon.com in a research report on Friday, July 31st. Zacks Research downgraded Amazon.com from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Needham & Company LLC reaffirmed a “buy” rating and set a $300.00 target price on shares of Amazon.com in a research report on Friday, July 31st. Finally, Oppenheimer reiterated an “outperform” rating on shares of Amazon.com in a research note on Friday, July 31st. Fifty-six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $321.63.
Get Our Latest Stock Report on AMZN Key Headlines Impacting Amazon.com Here are the key news stories impacting Amazon.com this week:
Positive Sentiment: AWS data-center push received support: Amazon Web Services pledged more than $1 billion over five years for communities hosting its U.S. data centers, including job training, education and infrastructure initiatives. The investment is intended to ease resistance to new facilities and help Amazon secure capacity for AI workloads. Amazon to invest $1 billion over five years in US data center communities Positive Sentiment: AI and AWS growth remain the main bullish catalyst: Reports highlighted AWS’s rapid expansion, a more than $1 billion Synopsys agreement supporting custom-chip development, and Anthropic’s expected long-term AWS commitments of roughly $110 billion. Amazon also launched an AI agent that audits customers’ cloud environments, potentially increasing AWS usage while improving customer cost, security and performance management. Amazon Is Both Landlord And Shareholder In Anthropic’s Giant Cloud Bet Positive Sentiment: Analyst confidence provided additional support: Goldman Sachs added Amazon to its conviction list, while New Street raised its price target to $385 and maintained a Buy rating. Analysts cited AWS growth, generative AI exposure and potential retail-margin improvement as reasons for longer-term upside. New Street Adjusts Price Target on Amazon.com to $385 Neutral Sentiment: Amazon is reportedly exploring an $8 billion chip sale-and-leaseback: Moving Nvidia AI chips to an investment vehicle could make the balance sheet more asset-light and help fund capital spending, but it also underscores the scale of Amazon’s AI infrastructure costs and financing requirements. Amazon seeks to offload $8 billion of Nvidia chips Negative Sentiment: Investors face profitability and regulatory risks: Analysts questioned how much AWS earnings are distorted by unrealized Anthropic investment gains, while surging AI capital expenditures could pressure free cash flow. Potential tougher EU cloud rules, data-center opposition, warehouse labor actions and Prime-related settlement payments add further uncertainty. What Are Amazon Investors Paying for AWS Without Investment Gains? Insider Activity In other news, CEO Matthew S. Garman sold 14,541 shares of Amazon.com stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $259.06, for a total value of $3,766,991.46. Following the completion of the transaction, the chief executive officer owned 17,794 shares in the company, valued at $4,609,713.64. This trade represents a 44.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Andrew Jassy sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $259.01, for a total transaction of $5,180,200.00. Following the completion of the sale, the chief executive officer directly owned 2,235,766 shares in the company, valued at approximately $579,085,751.66. This trade represents a 0.89% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 70,589 shares of company stock valued at $18,329,015. 8.90% of the stock is currently owned by corporate insiders.
Amazon.com Price Performance Shares of NASDAQ AMZN opened at $251.52 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.03 and a quick ratio of 0.87. The stock has a market capitalization of $2.71 trillion, a PE ratio of 20.23, a P/E/G ratio of 1.95 and a beta of 1.45. Amazon.com, Inc. has a one year low of $196.00 and a one year high of $287.20. The business’s fifty day moving average price is $257.06 and its 200-day moving average price is $248.51.
Amazon.com (NASDAQ:AMZN – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The e-commerce giant reported $5.75 earnings per share for the quarter, topping the consensus estimate of $1.82 by $3.93. Amazon.com had a return on equity of 18.00% and a net margin of 17.44%.The company had revenue of $200.61 billion during the quarter, compared to analyst estimates of $197.03 billion. During the same quarter last year, the firm posted $1.68 EPS. The firm’s revenue for the quarter was up 19.6% on a year-over-year basis. On average, equities research analysts anticipate that Amazon.com, Inc. will post 8.01 EPS for the current year.
Amazon.com Profile (Free Report)
Amazon.com, Inc is a global technology and commerce company that operates online marketplaces, physical stores, and a broad portfolio of digital and cloud-based services. The company offers consumer products across categories such as electronics, household goods, apparel, groceries, and entertainment, while also providing third-party sellers with tools for listing, selling, and fulfilling orders.
Amazon’s major businesses include Amazon Web Services (AWS), which provides cloud computing, storage, database, analytics, and artificial intelligence services; Prime, a membership program that includes shipping, streaming, and other benefits; and digital entertainment services such as Prime Video, Amazon Music, Kindle, and Audible.
Further Reading Five stocks we like better than Amazon.com Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter.
Angeles Wealth Management LLC lifted its stake in Amazon.com, Inc. (NASDAQ:AMZN – Free Report) by 18.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 118,524 shares of the e-commerce giant’s stock after purchasing an additional 18,648 shares during the period. Amazon.com accounts for about 1.1% of Angeles Wealth Management LLC’s investment portfolio, making the stock its 15th biggest holding. Angeles Wealth Management LLC’s holdings in Amazon.com were worth $28,249,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently modified their holdings of the company. Silvant Capital Management LLC purchased a new stake in Amazon.com in the 2nd quarter worth $60,065,000. Public Employees Retirement System of Ohio purchased a new position in shares of Amazon.com during the second quarter valued at about $909,868,000. Northstar Financial Companies Inc. bought a new stake in shares of Amazon.com in the second quarter worth about $3,376,000. Gryphon Financial Partners LLC increased its holdings in shares of Amazon.com by 7.5% in the first quarter. Gryphon Financial Partners LLC now owns 73,085 shares of the e-commerce giant’s stock worth $15,221,000 after purchasing an additional 5,125 shares during the last quarter. Finally, First Citizens Bank & Trust Co. increased its holdings in shares of Amazon.com by 1.7% in the first quarter. First Citizens Bank & Trust Co. now owns 303,862 shares of the e-commerce giant’s stock worth $63,285,000 after purchasing an additional 5,104 shares during the last quarter. Institutional investors own 72.20% of the company’s stock.
Key Headlines Impacting Amazon.com Here are the key news stories impacting Amazon.com this week:
Positive Sentiment: AWS data-center push received support: Amazon Web Services pledged more than $1 billion over five years for communities hosting its U.S. data centers, including job training, education and infrastructure initiatives. The investment is intended to ease resistance to new facilities and help Amazon secure capacity for AI workloads. Amazon to invest $1 billion over five years in US data center communities Positive Sentiment: AI and AWS growth remain the main bullish catalyst: Reports highlighted AWS’s rapid expansion, a more than $1 billion Synopsys agreement supporting custom-chip development, and Anthropic’s expected long-term AWS commitments of roughly $110 billion. Amazon also launched an AI agent that audits customers’ cloud environments, potentially increasing AWS usage while improving customer cost, security and performance management. Amazon Is Both Landlord And Shareholder In Anthropic’s Giant Cloud Bet Positive Sentiment: Analyst confidence provided additional support: Goldman Sachs added Amazon to its conviction list, while New Street raised its price target to $385 and maintained a Buy rating. Analysts cited AWS growth, generative AI exposure and potential retail-margin improvement as reasons for longer-term upside. New Street Adjusts Price Target on Amazon.com to $385 Neutral Sentiment: Amazon is reportedly exploring an $8 billion chip sale-and-leaseback: Moving Nvidia AI chips to an investment vehicle could make the balance sheet more asset-light and help fund capital spending, but it also underscores the scale of Amazon’s AI infrastructure costs and financing requirements. Amazon seeks to offload $8 billion of Nvidia chips Negative Sentiment: Investors face profitability and regulatory risks: Analysts questioned how much AWS earnings are distorted by unrealized Anthropic investment gains, while surging AI capital expenditures could pressure free cash flow. Potential tougher EU cloud rules, data-center opposition, warehouse labor actions and Prime-related settlement payments add further uncertainty. What Are Amazon Investors Paying for AWS Without Investment Gains? Analyst Ratings Changes A number of equities analysts recently commented on the company. Needham & Company LLC reissued a “buy” rating and set a $300.00 price target on shares of Amazon.com in a research note on Friday, July 31st. Pivotal Research reaffirmed a “buy” rating and issued a $333.00 price objective (up from $320.00) on shares of Amazon.com in a research note on Friday, July 31st. JPMorgan Chase & Co. upped their price objective on Amazon.com from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Mizuho set a $330.00 target price on Amazon.com and gave the company an “outperform” rating in a research report on Friday, July 31st. Finally, Royal Bank Of Canada raised their target price on shares of Amazon.com from $320.00 to $330.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Fifty-six equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $321.63. Check Out Our Latest Report on AMZN
Amazon.com Price Performance Shares of Amazon.com stock opened at $251.52 on Monday. The stock has a market cap of $2.71 trillion, a price-to-earnings ratio of 20.23, a price-to-earnings-growth ratio of 1.95 and a beta of 1.45. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.87 and a current ratio of 1.03. The stock has a 50 day moving average price of $257.06 and a 200-day moving average price of $248.51. Amazon.com, Inc. has a one year low of $196.00 and a one year high of $287.20.
Amazon.com (NASDAQ:AMZN – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The e-commerce giant reported $5.75 earnings per share for the quarter, beating the consensus estimate of $1.82 by $3.93. Amazon.com had a return on equity of 18.00% and a net margin of 17.44%.The company had revenue of $200.61 billion for the quarter, compared to analyst estimates of $197.03 billion. During the same quarter in the prior year, the firm posted $1.68 EPS. Amazon.com’s quarterly revenue was up 19.6% compared to the same quarter last year. Equities analysts expect that Amazon.com, Inc. will post 8.01 EPS for the current year.
Insider Buying and Selling In other news, SVP David Zapolsky sold 9,258 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $259.77, for a total transaction of $2,404,950.66. Following the transaction, the senior vice president owned 41,190 shares of the company’s stock, valued at approximately $10,699,926.30. This represents a 18.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Shelley Reynolds sold 2,343 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $259.01, for a total value of $606,860.43. Following the completion of the sale, the vice president owned 119,780 shares in the company, valued at approximately $31,024,217.80. The trade was a 1.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 70,589 shares of company stock worth $18,329,015 over the last three months. 8.90% of the stock is currently owned by company insiders.
Amazon.com Company Profile (Free Report)
Amazon.com, Inc is a global technology and commerce company that operates online marketplaces, physical stores, and a broad portfolio of digital and cloud-based services. The company offers consumer products across categories such as electronics, household goods, apparel, groceries, and entertainment, while also providing third-party sellers with tools for listing, selling, and fulfilling orders.
Amazon’s major businesses include Amazon Web Services (AWS), which provides cloud computing, storage, database, analytics, and artificial intelligence services; Prime, a membership program that includes shipping, streaming, and other benefits; and digital entertainment services such as Prime Video, Amazon Music, Kindle, and Audible.
See Also Five stocks we like better than Amazon.com Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter.
Advisory Solutions Group LLC bought a new position in shares of Amazon.com, Inc. (NASDAQ:AMZN – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 6,726 shares of the e-commerce giant’s stock, valued at approximately $1,603,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Trust Asset Management LLC grew its stake in Amazon.com by 3.3% in the 2nd quarter. Trust Asset Management LLC now owns 107,563 shares of the e-commerce giant’s stock valued at $26,000 after buying an additional 3,414 shares during the last quarter. TOP Private Wealth LLC. bought a new position in Amazon.com in the 2nd quarter worth $29,000. Bard Associates Inc. acquired a new position in Amazon.com during the 2nd quarter worth $32,000. Longfellow Investment Management Co. LLC acquired a new position in Amazon.com during the 2nd quarter worth $33,000. Finally, Lifetime Wealth Management P.C. bought a new stake in Amazon.com during the fourth quarter valued at about $45,000. Institutional investors and hedge funds own 72.20% of the company’s stock.
Key Stories Impacting Amazon.com Here are the key news stories impacting Amazon.com this week:
Positive Sentiment: AWS data-center push received support: Amazon Web Services pledged more than $1 billion over five years for communities hosting its U.S. data centers, including job training, education and infrastructure initiatives. The investment is intended to ease resistance to new facilities and help Amazon secure capacity for AI workloads. Amazon to invest $1 billion over five years in US data center communities Positive Sentiment: AI and AWS growth remain the main bullish catalyst: Reports highlighted AWS’s rapid expansion, a more than $1 billion Synopsys agreement supporting custom-chip development, and Anthropic’s expected long-term AWS commitments of roughly $110 billion. Amazon also launched an AI agent that audits customers’ cloud environments, potentially increasing AWS usage while improving customer cost, security and performance management. Amazon Is Both Landlord And Shareholder In Anthropic’s Giant Cloud Bet Positive Sentiment: Analyst confidence provided additional support: Goldman Sachs added Amazon to its conviction list, while New Street raised its price target to $385 and maintained a Buy rating. Analysts cited AWS growth, generative AI exposure and potential retail-margin improvement as reasons for longer-term upside. New Street Adjusts Price Target on Amazon.com to $385 Neutral Sentiment: Amazon is reportedly exploring an $8 billion chip sale-and-leaseback: Moving Nvidia AI chips to an investment vehicle could make the balance sheet more asset-light and help fund capital spending, but it also underscores the scale of Amazon’s AI infrastructure costs and financing requirements. Amazon seeks to offload $8 billion of Nvidia chips Negative Sentiment: Investors face profitability and regulatory risks: Analysts questioned how much AWS earnings are distorted by unrealized Anthropic investment gains, while surging AI capital expenditures could pressure free cash flow. Potential tougher EU cloud rules, data-center opposition, warehouse labor actions and Prime-related settlement payments add further uncertainty. What Are Amazon Investors Paying for AWS Without Investment Gains? Wall Street Analyst Weigh In Several equities research analysts have recently issued reports on AMZN shares. Rosenblatt Securities raised their price target on Amazon.com from $335.00 to $360.00 and gave the company a “buy” rating in a research report on Wednesday, September 30th. JPMorgan Chase & Co. boosted their price objective on Amazon.com from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Bank of America increased their target price on Amazon.com from $310.00 to $320.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Monness Crespi & Hardt raised their target price on Amazon.com from $315.00 to $330.00 and gave the company a “buy” rating in a report on Friday, July 31st. Finally, Truist Financial lifted their price target on Amazon.com from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Fifty-six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Amazon.com presently has a consensus rating of “Moderate Buy” and an average target price of $321.63. Check Out Our Latest Report on Amazon.com
Insider Buying and Selling at Amazon.com In related news, SVP David Zapolsky sold 9,258 shares of the firm’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $259.77, for a total value of $2,404,950.66. Following the completion of the transaction, the senior vice president directly owned 41,190 shares of the company’s stock, valued at $10,699,926.30. This trade represents a 18.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Shelley Reynolds sold 2,343 shares of Amazon.com stock in a transaction on Friday, August 21st. The stock was sold at an average price of $259.01, for a total transaction of $606,860.43. Following the sale, the vice president owned 119,780 shares in the company, valued at $31,024,217.80. This represents a 1.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 70,589 shares of company stock valued at $18,329,015 in the last quarter. 8.90% of the stock is currently owned by corporate insiders.
Amazon.com Stock Performance Shares of AMZN opened at $251.52 on Monday. Amazon.com, Inc. has a 12-month low of $196.00 and a 12-month high of $287.20. The company has a quick ratio of 0.87, a current ratio of 1.03 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $2.71 trillion, a price-to-earnings ratio of 20.23, a P/E/G ratio of 1.95 and a beta of 1.45. The stock’s 50-day moving average price is $257.06 and its 200 day moving average price is $248.51.
Amazon.com (NASDAQ:AMZN – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The e-commerce giant reported $5.75 EPS for the quarter, beating the consensus estimate of $1.82 by $3.93. Amazon.com had a return on equity of 18.00% and a net margin of 17.44%.The firm had revenue of $200.61 billion during the quarter, compared to analysts’ expectations of $197.03 billion. During the same quarter in the prior year, the firm posted $1.68 EPS. The company’s revenue for the quarter was up 19.6% on a year-over-year basis. As a group, research analysts predict that Amazon.com, Inc. will post 8.01 earnings per share for the current year.
Amazon.com Company Profile (Free Report)
Amazon.com, Inc is a global technology and commerce company that operates online marketplaces, physical stores, and a broad portfolio of digital and cloud-based services. The company offers consumer products across categories such as electronics, household goods, apparel, groceries, and entertainment, while also providing third-party sellers with tools for listing, selling, and fulfilling orders.
Amazon’s major businesses include Amazon Web Services (AWS), which provides cloud computing, storage, database, analytics, and artificial intelligence services; Prime, a membership program that includes shipping, streaming, and other benefits; and digital entertainment services such as Prime Video, Amazon Music, Kindle, and Audible.
Recommended Stories Five stocks we like better than Amazon.com Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter.
Ketron Financial lowered its stake in Microsoft Corporation (NASDAQ:MSFT – Free Report) by 11.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,056 shares of the software giant’s stock after selling 3,994 shares during the quarter. Microsoft comprises about 3.7% of Ketron Financial’s portfolio, making the stock its 6th biggest holding. Ketron Financial’s holdings in Microsoft were worth $11,958,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently bought and sold shares of MSFT. Friedenthal Financial raised its position in Microsoft by 6.2% in the first quarter. Friedenthal Financial now owns 431 shares of the software giant’s stock valued at $160,000 after purchasing an additional 25 shares during the period. Sequent Planning LLC lifted its stake in Microsoft by 0.7% during the 1st quarter. Sequent Planning LLC now owns 3,733 shares of the software giant’s stock worth $1,382,000 after acquiring an additional 25 shares in the last quarter. Riverpoint Wealth Management Holdings LLC lifted its stake in Microsoft by 0.5% during the 1st quarter. Riverpoint Wealth Management Holdings LLC now owns 5,543 shares of the software giant’s stock worth $2,052,000 after acquiring an additional 26 shares in the last quarter. American Investment Services Inc. boosted its holdings in Microsoft by 3.1% during the 1st quarter. American Investment Services Inc. now owns 876 shares of the software giant’s stock valued at $324,000 after acquiring an additional 26 shares during the period. Finally, REAP Financial Group LLC grew its position in Microsoft by 1.1% in the 2nd quarter. REAP Financial Group LLC now owns 2,453 shares of the software giant’s stock valued at $915,000 after acquiring an additional 26 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.
Microsoft Stock Performance Shares of Microsoft stock opened at $517.53 on Monday. The firm has a market capitalization of $3.84 trillion, a P/E ratio of 28.82, a P/E/G ratio of 1.66 and a beta of 1.10. Microsoft Corporation has a 52 week low of $349.20 and a 52 week high of $553.72. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. The firm’s 50 day moving average is $490.08 and its two-hundred day moving average is $430.19.
Microsoft (NASDAQ:MSFT – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, topping the consensus estimate of $4.24 by $0.50. The firm had revenue of $90.01 billion for the quarter, compared to analyst estimates of $87.62 billion. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. Microsoft’s revenue for the quarter was up 17.7% compared to the same quarter last year. During the same period last year, the business earned $3.65 EPS. Research analysts forecast that Microsoft Corporation will post 19.62 EPS for the current fiscal year. Microsoft Increases Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, December 10th. Investors of record on Thursday, November 19th will be given a $0.98 dividend. This is a boost from Microsoft’s previous quarterly dividend of $0.91. The ex-dividend date of this dividend is Thursday, November 19th. This represents a $3.92 dividend on an annualized basis and a dividend yield of 0.8%. Microsoft’s payout ratio is currently 20.27%.
Analyst Ratings Changes Several equities research analysts recently weighed in on MSFT shares. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Microsoft in a research note on Monday, July 20th. Mizuho reduced their price objective on Microsoft from $515.00 to $490.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 15th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Microsoft in a report on Thursday, September 10th. Barclays decreased their price objective on Microsoft from $545.00 to $512.00 and set an “overweight” rating for the company in a research note on Thursday, July 30th. Finally, KeyCorp reissued an “overweight” rating on shares of Microsoft in a research report on Thursday, September 3rd. Forty-three research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $571.18.
Check Out Our Latest Stock Analysis on Microsoft
Insider Transactions at Microsoft In other news, EVP Amy Hood sold 41,674 shares of Microsoft stock in a transaction on Monday, September 14th. The shares were sold at an average price of $498.27, for a total value of $20,764,903.98. Following the transaction, the executive vice president directly owned 533,624 shares of the company’s stock, valued at $265,888,830.48. The trade was a 7.24% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Satya Nadella sold 86,525 shares of the company’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $501.46, for a total transaction of $43,388,826.50. Following the completion of the sale, the chief executive officer owned 486,763 shares of the company’s stock, valued at approximately $244,092,173.98. This trade represents a 15.09% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 143,009 shares of company stock worth $71,420,699 in the last three months. Corporate insiders own 0.03% of the company’s stock.
Key Stories Impacting Microsoft Here are the key news stories impacting Microsoft this week:
Positive Sentiment: Azure and AI demand remain the primary catalyst. Investor data and analyst commentary point to accelerating Azure demand, while Microsoft’s recent earnings showed its fastest cloud growth in four years. The improving demand is helping ease concerns that the company’s substantial AI infrastructure spending will not generate adequate returns. Ca$htag: MSFT Azure Cloud Drives Soaring Demand Positive Sentiment: Wells Fargo added Microsoft to its Q4 Tactical Ideas list and raised its price target to $725, citing Azure’s growth potential and the prospect of improved AI monetization through Copilot. The action adds to a series of bullish analyst revisions; one report noted that 52 analysts covering Microsoft currently have no sell ratings. With Azure as a Catalyst, Microsoft Is Positioned for Sustained Growth Positive Sentiment: Microsoft’s OpenAI relationship provides potential additional value. Investors are increasingly focused on Microsoft’s stake and commercial partnership with OpenAI, particularly ahead of a possible OpenAI initial public offering that could provide a market reference for the investment. OpenAI’s Future IPO Keeps Me Buying Microsoft Positive Sentiment: Microsoft introduced new real-time AI speech models for customer-service agents, multilingual assistants and voice interfaces. The products broaden Microsoft’s enterprise AI offering and could support additional cloud consumption and software revenue. Microsoft Targets Contact Center Market With Real-Time AI Voice Models Neutral Sentiment: Investors are awaiting Microsoft’s October 7 Surface and Windows event. New hardware or Windows updates could support the ecosystem, although the event has not yet produced a material earnings catalyst. Microsoft Stock Notches Up Ahead of the Surface Show Negative Sentiment: Risks include heavy AI capital spending, valuation concerns and broader market concentration. Critics argue that rising data-center capacity could pressure compute pricing and returns, while strategists warn that a market correction could disproportionately affect megacap technology stocks. Microsoft’s dividend remains affordable, but AI infrastructure spending and lease commitments could limit future dividend growth. Morgan Stanley Strategist Sees Market Drawdown Potential Microsoft Profile (Free Report)
Microsoft Corporation is a global technology company that develops software, cloud services, devices, gaming products and business solutions. Founded in 1975 by Bill Gates and Paul Allen, the company is best known for the Windows operating system and Microsoft Office productivity software. Microsoft is headquartered in Redmond, Washington, and serves consumers, businesses, governments and educational institutions worldwide.
Microsoft’s productivity and business offerings include Microsoft 365 applications such as Word, Excel, PowerPoint and Outlook, along with collaboration tools including Teams.
Read More Five stocks we like better than Microsoft Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning? Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).
Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
Cumberland Partners Ltd lifted its holdings in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) by 18.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 176,987 shares of the software giant’s stock after purchasing an additional 27,230 shares during the quarter. Microsoft comprises about 4.3% of Cumberland Partners Ltd’s holdings, making the stock its 3rd biggest holding. Cumberland Partners Ltd’s holdings in Microsoft were worth $66,020,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Friedenthal Financial boosted its position in Microsoft by 6.2% in the 1st quarter. Friedenthal Financial now owns 431 shares of the software giant’s stock valued at $160,000 after buying an additional 25 shares during the period. Sequent Planning LLC grew its stake in shares of Microsoft by 0.7% in the first quarter. Sequent Planning LLC now owns 3,733 shares of the software giant’s stock worth $1,382,000 after acquiring an additional 25 shares in the last quarter. Riverpoint Wealth Management Holdings LLC increased its position in shares of Microsoft by 0.5% during the first quarter. Riverpoint Wealth Management Holdings LLC now owns 5,543 shares of the software giant’s stock worth $2,052,000 after acquiring an additional 26 shares during the period. American Investment Services Inc. increased its position in shares of Microsoft by 3.1% during the first quarter. American Investment Services Inc. now owns 876 shares of the software giant’s stock worth $324,000 after acquiring an additional 26 shares during the period. Finally, REAP Financial Group LLC raised its stake in shares of Microsoft by 1.1% in the second quarter. REAP Financial Group LLC now owns 2,453 shares of the software giant’s stock valued at $915,000 after acquiring an additional 26 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.
Analysts Set New Price Targets A number of research analysts recently issued reports on MSFT shares. Wells Fargo & Company lifted their target price on Microsoft from $700.00 to $725.00 and gave the company an “overweight” rating in a report on Thursday. Morgan Stanley restated an “overweight” rating on shares of Microsoft in a report on Thursday, July 30th. Mizuho reduced their price target on Microsoft from $515.00 to $490.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. Oppenheimer lifted their price objective on Microsoft from $515.00 to $570.00 and gave the company an “outperform” rating in a research note on Tuesday, September 22nd. Finally, TD Cowen reissued a “buy” rating and set a $540.00 price objective on shares of Microsoft in a research report on Thursday, July 30th. Forty-three analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $571.18.
Read Our Latest Stock Report on MSFT Insider Transactions at Microsoft In related news, CEO Satya Nadella sold 86,525 shares of the company’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $501.46, for a total value of $43,388,826.50. Following the completion of the sale, the chief executive officer directly owned 486,763 shares of the company’s stock, valued at $244,092,173.98. This represents a 15.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Judson Althoff sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total value of $4,878,900.00. Following the transaction, the chief executive officer owned 100,447 shares in the company, valued at $49,007,086.83. This represents a 9.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 143,009 shares of company stock worth $71,420,699. 0.03% of the stock is owned by company insiders.
Key Headlines Impacting Microsoft Here are the key news stories impacting Microsoft this week:
Positive Sentiment: Azure and AI demand remain the primary catalyst. Investor data and analyst commentary point to accelerating Azure demand, while Microsoft’s recent earnings showed its fastest cloud growth in four years. The improving demand is helping ease concerns that the company’s substantial AI infrastructure spending will not generate adequate returns. Ca$htag: MSFT Azure Cloud Drives Soaring Demand Positive Sentiment: Wells Fargo added Microsoft to its Q4 Tactical Ideas list and raised its price target to $725, citing Azure’s growth potential and the prospect of improved AI monetization through Copilot. The action adds to a series of bullish analyst revisions; one report noted that 52 analysts covering Microsoft currently have no sell ratings. With Azure as a Catalyst, Microsoft Is Positioned for Sustained Growth Positive Sentiment: Microsoft’s OpenAI relationship provides potential additional value. Investors are increasingly focused on Microsoft’s stake and commercial partnership with OpenAI, particularly ahead of a possible OpenAI initial public offering that could provide a market reference for the investment. OpenAI’s Future IPO Keeps Me Buying Microsoft Positive Sentiment: Microsoft introduced new real-time AI speech models for customer-service agents, multilingual assistants and voice interfaces. The products broaden Microsoft’s enterprise AI offering and could support additional cloud consumption and software revenue. Microsoft Targets Contact Center Market With Real-Time AI Voice Models Neutral Sentiment: Investors are awaiting Microsoft’s October 7 Surface and Windows event. New hardware or Windows updates could support the ecosystem, although the event has not yet produced a material earnings catalyst. Microsoft Stock Notches Up Ahead of the Surface Show Negative Sentiment: Risks include heavy AI capital spending, valuation concerns and broader market concentration. Critics argue that rising data-center capacity could pressure compute pricing and returns, while strategists warn that a market correction could disproportionately affect megacap technology stocks. Microsoft’s dividend remains affordable, but AI infrastructure spending and lease commitments could limit future dividend growth. Morgan Stanley Strategist Sees Market Drawdown Potential Microsoft Price Performance Shares of NASDAQ:MSFT opened at $517.53 on Monday. The firm has a 50 day simple moving average of $490.08 and a 200-day simple moving average of $430.19. Microsoft Corporation has a twelve month low of $349.20 and a twelve month high of $553.72. The company has a current ratio of 1.23, a quick ratio of 1.22 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $3.84 trillion, a PE ratio of 28.82, a P/E/G ratio of 1.66 and a beta of 1.10.
Microsoft (NASDAQ:MSFT – Get Free Report) last posted its earnings results on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, beating analysts’ consensus estimates of $4.24 by $0.50. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The firm had revenue of $90.01 billion for the quarter, compared to the consensus estimate of $87.62 billion. During the same period last year, the firm posted $3.65 EPS. The company’s revenue was up 17.7% on a year-over-year basis. On average, equities analysts predict that Microsoft Corporation will post 19.62 EPS for the current fiscal year.
Microsoft Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 10th. Shareholders of record on Thursday, November 19th will be issued a dividend of $0.98 per share. The ex-dividend date of this dividend is Thursday, November 19th. This is a positive change from Microsoft’s previous quarterly dividend of $0.91. This represents a $3.92 annualized dividend and a dividend yield of 0.8%. Microsoft’s dividend payout ratio is 20.27%.
Microsoft Profile (Free Report)
Microsoft Corporation is a global technology company that develops software, cloud services, devices, gaming products and business solutions. Founded in 1975 by Bill Gates and Paul Allen, the company is best known for the Windows operating system and Microsoft Office productivity software. Microsoft is headquartered in Redmond, Washington, and serves consumers, businesses, governments and educational institutions worldwide.
Microsoft’s productivity and business offerings include Microsoft 365 applications such as Word, Excel, PowerPoint and Outlook, along with collaboration tools including Teams.
Read More Five stocks we like better than Microsoft Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning? Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).
Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
Microsoft mění strategii AI na účtování podle využití, protože Copilot a další nástroje zatím nejsou v podnicích dost rozšířené. Nadella chce, aby byla AI nasazená napříč firmami, ne jen v několika produktech.
On a sunny day in Seattle in late September, about 50 executives representing large Microsoft customers had a rare opportunity. They could ask anything of CEO Satya Nadella.
One attendee wanted to know what Microsoft could do to help companies adapt to the artificial intelligence age. Nadella responded by emphasizing the importance of "diffusion inside the enterprise," meaning AI tools need to be widely deployed.
"Like all things, change is always bottom up, top down, and middle up," said Nadella, sporting a tight black crewneck and dark gray slacks, as he strode across the stage at the downtown Paccar Pavilion.
For the 59-year-old Nadella, who's spent over half his life at Microsoft, the gathering landed at a pivotal moment, as the software giant tries to magnify its role in the AI boom. Of late, Nadella has been inserting himself more into the AI discourse, posting on X last month about the need for "deliberate pacing" in model development, and days later addressing safety fears at the All-In Summit in Los Angeles.
Despite its almost $4 trillion market cap, Microsoft has yet to break out as an AI leader. Nvidia dominates in AI chips, Anthropic and OpenAI boast the foremost models, Meta just released the first mass-market personal agent, and Google's Gemini-powered services are popular with businesses and consumers.
Microsoft was aggressively early to AI through an investment in OpenAI, but that alliance has frayed. While the software giant has a big business in renting out chips for AI developers through its Azure cloud, its Copilot technology isn't pervasive in the workplace, and its proprietary AI models remain niche.
The company is hosting a Windows and Surface event in San Francisco on Wednesday, describing it in an invitation as "a conversation on how local AI will shape the next chapter of the PC."
Wall Street is lukewarm on the story. Even factoring in a sharp third-quarter rally, the stock is trailing its megacap peers and the broader Nasdaq this year, up just 7% as of Friday's close. Microsoft hasn't beaten the S&P 500 in a calendar year since 2023.
Nasdaq vs. S&P 500 since the end of 2023
Tiffany Wade, co-portfolio manager at Microsoft shareholder Columbia Threadneedle, said there are a lot of unknowns about Copilot, which is the centerpiece of Nadella's AI strategy.
"I think there needs to be a little bit more maturity of the product before we figure out actually what the best solution or what pricing is," Wade said in an interview.
For longtime Microsoft investors, Nadella has a solid track record when it comes to navigating industry shifts. He was named CEO in 2014, succeeding Steve Ballmer, who had presided over a roughly 33% drop in the stock price during his 14-year tenure, as Microsoft slipped into the beleaguered category of legacy software.
Nadella proceeded to turn Microsoft into a cloud powerhouse. He tossed aside perpetual Office software licenses and pushed the company into subscription-based software-as-a-service offerings alongside Azure infrastructure. And he permitted customers to integrate products from bitter rivals like Oracle and Salesforce, rather than insisting on a pure Microsoft stack.
Trained as an electrical engineer and computer scientist, Nadella became a savvy dealmaker, expanding Microsoft through acquisitions of "Minecraft"-maker Mojang, business social network LinkedIn and code-sharing service GitHub.
In recent months, Nadella has acknowledged to investors that he's got to change the business model yet again, this time to reflect the AI-fueled move toward consumption-based pricing. That means becoming a vendor of large volumes of tokens, which measure computing usage and represent the currency of the AI economy.
Success would mean "further expanding our TAM," Nadella said on Microsoft's July earnings call, adopting the acronym for total addressable market.
watch now
Much of the growth story Nadella preaches involves the production of software. Develop more code and do it faster, boosted by the latest and greatest AI tools.
"We went from the code assist to the agentic coding to software factory all within one year," Nadella said at the customer gathering late last month.
Now he wants to see Microsoft clients open their own software factories, spending more along the way to help churn out code. He's also hoping to empower non-technical knowledge workers. Some of Nadella's lieutenants at the event unveiled a Copilot "super app" that can perform increasingly complex tasks, generate simple applications and function as a virtual teammate.
Nadella had a preview of what was coming.
Microsoft first invested in OpenAI in 2019, when the company was still a fledgling lab. In 2021, a year before ChatGPT launched, Microsoft and OpenAI collaborated to release GitHub Copilot, a tool that could write parts of applications and websites based on vast swaths of public source code.
They'd created an early sensation. But as the generative AI market took off, developers moved to products from AI-native startups like Cursor, now owned by SpaceX, and Anthropic, which rolled out Claude Code.
'Learned lessons'Microsoft's sluggishness in keeping up with the rapid changes cost GitHub market share.
Earlier this year, Microsoft adjusted the pricing for the coding tool to align more with computing demand. Some customers initially balked, but by July the company said it had racked up 50 million users, up from 26 million last October, meaning that one in five on GitHub were on board.
Nadella said on the July earnings call that GitHub Copilot sales growth accelerated 60% from the previous quarter, with "significant consumption revenue after the new model went into effect."
"GitHub Copilot went out and learned lessons," said Kyle Daigle, the unit's operating chief, in an interview.
Daigle said GitHub employees shared their lessons with other teams at Microsoft that are eyeing consumption-based pricing schemes.
Hayete Gallot, Microsoft's executive vice president for security products, said the company will charge clients according to how intensely they use the technology.
"I always say to my team, when customers consume, it means we add value. And for me, the truth starts with customers," Gallot said. "If they don't consume, it means we're not giving value."
Currently, Microsoft's enterprise portfolio is reliant on subscriptions. For its core Microsoft 365 productivity suite, which includes Word, Excel and Teams, customers sign up for years at a time, and Copilot costs an extra $30 per person each month. Microsoft has 30 million Copilot seats. The commercial Office 365 base exceeds 450 million.
One area of uncertainty in Microsoft's AI roadmap revolves around Mustafa Suleyman.
Suleyman previously co-founded AI lab DeepMind, which Google bought in 2014. Nadella hired him in 2024 to lead AI initiatives as Microsoft's relationship with OpenAI was cooling.
Last year, Microsoft lost its status as OpenAI's exclusive cloud provider, and this year its license on OpenAI intellectual property became non-exclusive. That left the software company with a massive investment in the AI lab but less preferential treatment. Microsoft said in April that it continues to serve as OpenAI's "primary cloud partner."
Suleyman's group has rolled out models for coding, image generation and reasoning. This week he boasted on X that a new speech-to-text model was "the most accurate real time transcription model in the world... #1 !!!" But for raw digital intellect, the team has yet to rival Anthropic or OpenAI, according to independent leaderboards.
Microsoft executives say there are benefits to having model and application development under the same roof. The group building Teams and other Office productivity apps has seen higher performance from Suleyman's transcription models at a lower price, and engineers get clear feedback as they build out products, said Executive Vice President Charles Lamanna.
"The collaboration is much tighter with Mustafa," he said.
Suleyman maintains a high profile at Microsoft, but his responsibilities have shifted. In March, Microsoft announced that it was bringing together the engineering groups for its commercial and consumer Copilot assistants, as adoption had been sluggish. Jacob Andreou was promoted to executive vice president for Copilot experience, and Suleyman was charged with focusing on model development.
Nadella, meanwhile, has been downplaying the importance of world-beating models in isolation.
"In my view, our priority has to be building a frontier ecosystem, not just a frontier model, so value flows broadly across every company, every industry, and every country," he wrote in a post on his SN Scratchpad website in June.
At the September Copilot event, Nadella stood before a slide declaring that Copilot could connect to "every model," with the Anthropic, OpenAI, SpaceX and Microsoft AI logos.
Fixing the economicsIncreasingly, Microsoft is finding the model leaders encroaching on its turf, as they release products for cybersecurity, customer service and other functions.
In January, as Anthropic's Claude Code was building momentum, Microsoft executives were impressed with its ability to tap a bevy of tools to get things done, said Jared Spataro, Microsoft's marketing chief for AI at work. Microsoft was losing deals to Anthropic, promoting a close study of a rising competitor, said a person familiar with the matter, who asked not to be named due to confidentiality.
A Microsoft spokesperson declined to comment.
Spataro said the company sensed a need to change the mechanics.
"It became very clear to us at that moment. Like, oh wow, the economics are not going to be such that we're going to be able to offer now the best outcome within a fixed price per user per month," Spataro said. "We realized that we needed to start to think about the business model."
The company got cracking on a more comprehensive approach to consumption-based pricing that it calls usage-based billing, or UBB. The first UBB product was Copilot Cowork, which accepts large productivity assignments and shows its progress, Spataro said.
Nadella said on the July earnings call that "earlier this month, we added usage-based billing to Cowork with thousands of customers already paying for and actively using it."
Derrick Wood, an analyst at Cowen, said it was a strong signal.
"It may have the effect of what we saw when Claude Code, for example, shifted to consumption pricing, and you saw token bills go significantly higher," said Wood, who recommends buying Microsoft shares. "There's definitely the possibility for that to happen with Cowork."
Nadella is a user. On a podcast recorded after the September event, he said he can ask Cowork to prepare a supply chain optimization spreadsheet showing multiple scenarios.
"It'll create a fantastic artifact," he said.
David Berry, a vice president at advisory group Directions on Microsoft, said budget-conscious IT executives aren't all ready to take the Cowork plunge.
"There's a very real concern that you just kind of turn it on and people are going to start draining the bank," Berry said. "There's no way to determine if people are actually getting any benefit from it."
With the ChatGPT era nearing its four-year anniversary, Microsoft is still looking for a smash hit, whether at the model or application layer. While Nadella earned investor trust in reviving Microsoft once, he can't afford to let the company become an also-ran in AI.
Berry said he still sees Nadella as the right person to command the ship.
"He seems to be able to handle the situations or identify the situations and come up with a plan to change and evolve the business," he said. "The challenge is we're facing a lot more of the unknowns in a sense with AI, so it's a lot of different market dynamics going on, but he seems to have a plan, and he's working the plan."
In Seattle, Nadella ended his response to the transformation question by saying that those at the top of organizations play a key role.
"Leaders who are hands-on are able to change," he said. "Otherwise, they're all from press event to press event, right?"
He added, "It's kind of like you've got to be in it."
AMD má pro OpenAI a Meta opce až na 320 milionů akcií za 0,01 USD, což by při plném uplatnění zvýšilo počet akcií zhruba na 1,95 miliardy. Vše ale závisí na dodávkách GPU a splnění podmínek.
When Advanced Micro Devices (AMD +2.95%) agreed in October 2025 to supply OpenAI with up to 6 gigawatts of its artificial intelligence (AI) chips, it also gave OpenAI a warrant for up to 160 million AMD shares at $0.01 each. In February, Meta Platforms (META +0.30%) signed on for up to another 6 gigawatts and got a similar deal.
The last batch of shares under each warrant carries a $600 stock price threshold. This looked far off when the OpenAI deal was announced, with AMD stock near $165. But the stock first closed above $600 on Sept. 21, and it traded around $616 as of this writing.
At that price, 320 million shares would be worth about $197 billion.
Image source: Advanced Micro Devices Inc.
AMD stock is already past $600The two warrants work nearly the same way. Each covers up to 160 million shares at an exercise price of a penny. The first tranche vests with the customer's first gigawatt of AMD Instinct graphics processing units (GPUs), and all 160 million shares vest only when its purchases hit 6 gigawatts. A gigawatt measures the electricity a data center draws, so it sizes a deployment by power instead of by chip count.
Each tranche also has a stock price threshold, and those climb to $600 for the final tranche. OpenAI's warrant adds separate stock-performance thresholds on top of that. OpenAI and Meta have technical and commercial conditions to meet, too, before vested shares can be exercised. OpenAI's warrant runs through Oct. 5, 2030, and Meta's through Feb. 23, 2031.
As of June 27, no warrant shares had vested, according to AMD's latest quarterly filing. That's not a surprise, because shipments for both customers' first gigawatt were set to start in the second half of this year. But with the stock over $600, I think the GPU deliveries now matter more for vesting than the share price does.
AMD had around 1.63 billion shares outstanding as of July 29, according to its second-quarter 10-Q. Adding 320 million would bring the total to around 1.95 billion.
In other words, OpenAI and Meta might wind up owning around 16% of the enlarged company. Every current share's claim on AMD's profit would drop by about the same 16%, with the same earnings spread among more shares.
And buybacks can't help much. AMD bought back just $221 million of its stock in the first half of 2026. Even the $9.2 billion left on its authorization as of June 27 would retire only around 15 million shares at about $616 per share.
Meanwhile, AMD's pending all-stock purchase of AI research lab World Labs, valued at about $8.2 billion, might add roughly 13 million extra shares at this price.
12 gigawatts of GPUsThe warrant shares only appear if the GPUs ship, though.
"[I]n terms of the revenue per gigawatt, I think we've said double-digit billions. We're still in that range," CEO Lisa Su said on AMD's second-quarter earnings call in August.
Even at the bottom of that range, 12 gigawatts comes to at least $120 billion in revenue before every warrant share vests. That's more than seven times the $16.6 billion AMD's data center segment brought in during all of 2025.
And the segment is gaining speed. Data center revenue climbed from $5.4 billion in Q4 2025 to $5.8 billion in Q1 2026 and $6.7 billion in Q2 -- more than doubling year over year in that latest quarter. Sequential growth accelerated from around 7% to 16%.
Sure, AMD is giving up lots of stock for these sales. Split evenly, 320 million shares across 12 gigawatts is around 27 million shares a gigawatt, or about $16 billion in stock at $616 a share. AMD hasn't revealed the size of each tranche, so the real number per gigawatt might differ.
Management argues the trade pays off. When the OpenAI deal was announced, CFO Jean Hu said it was "expected to be highly accretive to AMD's non-GAAP earnings-per-share." In other words, the extra profit should more than make up for the extra shares.
Premium Feature
Moneyball Superscore
94/100
Today's Change
(
2.95
%) $
18.18
Current Price
$
633.91
The dilution isn't my top worryI think management's case is plausible. After all, the warrant shares can only exist if AMD delivers the sales behind them.
My bigger concern is the price. AMD stock costs around 40 times the earnings analysts expect for 2027. If all 320 million warrant shares existed now, the same profit would put the stock closer to 47 times earnings.
The stock is also already past the $600 mark set for the last tranche. But at around $616 per share, I think investors are paying now for gigawatts AMD still needs to deliver over the next several years.
Oriental Harbor Investment Master Fund ve 2. čtvrtletí snížil podíl v NVIDIA o 15,7 % a prodal 201 882 akcií. Po transakci držel 1 083 827 akcií v hodnotě 216,863,000 USD.
Oriental Harbor Investment Master Fund reduced its stake in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 15.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,083,827 shares of the computer hardware maker’s stock after selling 201,882 shares during the period. NVIDIA makes up approximately 13.1% of Oriental Harbor Investment Master Fund’s portfolio, making the stock its 3rd biggest position. Oriental Harbor Investment Master Fund’s holdings in NVIDIA were worth $216,863,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also made changes to their positions in the stock. Bank of America Corp DE boosted its position in shares of NVIDIA by 2.1% during the first quarter. Bank of America Corp DE now owns 191,200,989 shares of the computer hardware maker’s stock worth $33,345,453,000 after buying an additional 4,019,505 shares during the period. Invesco Ltd. raised its holdings in shares of NVIDIA by 0.3% in the 4th quarter. Invesco Ltd. now owns 143,239,504 shares of the computer hardware maker’s stock valued at $26,714,167,000 after buying an additional 446,178 shares during the period. Amundi lifted its stake in NVIDIA by 10.4% during the 1st quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock worth $23,329,141,000 after acquiring an additional 12,575,177 shares in the last quarter. J. Stern & Co. LLP grew its position in NVIDIA by 13,709.1% in the 4th quarter. J. Stern & Co. LLP now owns 125,760,307 shares of the computer hardware maker’s stock valued at $23,454,297,000 after acquiring an additional 124,849,603 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in NVIDIA by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 94,521,253 shares of the computer hardware maker’s stock worth $16,479,126,000 after purchasing an additional 555,221 shares during the period. 65.27% of the stock is currently owned by institutional investors and hedge funds.
NVIDIA Price Performance Shares of NVDA opened at $233.95 on Monday. The firm has a market capitalization of $5.64 trillion, a price-to-earnings ratio of 29.58, a PEG ratio of 1.81 and a beta of 2.22. The firm’s fifty day simple moving average is $218.74 and its 200-day simple moving average is $207.65. NVIDIA Corporation has a twelve month low of $164.27 and a twelve month high of $237.88. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14.
NVIDIA (NASDAQ:NVDA – Get Free Report) last issued its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.09 by $0.13. The firm had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The company’s revenue was up 105.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.05 earnings per share. Equities analysts forecast that NVIDIA Corporation will post 9.25 EPS for the current fiscal year. NVIDIA announced that its board has authorized a share repurchase program on Monday, September 28th that authorizes the company to buyback $150.00 billion in outstanding shares. This buyback authorization authorizes the computer hardware maker to buy up to 2.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its shares are undervalued.
NVIDIA Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Thursday, September 10th. NVIDIA’s payout ratio is 12.64%.
Insider Transactions at NVIDIA In other news, Director Mark A. Stevens sold 622,239 shares of the firm’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $231.62, for a total transaction of $144,122,997.18. Following the sale, the director owned 2,336,531 shares of the company’s stock, valued at approximately $541,187,310.22. This trade represents a 21.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Timothy S. Teter sold 30,460 shares of the business’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $222.80, for a total value of $6,786,488.00. Following the sale, the executive vice president owned 2,687,660 shares of the company’s stock, valued at approximately $598,810,648. The trade was a 1.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,766,118 shares of company stock valued at $399,450,353. 3.94% of the stock is currently owned by corporate insiders.
Key Headlines Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Analysts Set New Price Targets NVDA has been the topic of several research reports. Wells Fargo & Company set a $210.00 price target on shares of NVIDIA in a research report on Friday. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of NVIDIA in a research note on Monday, August 31st. Itau BBA Securities decreased their price target on shares of NVIDIA from $256.00 to $218.00 in a research report on Wednesday, June 24th. UBS Group set a $300.00 price target on shares of NVIDIA and gave the stock a “buy” rating in a research note on Thursday, August 27th. Finally, Piper Sandler initiated coverage on NVIDIA in a research report on Wednesday, September 9th. They set an “overweight” rating and a $300.00 price objective on the stock. Four analysts have rated the stock with a Strong Buy rating, fifty have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $320.71.
View Our Latest Research Report on NVDA
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Recommended Stories Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Fischer Financial Services Inc. grew its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 3.0% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 109,580 shares of the computer hardware maker’s stock after acquiring an additional 3,197 shares during the quarter. NVIDIA comprises about 5.5% of Fischer Financial Services Inc.’s portfolio, making the stock its 6th biggest holding. Fischer Financial Services Inc.’s holdings in NVIDIA were worth $21,926,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. Lifetime Wealth Management P.C. bought a new position in NVIDIA in the fourth quarter valued at approximately $26,000. Longview Financial Advisors Inc. bought a new position in shares of NVIDIA in the 1st quarter valued at $27,000. Langley Wealth Management LLC bought a new position in shares of NVIDIA in the 2nd quarter valued at $34,000. Phillip James Consulting Co. acquired a new position in shares of NVIDIA during the 1st quarter worth $40,000. Finally, Frankly Finances LLC acquired a new position in NVIDIA during the second quarter worth about $60,000. 65.27% of the stock is owned by institutional investors.
NVIDIA Stock Performance NASDAQ NVDA opened at $233.95 on Monday. The firm has a market capitalization of $5.64 trillion, a PE ratio of 29.58, a price-to-earnings-growth ratio of 1.81 and a beta of 2.22. The business’s 50-day moving average price is $218.74 and its two-hundred day moving average price is $207.65. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14. NVIDIA Corporation has a 12 month low of $164.27 and a 12 month high of $237.88.
NVIDIA (NASDAQ:NVDA – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.13. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%.The company had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same period last year, the company earned $1.05 earnings per share. The firm’s revenue was up 105.9% compared to the same quarter last year. On average, analysts expect that NVIDIA Corporation will post 9.25 EPS for the current year. NVIDIA Announces Dividend The company also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Thursday, September 10th were given a $0.25 dividend. The ex-dividend date was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. NVIDIA’s payout ratio is 12.64%.
NVIDIA declared that its Board of Directors has initiated a stock buyback program on Monday, September 28th that authorizes the company to buyback $150.00 billion in outstanding shares. This buyback authorization authorizes the computer hardware maker to purchase up to 2.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.
Analysts Set New Price Targets NVDA has been the subject of a number of research reports. Sanford C. Bernstein reissued a “buy” rating on shares of NVIDIA in a report on Monday, September 21st. Mizuho set a $315.00 price target on shares of NVIDIA and gave the stock an “outperform” rating in a report on Thursday, August 27th. Piper Sandler began coverage on NVIDIA in a research note on Wednesday, September 9th. They issued an “overweight” rating and a $300.00 price target for the company. BMO Capital Markets set a $340.00 price objective on NVIDIA and gave the company an “outperform” rating in a report on Thursday, August 20th. Finally, China Renaissance boosted their price objective on NVIDIA from $319.00 to $330.00 and gave the stock a “buy” rating in a research report on Monday, August 31st. Four analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $320.71.
View Our Latest Stock Report on NVDA
Key Stories Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Insider Activity In other news, CFO Colette Kress sold 34,918 shares of NVIDIA stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $219.05, for a total value of $7,648,787.90. Following the completion of the transaction, the chief financial officer directly owned 765,103 shares of the company’s stock, valued at approximately $167,595,812.15. This trade represents a 4.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark A. Stevens sold 622,239 shares of the firm’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the sale, the director directly owned 2,336,531 shares of the company’s stock, valued at $541,187,310.22. This represents a 21.03% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 1,766,118 shares of company stock valued at $399,450,353. 3.94% of the stock is currently owned by insiders.
NVIDIA Company Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Featured Stories Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning? Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Advisors Capital Management LLC raised its holdings in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 4.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,271,599 shares of the computer hardware maker’s stock after purchasing an additional 54,830 shares during the period. NVIDIA comprises about 2.7% of Advisors Capital Management LLC’s portfolio, making the stock its 4th largest holding. Advisors Capital Management LLC’s holdings in NVIDIA were worth $254,434,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of NVDA. Lifetime Wealth Management P.C. bought a new position in shares of NVIDIA in the fourth quarter valued at approximately $26,000. Longview Financial Advisors Inc. acquired a new position in shares of NVIDIA during the first quarter valued at approximately $27,000. Phillip James Consulting Co. bought a new stake in NVIDIA during the first quarter worth approximately $40,000. Frankly Finances LLC bought a new stake in NVIDIA during the second quarter worth approximately $60,000. Finally, Lam Group Inc. acquired a new stake in NVIDIA in the first quarter worth approximately $77,000. 65.27% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth Several equities analysts have recently issued reports on the company. KeyCorp reiterated an “overweight” rating and set a $330.00 price target on shares of NVIDIA in a research report on Monday, August 24th. HSBC upped their price objective on NVIDIA from $360.00 to $365.00 in a report on Thursday, August 27th. China Renaissance raised their target price on NVIDIA from $319.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, August 31st. JPMorgan Chase & Co. lifted their target price on NVIDIA from $280.00 to $320.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. Finally, UBS Group set a $300.00 price target on shares of NVIDIA and gave the company a “buy” rating in a report on Thursday, August 27th. Four analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $320.71.
View Our Latest Stock Analysis on NVDA More NVIDIA News Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution NVIDIA Stock Performance Shares of NASDAQ NVDA opened at $233.95 on Monday. The company has a quick ratio of 3.85, a current ratio of 4.59 and a debt-to-equity ratio of 0.14. NVIDIA Corporation has a 12 month low of $164.27 and a 12 month high of $237.88. The company has a market cap of $5.64 trillion, a price-to-earnings ratio of 29.58, a P/E/G ratio of 1.81 and a beta of 2.22. The business has a fifty day simple moving average of $218.74 and a 200-day simple moving average of $207.65.
NVIDIA (NASDAQ:NVDA – Get Free Report) last released its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.13. The business had revenue of $96.22 billion for the quarter, compared to the consensus estimate of $92.27 billion. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The firm’s quarterly revenue was up 105.9% compared to the same quarter last year. During the same period last year, the firm posted $1.05 earnings per share. Sell-side analysts predict that NVIDIA Corporation will post 9.25 EPS for the current year.
NVIDIA Announces Dividend The business also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Thursday, September 10th were paid a $0.25 dividend. The ex-dividend date of this dividend was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. NVIDIA’s dividend payout ratio is 12.64%.
NVIDIA declared that its board has approved a share repurchase program on Monday, September 28th that permits the company to repurchase $150.00 billion in outstanding shares. This repurchase authorization permits the computer hardware maker to buy up to 2.8% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.
Insider Buying and Selling In other NVIDIA news, EVP Timothy S. Teter sold 30,460 shares of the business’s stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $222.80, for a total value of $6,786,488.00. Following the transaction, the executive vice president owned 2,687,660 shares in the company, valued at $598,810,648. The trade was a 1.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Colette Kress sold 34,918 shares of the firm’s stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $219.05, for a total value of $7,648,787.90. Following the sale, the chief financial officer directly owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,766,118 shares of company stock worth $399,450,353. Corporate insiders own 3.94% of the company’s stock.
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Featured Stories Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Asahi Life Asset Management ve 2. čtvrtletí snížila podíl v NVIDIA o 5,6 % a prodala 2 716 akcií. Po prodeji držela 45 848 akcií v hodnotě 9,174 milionu USD.
Asahi Life Asset Management CO. LTD. lessened its holdings in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 5.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,848 shares of the computer hardware maker’s stock after selling 2,716 shares during the quarter. NVIDIA comprises approximately 5.2% of Asahi Life Asset Management CO. LTD.’s portfolio, making the stock its 3rd biggest holding. Asahi Life Asset Management CO. LTD.’s holdings in NVIDIA were worth $9,174,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the business. Financial Alternatives Inc boosted its holdings in NVIDIA by 24.9% during the 2nd quarter. Financial Alternatives Inc now owns 3,192 shares of the computer hardware maker’s stock valued at $639,000 after acquiring an additional 636 shares during the period. MSH Capital Advisors LLC grew its position in NVIDIA by 55.6% during the 2nd quarter. MSH Capital Advisors LLC now owns 31,284 shares of the computer hardware maker’s stock worth $6,260,000 after acquiring an additional 11,177 shares during the last quarter. Strategic Equity Management increased its stake in NVIDIA by 24.9% in the 2nd quarter. Strategic Equity Management now owns 1,772 shares of the computer hardware maker’s stock worth $355,000 after purchasing an additional 353 shares during the period. Toews Corp ADV purchased a new position in NVIDIA in the 2nd quarter worth approximately $479,000. Finally, Edmond DE Rothschild Holding S.A. lifted its position in NVIDIA by 17.9% in the second quarter. Edmond DE Rothschild Holding S.A. now owns 1,537,950 shares of the computer hardware maker’s stock valued at $307,728,000 after purchasing an additional 233,722 shares during the last quarter. Hedge funds and other institutional investors own 65.27% of the company’s stock.
Insider Buying and Selling at NVIDIA In related news, CFO Colette Kress sold 34,918 shares of NVIDIA stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the sale, the chief financial officer directly owned 765,103 shares in the company, valued at $167,595,812.15. The trade was a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark A. Stevens sold 622,239 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the completion of the sale, the director directly owned 2,336,531 shares in the company, valued at approximately $541,187,310.22. The trade was a 21.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 1,766,118 shares of company stock valued at $399,450,353. 3.94% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes A number of research firms have recently weighed in on NVDA. UBS Group set a $300.00 price objective on NVIDIA and gave the company a “buy” rating in a research note on Thursday, August 27th. Wall Street Zen lowered shares of NVIDIA from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 26th. BMO Capital Markets set a $340.00 price target on shares of NVIDIA and gave the company an “outperform” rating in a report on Thursday, August 20th. Melius Research set a $420.00 price target on shares of NVIDIA in a research report on Thursday, August 27th. Finally, Morgan Stanley set a $230.00 price target on shares of NVIDIA in a report on Friday. Four investment analysts have rated the stock with a Strong Buy rating, fifty have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $320.71. Get Our Latest Stock Report on NVIDIA
NVIDIA Price Performance Shares of NASDAQ NVDA opened at $233.95 on Monday. The firm has a fifty day simple moving average of $218.74 and a two-hundred day simple moving average of $207.65. NVIDIA Corporation has a 12 month low of $164.27 and a 12 month high of $237.88. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $5.64 trillion, a PE ratio of 29.58, a price-to-earnings-growth ratio of 1.81 and a beta of 2.22.
NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The firm had revenue of $96.22 billion for the quarter, compared to analyst estimates of $92.27 billion. During the same quarter in the previous year, the firm posted $1.05 EPS. The company’s revenue for the quarter was up 105.9% compared to the same quarter last year. Equities analysts expect that NVIDIA Corporation will post 9.25 earnings per share for the current year.
NVIDIA announced that its Board of Directors has approved a share buyback plan on Monday, September 28th that allows the company to buyback $150.00 billion in outstanding shares. This buyback authorization allows the computer hardware maker to reacquire up to 2.8% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s management believes its stock is undervalued.
NVIDIA Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Thursday, September 10th. NVIDIA’s payout ratio is presently 12.64%.
NVIDIA News Roundup Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution NVIDIA Company Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
See Also Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Algebris UK Ltd. ve 2. čtvrtletí nově nakoupila 11 098 akcií NVIDIA za zhruba 2,214 milionu USD. Institucionální investoři nyní drží 65,27 % akcií společnosti.
Algebris UK Ltd. purchased a new position in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 11,098 shares of the computer hardware maker’s stock, valued at approximately $2,214,000.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Lifetime Wealth Management P.C. bought a new stake in shares of NVIDIA during the 4th quarter valued at about $26,000. Longview Financial Advisors Inc. bought a new stake in NVIDIA in the first quarter worth approximately $27,000. Langley Wealth Management LLC acquired a new position in NVIDIA in the second quarter valued at approximately $34,000. Phillip James Consulting Co. acquired a new position in NVIDIA in the first quarter valued at approximately $40,000. Finally, Frankly Finances LLC bought a new position in shares of NVIDIA during the 2nd quarter worth approximately $60,000. Institutional investors and hedge funds own 65.27% of the company’s stock.
Key NVIDIA News Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution NVIDIA Price Performance NVDA stock opened at $233.95 on Monday. NVIDIA Corporation has a twelve month low of $164.27 and a twelve month high of $237.88. The company has a quick ratio of 3.85, a current ratio of 4.59 and a debt-to-equity ratio of 0.14. The stock’s 50 day moving average is $218.74 and its 200-day moving average is $207.65. The firm has a market capitalization of $5.64 trillion, a PE ratio of 29.58, a P/E/G ratio of 1.81 and a beta of 2.22. NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.09 by $0.13. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%.The business had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same quarter in the prior year, the company posted $1.05 earnings per share. NVIDIA’s revenue was up 105.9% compared to the same quarter last year. Sell-side analysts expect that NVIDIA Corporation will post 9.25 EPS for the current fiscal year.
NVIDIA announced that its Board of Directors has initiated a stock buyback program on Monday, September 28th that authorizes the company to buyback $150.00 billion in shares. This buyback authorization authorizes the computer hardware maker to buy up to 2.8% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.
NVIDIA Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Thursday, September 10th. NVIDIA’s payout ratio is currently 12.64%.
Insider Transactions at NVIDIA In related news, CFO Colette Kress sold 34,918 shares of the firm’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the transaction, the chief financial officer directly owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy S. Teter sold 30,460 shares of NVIDIA stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the sale, the executive vice president directly owned 2,687,660 shares in the company, valued at approximately $598,810,648. This represents a 1.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,766,118 shares of company stock worth $399,450,353 in the last quarter. 3.94% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth Several analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of NVIDIA in a research report on Monday, August 31st. Piper Sandler started coverage on shares of NVIDIA in a research note on Wednesday, September 9th. They set an “overweight” rating and a $300.00 target price on the stock. Sanford C. Bernstein restated a “buy” rating on shares of NVIDIA in a report on Monday, September 21st. JPMorgan Chase & Co. lifted their price target on shares of NVIDIA from $280.00 to $320.00 and gave the company an “overweight” rating in a research note on Thursday, August 27th. Finally, KeyCorp reiterated an “overweight” rating and set a $330.00 price objective on shares of NVIDIA in a report on Monday, August 24th. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $320.71.
Get Our Latest Analysis on NVDA
NVIDIA Company Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Featured Stories Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Trillium Asset Management ve 2. čtvrtletí snížila podíl v NVIDIA o 18,3 % a prodala 266 278 akcií. Po prodeji držela 1 192 453 akcií v hodnotě 238,6 milionu USD.
Trillium Asset Management LLC cut its stake in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 18.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,192,453 shares of the computer hardware maker’s stock after selling 266,278 shares during the period. NVIDIA makes up approximately 7.3% of Trillium Asset Management LLC’s holdings, making the stock its largest holding. Trillium Asset Management LLC’s holdings in NVIDIA were worth $238,598,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the company. Lifetime Wealth Management P.C. purchased a new position in NVIDIA during the 4th quarter valued at about $26,000. Longview Financial Advisors Inc. acquired a new position in shares of NVIDIA in the first quarter valued at approximately $27,000. Langley Wealth Management LLC acquired a new position in shares of NVIDIA in the second quarter valued at approximately $34,000. Phillip James Consulting Co. purchased a new position in shares of NVIDIA during the first quarter valued at approximately $40,000. Finally, Frankly Finances LLC purchased a new position in shares of NVIDIA during the second quarter valued at approximately $60,000. Hedge funds and other institutional investors own 65.27% of the company’s stock.
More NVIDIA News Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Analyst Upgrades and Downgrades A number of equities research analysts have recently commented on the company. Raymond James Financial set a $515.00 price objective on NVIDIA and gave the company a “strong-buy” rating in a research report on Thursday, August 27th. Wells Fargo & Company set a $210.00 target price on shares of NVIDIA in a research note on Friday. Citigroup reiterated a “buy” rating and set a $315.00 target price (up from $300.00) on shares of NVIDIA in a report on Thursday, August 27th. Wedbush boosted their target price on shares of NVIDIA from $330.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. Finally, China Renaissance upped their target price on shares of NVIDIA from $319.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, August 31st. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $320.71. Get Our Latest Stock Analysis on NVDA
NVIDIA Price Performance Shares of NVDA opened at $233.95 on Monday. The firm has a market cap of $5.64 trillion, a price-to-earnings ratio of 29.58, a PEG ratio of 1.81 and a beta of 2.22. NVIDIA Corporation has a 52 week low of $164.27 and a 52 week high of $237.88. The stock has a 50 day moving average of $218.74 and a 200-day moving average of $207.65. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14.
NVIDIA (NASDAQ:NVDA – Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 EPS for the quarter, beating the consensus estimate of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The business had revenue of $96.22 billion during the quarter, compared to analyst estimates of $92.27 billion. During the same period in the previous year, the business posted $1.05 EPS. The company’s quarterly revenue was up 105.9% on a year-over-year basis. As a group, analysts forecast that NVIDIA Corporation will post 9.25 EPS for the current year.
NVIDIA Dividend Announcement The business also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Thursday, September 10th. NVIDIA’s payout ratio is 12.64%.
NVIDIA declared that its board has authorized a stock repurchase program on Monday, September 28th that permits the company to repurchase $150.00 billion in outstanding shares. This repurchase authorization permits the computer hardware maker to purchase up to 2.8% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.
Insiders Place Their Bets In other NVIDIA news, CFO Colette Kress sold 34,918 shares of the company’s stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $219.05, for a total value of $7,648,787.90. Following the completion of the sale, the chief financial officer directly owned 765,103 shares in the company, valued at $167,595,812.15. This represents a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy Teter sold 30,460 shares of the company’s stock in a transaction on Monday, September 21st. The shares were sold at an average price of $222.80, for a total value of $6,786,488.00. Following the completion of the sale, the executive vice president owned 2,687,660 shares of the company’s stock, valued at approximately $598,810,648. This trade represents a 1.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,766,118 shares of company stock worth $399,450,353 over the last ninety days. Company insiders own 3.94% of the company’s stock.
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Read More Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Oxford Financial Group LTD. LLC ve 2. čtvrtletí snížila podíl v NVIDIA o 23,6 % a prodala 27 153 akcií. Po prodeji držela 87 951 akcií v hodnotě 17,598 milionu USD.
Oxford Financial Group LTD. LLC reduced its holdings in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 23.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,951 shares of the computer hardware maker’s stock after selling 27,153 shares during the period. NVIDIA comprises about 0.9% of Oxford Financial Group LTD. LLC’s holdings, making the stock its 15th largest holding. Oxford Financial Group LTD. LLC’s holdings in NVIDIA were worth $17,598,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in NVDA. Kilter Group LLC lifted its position in NVIDIA by 5.9% in the 2nd quarter. Kilter Group LLC now owns 8,795 shares of the computer hardware maker’s stock worth $1,760,000 after buying an additional 491 shares in the last quarter. D L Carlson Investment Group Inc. grew its holdings in shares of NVIDIA by 0.6% during the 2nd quarter. D L Carlson Investment Group Inc. now owns 114,511 shares of the computer hardware maker’s stock valued at $22,912,000 after acquiring an additional 706 shares in the last quarter. Fischer Financial Services Inc. grew its holdings in shares of NVIDIA by 3.0% during the 2nd quarter. Fischer Financial Services Inc. now owns 109,580 shares of the computer hardware maker’s stock valued at $21,926,000 after acquiring an additional 3,197 shares in the last quarter. Ninepoint Partners LP acquired a new position in shares of NVIDIA in the second quarter worth $5,039,000. Finally, SGL Investment Advisors Inc. increased its position in NVIDIA by 1.4% in the 2nd quarter. SGL Investment Advisors Inc. now owns 40,345 shares of the computer hardware maker’s stock worth $8,777,000 after purchasing an additional 549 shares during the last quarter. Institutional investors and hedge funds own 65.27% of the company’s stock.
NVIDIA News Roundup Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Wall Street Analyst Weigh In Several brokerages have recently commented on NVDA. President Capital increased their price target on shares of NVIDIA from $295.00 to $330.00 in a research note on Thursday, August 27th. BMO Capital Markets set a $340.00 price target on NVIDIA and gave the stock an “outperform” rating in a research report on Thursday, August 20th. Raymond James Financial set a $515.00 target price on shares of NVIDIA and gave the company a “strong-buy” rating in a research note on Thursday, August 27th. Zacks Research raised shares of NVIDIA from a “hold” rating to a “strong-buy” rating in a report on Monday, September 21st. Finally, Weiss Ratings restated a “buy (b)” rating on shares of NVIDIA in a research report on Wednesday, July 8th. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $320.71. Read Our Latest Analysis on NVIDIA
Insider Activity at NVIDIA In other NVIDIA news, CFO Colette Kress sold 34,918 shares of the stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the sale, the chief financial officer owned 765,103 shares of the company’s stock, valued at $167,595,812.15. This represents a 4.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy S. Teter sold 30,460 shares of the firm’s stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the sale, the executive vice president owned 2,687,660 shares of the company’s stock, valued at $598,810,648. The trade was a 1.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,766,118 shares of company stock valued at $399,450,353 over the last ninety days. 3.94% of the stock is owned by insiders.
NVIDIA Stock Performance Shares of NASDAQ:NVDA opened at $233.95 on Monday. The business’s fifty day moving average price is $218.74 and its two-hundred day moving average price is $207.65. The company has a debt-to-equity ratio of 0.14, a current ratio of 4.59 and a quick ratio of 3.85. NVIDIA Corporation has a fifty-two week low of $164.27 and a fifty-two week high of $237.88. The stock has a market capitalization of $5.64 trillion, a price-to-earnings ratio of 29.58, a price-to-earnings-growth ratio of 1.81 and a beta of 2.22.
NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The firm had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same period last year, the firm posted $1.05 EPS. The firm’s quarterly revenue was up 105.9% on a year-over-year basis. As a group, analysts predict that NVIDIA Corporation will post 9.25 EPS for the current fiscal year.
NVIDIA Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Thursday, September 10th were paid a $0.25 dividend. The ex-dividend date was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. NVIDIA’s dividend payout ratio (DPR) is 12.64%.
NVIDIA declared that its Board of Directors has initiated a stock repurchase plan on Monday, September 28th that permits the company to buyback $150.00 billion in outstanding shares. This buyback authorization permits the computer hardware maker to reacquire up to 2.8% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.
NVIDIA Company Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Read More Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
PCM Encore LLC trimmed its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 3.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 129,660 shares of the computer hardware maker’s stock after selling 4,491 shares during the quarter. NVIDIA comprises 4.6% of PCM Encore LLC’s investment portfolio, making the stock its 2nd biggest holding. PCM Encore LLC’s holdings in NVIDIA were worth $25,944,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Bank of America Corp DE boosted its holdings in NVIDIA by 2.1% in the 1st quarter. Bank of America Corp DE now owns 191,200,989 shares of the computer hardware maker’s stock valued at $33,345,453,000 after purchasing an additional 4,019,505 shares in the last quarter. Invesco Ltd. lifted its stake in shares of NVIDIA by 0.3% in the fourth quarter. Invesco Ltd. now owns 143,239,504 shares of the computer hardware maker’s stock valued at $26,714,167,000 after purchasing an additional 446,178 shares during the period. J. Stern & Co. LLP boosted its stake in shares of NVIDIA by 13,709.1% during the 4th quarter. J. Stern & Co. LLP now owns 125,760,307 shares of the computer hardware maker’s stock worth $23,454,297,000 after acquiring an additional 124,849,603 shares in the last quarter. Amundi raised its holdings in NVIDIA by 10.4% during the first quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock worth $23,329,141,000 after purchasing an additional 12,575,177 shares during the last quarter. Finally, Deutsche Bank AG boosted its position in shares of NVIDIA by 2.3% in the 2nd quarter. Deutsche Bank AG now owns 91,954,159 shares of the computer hardware maker’s stock worth $18,399,108,000 after buying an additional 2,045,101 shares in the last quarter. Hedge funds and other institutional investors own 65.27% of the company’s stock.
Analyst Upgrades and Downgrades A number of research firms recently issued reports on NVDA. Jefferies Financial Group reaffirmed a “buy” rating on shares of NVIDIA in a research note on Wednesday, August 26th. Royal Bank Of Canada raised their price target on NVIDIA from $300.00 to $330.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Weiss Ratings restated a “buy (b)” rating on shares of NVIDIA in a report on Wednesday, July 8th. Piper Sandler assumed coverage on shares of NVIDIA in a research note on Wednesday, September 9th. They set an “overweight” rating and a $300.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of NVIDIA in a report on Monday, August 31st. Four research analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $320.71.
Check Out Our Latest Stock Analysis on NVDA Key Headlines Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution NVIDIA Stock Performance Shares of NVDA stock opened at $233.95 on Monday. The company’s fifty day simple moving average is $218.74 and its 200-day simple moving average is $207.65. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14. NVIDIA Corporation has a 52 week low of $164.27 and a 52 week high of $237.88. The company has a market cap of $5.64 trillion, a PE ratio of 29.58, a P/E/G ratio of 1.81 and a beta of 2.22.
NVIDIA (NASDAQ:NVDA – Get Free Report) last issued its earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.13. The company had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%.The company’s revenue was up 105.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.05 earnings per share. As a group, equities research analysts anticipate that NVIDIA Corporation will post 9.25 EPS for the current year.
NVIDIA Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th were issued a $0.25 dividend. The ex-dividend date was Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. NVIDIA’s payout ratio is currently 12.64%.
NVIDIA declared that its board has approved a share repurchase program on Monday, September 28th that permits the company to buyback $150.00 billion in outstanding shares. This buyback authorization permits the computer hardware maker to buy up to 2.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.
Insider Buying and Selling In other NVIDIA news, Director Mark A. Stevens sold 622,239 shares of NVIDIA stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $231.62, for a total transaction of $144,122,997.18. Following the sale, the director directly owned 2,336,531 shares in the company, valued at $541,187,310.22. The trade was a 21.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Colette Kress sold 34,918 shares of the stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $219.05, for a total value of $7,648,787.90. Following the transaction, the chief financial officer owned 765,103 shares of the company’s stock, valued at approximately $167,595,812.15. This trade represents a 4.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,766,118 shares of company stock worth $399,450,353. 3.94% of the stock is currently owned by corporate insiders.
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Read More Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Silvant Capital Management ve 2. čtvrtletí zvýšil podíl v NVIDIA o 1,9 % na 2 174 219 akcií. NVIDIA je nyní jeho největší pozicí s hodnotou 435,04 mil. USD.
Silvant Capital Management LLC increased its stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 1.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,174,219 shares of the computer hardware maker’s stock after buying an additional 40,560 shares during the quarter. NVIDIA accounts for 12.7% of Silvant Capital Management LLC’s investment portfolio, making the stock its largest holding. Silvant Capital Management LLC’s holdings in NVIDIA were worth $435,040,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. Impax Asset Management Group plc increased its stake in shares of NVIDIA by 2.2% during the 2nd quarter. Impax Asset Management Group plc now owns 3,722,756 shares of the computer hardware maker’s stock worth $744,886,000 after purchasing an additional 81,671 shares during the last quarter. KilterHowling LLC raised its stake in shares of NVIDIA by 2.6% in the second quarter. KilterHowling LLC now owns 8,185 shares of the computer hardware maker’s stock valued at $1,638,000 after buying an additional 211 shares during the period. Kilter Group LLC raised its stake in shares of NVIDIA by 5.9% in the second quarter. Kilter Group LLC now owns 8,795 shares of the computer hardware maker’s stock valued at $1,760,000 after buying an additional 491 shares during the period. D L Carlson Investment Group Inc. lifted its position in shares of NVIDIA by 0.6% during the 2nd quarter. D L Carlson Investment Group Inc. now owns 114,511 shares of the computer hardware maker’s stock valued at $22,912,000 after buying an additional 706 shares during the last quarter. Finally, Fischer Financial Services Inc. grew its stake in shares of NVIDIA by 3.0% during the 2nd quarter. Fischer Financial Services Inc. now owns 109,580 shares of the computer hardware maker’s stock worth $21,926,000 after acquiring an additional 3,197 shares during the period. 65.27% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades Several research firms recently commented on NVDA. Truist Financial raised their price objective on shares of NVIDIA from $307.00 to $346.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Daiwa Securities Group decreased their price objective on shares of NVIDIA from $255.00 to $245.00 and set an “outperform” rating on the stock in a research report on Thursday, September 17th. Cantor Fitzgerald restated an “overweight” rating and set a $350.00 price target on shares of NVIDIA in a research report on Thursday. Morgan Stanley set a $230.00 price objective on NVIDIA in a research report on Friday. Finally, JPMorgan Chase & Co. boosted their target price on NVIDIA from $280.00 to $320.00 and gave the stock an “overweight” rating in a research report on Thursday, August 27th. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $320.71.
Read Our Latest Analysis on NVIDIA Trending Headlines about NVIDIA Here are the key news stories impacting NVIDIA this week:
Positive Sentiment: Morgan Stanley named NVIDIA its top semiconductor pick, maintaining an Overweight rating and setting a $300 price target. The firm believes NVIDIA’s software ecosystem, scale and positioning across AI infrastructure trends give it a durable competitive moat. Morgan Stanley names NVIDIA a top pick Positive Sentiment: NVIDIA’s recently announced $150 billion buyback authorization lifts total remaining repurchase capacity to approximately $235 billion. Investors view the plan as a sign of management confidence and a potential source of per-share earnings support. NVIDIA buyback analysis Positive Sentiment: Analysts continue to raise expectations for hyperscaler spending, with Barclays estimating NVIDIA could generate $401 billion in hyperscaler revenue in 2027. CoreWeave’s launch of the Vera Rubin platform and additional enterprise customers also supports demand for NVIDIA’s next-generation systems. Barclays hyperscaler revenue estimate Neutral Sentiment: The broader semiconductor and technology complex is attracting buying interest as AI investment remains a major market leadership theme. However, NVIDIA’s valuation and substantial market concentration leave the stock sensitive to interest rates, economic data and shifts in institutional positioning. Negative Sentiment: Investors are monitoring reports that Amazon may move roughly $8 billion of NVIDIA chips off its balance sheet through leasing or financing structures. While this could improve customer flexibility, it adds scrutiny around AI infrastructure financing and so-called circular transactions. Amazon NVIDIA chip balance-sheet report Negative Sentiment: Export-control concerns remain a headline risk after prosecutors alleged a California man helped smuggle approximately $300 million of NVIDIA chips to China. Separately, Michael Burry warned that GPU depreciation could undermine the economics of the AI infrastructure boom, while Alphabet’s growing use of internally designed chips represents a longer-term competitive threat. NVIDIA chip smuggling prosecution Insider Buying and Selling In related news, Director Mark Stevens sold 622,239 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $231.62, for a total value of $144,122,997.18. Following the sale, the director directly owned 2,336,531 shares of the company’s stock, valued at $541,187,310.22. This represents a 21.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Timothy Teter sold 30,460 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the transaction, the executive vice president owned 2,687,660 shares of the company’s stock, valued at approximately $598,810,648. The trade was a 1.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,766,118 shares of company stock valued at $399,450,353 over the last ninety days. Company insiders own 3.94% of the company’s stock.
NVIDIA Stock Performance NASDAQ:NVDA opened at $233.95 on Monday. NVIDIA Corporation has a twelve month low of $164.27 and a twelve month high of $237.88. The company has a quick ratio of 3.85, a current ratio of 4.59 and a debt-to-equity ratio of 0.14. The firm’s fifty day simple moving average is $218.74 and its 200 day simple moving average is $207.65. The stock has a market cap of $5.64 trillion, a P/E ratio of 29.58, a price-to-earnings-growth ratio of 1.81 and a beta of 2.22.
NVIDIA (NASDAQ:NVDA – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The company had revenue of $96.22 billion during the quarter, compared to the consensus estimate of $92.27 billion. During the same period in the prior year, the firm earned $1.05 earnings per share. NVIDIA’s revenue was up 105.9% on a year-over-year basis. As a group, research analysts predict that NVIDIA Corporation will post 9.25 EPS for the current year.
NVIDIA Announces Dividend The company also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Thursday, September 10th were given a dividend of $0.25 per share. The ex-dividend date was Thursday, September 10th. This represents a $1.00 annualized dividend and a dividend yield of 0.4%. NVIDIA’s payout ratio is currently 12.64%.
NVIDIA declared that its board has initiated a stock repurchase plan on Monday, September 28th that allows the company to repurchase $150.00 billion in outstanding shares. This repurchase authorization allows the computer hardware maker to repurchase up to 2.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its stock is undervalued.
NVIDIA Profile (Free Report)
NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.
The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.
Further Reading Five stocks we like better than NVIDIA Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam? The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers? MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning? Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).
Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.
Canadian Goldfields dokončila odběr 329 půdních vzorků na projektu Miminiska a brzy zahájí plošný letecký magnetický průzkum, aby našla nové cíle pro další vrtání.
VANCOUVER, British Columbia, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Canadian Goldfields Discovery Corp. (TSX-V: CGM, OTCQB: CGMXF) (“Canadian Goldfields” or the “Company”) is pleased to announce the completion of soil geochemistry and upcoming commencement of a property-wide airborne magnetic survey at its 6,366-hectare Miminiska Gold Project in northwestern Ontario. The programs are intended to identify new exploration targets, support future drilling and further define regional controls on gold mineralization.
Construction of a winterized exploration camp is underway at Miminiska to support continued field activities and future drilling. Approximately 40% of current site staff are members of the Eabametoong First Nation (“EFN”).
Ian Dasti, Vice-President of Exploration, P.Geo., commented: “We have a 14-kilometre prospective trend at Miminiska with historical drilling concentrated at the Miminiska and Frond Zones, leaving more than 12 kilometres of strike largely untested. Our current programs are designed to systematically evaluate this broader opportunity. By integrating soil geochemistry with property-wide airborne magnetics and our existing geological data, we aim to improve our understanding of the controls on gold mineralization and advance growth-focused target generation for future drilling.”
Highlights
Growth-Focused Target Generation: Soil geochemistry and upcoming property-wide airborne magnetics will be integrated with geological data to develop new exploration targets for future drilling.Systematic Geochemical Coverage: 329 soil samples collected between Frond and Wottam Lake on a 50 m × 100 m grid, with assays pending.Property-Wide Airborne Geophysics: HeliGT airborne magnetic survey expected to commence before the end of October to further define geological and structural controls on gold mineralization.Winter Exploration Infrastructure: Winterized exploration camp under construction to support continued field activities and future drilling.Strong Local Participation: 40% of current Miminiska site staff are members of Eabametoong First Nation. Soil Geochemistry
The Company completed 329 soil samples, including quality-control samples, along 39 Ha of the prospective trend between Frond and Wottam Lake on a 50-metre by 100-metre grid. The program is designed to:
Initiate systematic geochemical coverage across prospective ground between Frond and Wottam Lake;Identify gold and trace-element geochemical patterns for follow-up exploration; andSupport target generation through integration with geological mapping, historical data and airborne geophysics. Samples have been submitted to Activation Laboratories Ltd. (“Actlabs”) for gold and trace-element analysis, with results anticipated before the end of October 2026.
Airborne Geophysics
The Company is preparing to commence a HeliGT airborne magnetic survey across the entire Miminiska Property using SHA Geophysics. The survey is designed to:
Provide high-resolution magnetic coverage across the 6,366-hectare Project;Further define geological and structural controls on gold mineralization; andSupport target generation through integration with soil geochemistry, geological mapping and historical data. The survey is expected to commence before the end of October 2026.
Winter Exploration Camp
Construction of the Company’s winterized exploration camp at Miminiska is underway to support continued field activities and future drilling.
Approximately 40% of current Miminiska site staff are members of Eabametoong First Nation (“EFN”). Canadian Goldfields continues to work collaboratively with EFN as exploration activities at Miminiska advance.
Selected Historical Drill Results
Approximately 28,000 metres of historical drilling has been completed at Miminiska, concentrated principally at the Miminiska and Frond Zones. Selected historical drill results are presented below. These results are historical in nature, have not been independently verified by the Qualified Person and are reported as core lengths that do not necessarily represent true widths.
AreaHole IDAzimuth (°)Dip (°)From (m)To (m)Interval (m)Au (g/t)Miminiska0603-08358.4-7051.9472.7820.845.75Miminiska88C-10315-5065.3869.343.9612.69Miminiska0603-18358.1-50120.57131.7511.184.49 including 120.57124.303.737.29Miminiska0604-32358-66235.78241.105.3213.95Frond87-13144-50125.79127.101.3114.74Frond87-10144-4567.7969.041.257.53Frond87-14144-6561.6662.000.3437.02Frond87-15144-7092.2093.150.9511.32 NI 43-101 Technical Report on the Miminiska Property, Northern Ontario, Canada, prepared by APEX Geoscience Ltd. for Canadian Goldfields, authored by Qualified Persons Edward Parker, B.Sc., P.Geo., and Eliza D. Verigeanu, M.Sc., P.Geo. Frond Zone results adapted from Neal & Miller Report, 1987. Effective date of December 1, 2025.
About Canadian Goldfields Discovery Corp.
Canadian Goldfields Discovery Corp. is a Canadian mineral exploration company focused on advancing district-scale gold opportunities in Ontario, Canada. The Company’s portfolio includes the flagship Miminiska Gold Project in northwestern Ontario and the Swayze Central Gold Property located within the prospective Swayze Greenstone Belt near Timmins.
Miminiska hosts a gold-rich banded iron formation (“BIF”) system with multiple high-grade intercepts drilled across the Miminiska and Frond Zones and more than 14 km of underexplored strike extent. Supported by approximately 28,000 m of historical drilling, the project demonstrates significant scale potential with mineralization remaining open along strike and at depth. The Swayze Central Gold Property complements the Company’s portfolio with historical high-grade gold occurrences and additional district-scale exploration upside in one of Canada’s most established mining regions.
Canadian Goldfields is led by a lean and execution-focused leadership team committed to disciplined exploration, systematic discovery and long-term value creation through the advancement of high-quality gold assets in tier-one mining jurisdictions.
On behalf of the Company,
John G. Booth, Chief Executive Officer and Director
Additional Information
Harp Gosal | Director of Capital Markets & Communications
Canadian Goldfields Discovery Corp.
Phone: (604) 218-1142
Email: [email protected]
Qualified Persons and Technical Disclosure
The scientific and technical information contained in this news release has been reviewed and approved by Ian Raymond Dasti, P.Geo, Vice-President of Exploration of Canadian Goldfields Discovery Corp., and a Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI-43101”).
Mr. Dasti has reviewed the technical information disclosed in this news release and has approved its dissemination. The information presented herein relates to planned exploration activities at the Company’s Miminiska Gold Project, including the design and objectives of the geochemical soil sampling program.
Historical exploration information referenced in this news release has been compiled from publicly available sources and historical reports. A Qualified Person has not completed sufficient work to independently verify all historical information, and the Company is not treating such information as current mineral resources or mineral reserves as defined by NI 43-101. Historical results, mineral occurrences, and exploration data should not be relied upon as indicative of future exploration results.
The Company considers historical exploration information to be relevant for the purpose of guiding future exploration programs; however, readers are cautioned that such information may not be representative of actual mineralization or exploration potential on the Property.
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by many material factors, many of which are beyond their respective control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the Company’s planned exploration program for the Miminiska Gold Property is subject to change. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company does not undertake to publicly update or revise forward-looking information.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
The Pentagon placed a massive bet on a single American company to break China's stranglehold on rare earth magnets, and General Motors is first in line to find out if that wager pays off.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
On July 10, 2025, the Department of Defense agreed to buy $400 million of convertible preferred stock in MP Materials (NYSE:MP), along with a ten-year warrant. The government’s projected ownership stake of 15% made it the company’s largest shareholder. The deal also included a $150 million loan to expand Mountain Pass and a 10-year commitment to buy all of the company’s output at $110/kg for neodymium-praseodymium (NdPr), the key rare earth input in permanent magnets.
General Motors (NYSE:GM | GM Price Prediction) is first in line for MP’s magnets, according to The Business Journals. The Pentagon deal and GM supply agreement fund different facilities on separate schedules.
Pentagon Capital Targets Mountain Pass and a Future Plant Pentagon money funds upgrades at Mountain Pass in California and a separate magnet plant called 10X. Commissioning at 10X is expected around 2028. The Department of War remains MP’s partner on the project.
GM’s Magnets Come From an Already Running Texas Plant GM’s magnets come from a different facility, and MP paid for it. The two companies signed their supply agreement in December 2021 and released the details in April 2022. MP backed the deal with a $700 million investment commitment of its own to supply magnets for GM’s Ultium-platform electric vehicles. MP began commercially producing rare earth metal for GM in 2024. Its Independence facility in Fort Worth has made neodymium-iron-boron magnets since December 2025, according to MP’s fourth-quarter 2025 earnings release filed with the SEC.
Reports on delivery timing conflict. In mid-September, The Business Journals reported that MP delivered its first magnets to GM from Fort Worth. Days later, GM Authority described GM as “About To” take delivery. On MP’s August earnings call, the CFO said regular production deliveries should begin sometime in the fourth quarter of 2026, starting at small volumes. No exact shipment date has been made public. The best reading of the record is that the milestone is underway or very close.
Mine to Magnet Under One Roof Co-founder and CEO James Litinsky said “no single entity” elsewhere handles the entire supply chain under one roof. MP is America’s only fully integrated rare earth producer, from mining and processing through metallization and magnet manufacturing. Its customers include Apple (NASDAQ:AAPL) and U.S. aerospace and defense contractors.
China has dominated rare earths since Deng Xiaoping’s 1992 comment that the Middle East has oil and China has rare earths. MP stopped selling concentrate to China in July 2025.
Stock Already Traded the Pentagon Story MP’s share price at each of its recent filings shows how the market responded. At its May 8, 2025 filing, before the agreement, shares stood at $23.90. At its August 7, 2025 filing, weeks after the deal, they were at $77.05. They were at $72.20 at the May 7, 2026 filing and $48.47 at the August 6, 2026 filing.
The shares closed at $46.98 on Friday, October 2, 2026, up 1.93% for the session. That close left them down 33.81% over one year and 14.13% over one month, for a market value of $8.37 billion. Over ten years, they are up 369.70%.
The stock ran up sharply on Pentagon news, then gave back much of the gain. MP rallied on unrelated headlines, including a 6% surge in late September as traders considered the critical minerals growth story, according to 24/7 Wall St.
China’s grip on the rare earth supply chain is the whole reason the Pentagon wrote the check, and we mapped out why the fix takes years, not weeks, in a free guide here: The Next Nvidia Playbook.
Amin Credits MP’s Pace for the Shorter Timeline GM’s chief supply officer Shilpan Amin said the full development cycle should have taken 8 years. The companies got there in 5 years because of MP’s pace. Litinsky said finding customers who believe in you is the “hardest thing” early on. GM signed as an anchor customer in 2021, before Washington invested capital, and that commitment cut the schedules.
The GM milestone shows Independence works. Government capital depends on 10X, still under construction and expected to begin commissioning around 2028.
Contact [email protected] for any questions or corrections.
A prominent fund manager went on live television to call Chevron and ExxonMobil cheap laggards, but the actual performance data from the past year tells a very different story about who is really falling behind.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
On CNBC on Friday, Oct. 2, Michael Cuggino, president of Permanent Portfolio Family of Funds, said energy stocks “have not kept up with the broader market even as we speak.” He used that point to recommend Chevron (NYSE:CVX | CVX Price Prediction) and ExxonMobil (NYSE:XOM) as cheap total-return plays. The performance numbers point the other way.
Oil Majors Have Outrun the Index by a Wide Margin As of Friday’s close on Oct. 2, Exxon is up more than 34% over the past year at $164.39. Chevron is up nearly 33% at $207.20. Over the same period, the S&P 500 gained less than 13%. Chevron also set a 52-week high of $214.06 on Sept. 11. Over the last month, the benchmark index edged up 0.75%, while Chevron lost 2.16% and Exxon gained 0.15%.
Cuggino’s Valuation Case Holds Up, With One Adjustment Cuggino’s argument is about price. He said both stocks trade at about 13 times next year’s earnings, with dividend yields of 3.5% and 2.5%. He compared that with an S&P 500 offering a 4.5% earnings yield. Checked against consensus 2027 EPS of $14.1367 for Chevron and $11.0760 for Exxon, both stocks trade closer to 15x. Their current yields are 3.42% and 2.53%. That is a little more expensive than the on-air figure, but still a discount to the market.
Others share his view. On Sept. 8, Jim Cramer called Chevron the portfolio version of a kicker: an excellent 3.44% yield that usually doesn’t move with the rest of the market.
Rising Earnings Estimates Explain the Rally Chevron’s second quarter brought adjusted EPS of $6.06, revenue up 51.4% to $67.20B, and free cash flow of $18.1 billion. Brent averaged $104 per barrel in the quarter. CEO Mike Wirth said: “Costs always matter. They always will.”
Analysts have been raising their numbers. The 2027 consensus for Chevron was $12.6254 90 days ago. Over the past 30 days, 10 analysts revised up and 3 revised down. Exxon CEO Darren Woods described a quarter with “more than $14 billion of earnings, more than $17 billion of free cash flow, and a more than $7 billion reduction in net debt.”
Microsoft Is Buying Chevron’s Power for AI Chevron signed a 20-year take-or-pay power purchase agreement with Microsoft (NASDAQ:MSFT). The deal covers 2.67 gigawatts of capacity for a West Texas data center complex, and Chevron expects “mid-teens returns.” Wirth said the company is ready “to help power American AI dominance.” The companies building AI depend on energy majors to grow, and this deal gives Chevron a long-dated source of committed revenue.
A Slide in Crude Would Undercut the Pitch WTI peaked at $102.13 in May and fallen to $83.9 by August. In its May outlook, the EIA forecast Brent averaging $79.39 in 2027. If prices follow that path, estimates shrink and today’s 15x multiple looks less cheap. Wall Street is also split: Chevron has 20 Buy ratings or Strong Buy ratings, while Exxon has 15 Hold ratings.
The stocks have already outpaced the market on returns. The case for owning them now rests on valuation, income and earnings revisions. Watch the third-quarter reports, where consensus calls for $4.7322 per share at Chevron and $3.6501 at Exxon.
Contact [email protected] for any questions or corrections.
